chrom,start,end,ref,alt,gene,transcript,exon,codon_change,aa_change,aa_length,impact,impact_severity,polyphen_pred,sift_pred,cadd13_phred,exac_all,interpro_domain,avsnp147,clinvar_sig,gnomad_genome_all,jostins,max_aaf_all,nod2,num_exac_het,num_exac_hom,primimmudef,veoibd,samples,inheritance_model,Ensembl,Gene description,Protein class,Biological process,RNA tissue specific ,Tissue RNA - colon ,Tissue RNA - duodenum ,Tissue RNA - esophagus ,Tissue RNA - lymph node ,Tissue RNA - rectum ,Tissue RNA - small intestine ,Tissue RNA - stomach 1 ,Tissue RNA - B-cells ,Tissue RNA - dendritic cells ,Tissue RNA - granulocytes ,Tissue RNA - monocytes ,Tissue RNA - NK-cells ,Tissue RNA - T-cells ,Interactor 1,Interactor 2,T Score,StringDb fxns,Fasta,Domains,cadd,cadd_score,strand,gene_symbol_source,variant_allele,biotype,hgnc_id,transcript_id,gene_id,consequence_terms,gene_symbol,provean_pred,protein_end,mpc_score,cdna_end,polyphen2_hdiv_pred,cds_start,vest4_score,phastcons30way_mammalian,fathmm_pred,polyphen_prediction,aloft_confidence,polyphen_score,phylop17way_primate,mutationassessor_pred,deogen2_pred,phastcons17way_primate,polyphen2_hvar_pred,phylop30way_mammalian,sift_score,sift_prediction,cdna_start,mvp_score,amino_acids,protein_start,aloft_pred,codons,sift4g_pred,phylop100way_vertebrate,phastcons100way_vertebrate,cds_end,flags,geuvadis_eqtl_target_gene,siphy_29way_logodds,eigen-pc-phred_coding,fathmm-mkl_coding_pred,dann_score,integrated_confidence_value,revel_score,metasvm_pred,integrated_fitcons_score,m-cap_pred,metalr_pred,mutationtaster_pred,genocanyon_score,fathmm-xf_coding_pred,mutpred_score,primateai_pred,lrt_pred,clinvar_omim_id,clinvar_trait,clinvar_review,clinvar_medgen_id,clinvar_orphanet_id,clinvar_clnsig,clinvar_id,gtex_v7_gene,gtex_v7_tissue,distance,veo_ibd
chrX,49228029,49228030,T,C,CACNA1F,ENST00000323022,,,,-/1966,LOW,MED,,,None,None,.,rs6609854,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000102001,Calcium voltage-gated channel subunit alpha1 F,"['Disease related genes', 'FDA approved drug targets', 'Plasma proteins', 'Predicted intracellular proteins', 'Predicted membrane proteins', 'Transporters', 'Voltage-gated ion channels']","['Calcium transport', 'Ion transport', 'Sensory transduction', 'Transport', 'Vision']",{'retina': '55.8'},1,1.9,0.7,2.7,1.5,3.7,1,1.4,4.6,2,0.9,0.5,1,"CACNG8,CACNB3,CACNB3,CACNB2,CACNB2,CACNB2,CACNA2D1,CACNA2D1,CACNA2D1,CACNA2D1,CACNA1F,CACNA1F,CACNA1F,CACNA1F,CACNA1F,CACNA2D4,CACNA2D4,CACNA2D4,CACNA2D4,CACNA2D4,CACNA2D4,CACNB1,CACNB1,CACNB1,CACNB1,CACNB1,CACNB1,CACNB1,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D3,CACNA2D3,CACNA2D3,CACNA2D3,CACNA2D3,CACNA2D3,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4","CACNG1,CACNG1,CACNG8,CACNG1,CACNG8,CACNB3,CACNG1,CACNG8,CACNB3,CACNB2,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNA1F,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNA1F,CACNA2D4,CACNG1,CACNG8,CACNB3,CACNB2,CACNA1F,CACNA2D4,CACNB1,CACNG1,CACNG8,CACNB3,CACNB2,CACNA1F,CACNB1,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNA1F,CACNA2D4,CACNB1,CACNA2D2,CACNA2D3","[0.761, 0.221, 0.241, 0.355, 0.459, 0.028796, 0.85, 0.552, 0.716, 0.794, 0.541, 0.31, 0.387, 0.532, 0.661, 0.63, 0.224, 0.757, 0.549, 0.20075, 0.698, 0.905, 0.645, 0.031234, 0.021924, 0.913, 0.542, 0.646, 0.758, 0.477, 0.514, 0.528, 0.502, 0.190938, 0.626, 0.629, 0.258, 0.498, 0.404, 0.318, 0.652, 0.642, 0.386, 0.028035, 0.01961, 0.673, 0.445, 0.591, 0.023199, 0.712, 0.507]","['photoreceptor outer segment', 'cell', 'plasma membrane', 'voltage-gated calcium channel complex', 'cilium', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'protein-containing complex', 'ion channel complex', 'cation channel complex', 'calcium channel complex', 'somatodendritic compartment', 'cell projection', 'neuron projection', 'neuronal cell body', 'perikaryon', 'organelle', 'cell body', 'organelle part', 'membrane part', 'ciliary part', 'plasma membrane part', 'cell projection part', 'cell part', 'cell periphery', 'neuron part', 'non-motile cilium', '9+0 non-motile cilium', 'photoreceptor cell cilium', 'membrane protein complex', 'plasma membrane protein complex', 'plasma membrane bounded cell projection', 'plasma membrane bounded cell projection part', 'transmembrane transporter complex', 'transporter complex', 'transporter activity', 'ion channel activity', 'voltage-gated ion channel activity', 'voltage-gated calcium channel activity', 'cation channel activity', 'calcium channel activity', 'binding', 'cation transmembrane transporter activity', 'high voltage-gated calcium channel activity', 'ion transmembrane transporter activity', 'calcium ion transmembrane transporter activity', 'channel activity', 'inorganic molecular entity transmembrane transporter activity', 'passive transmembrane transporter activity', 'voltage-gated channel activity', 'gated channel activity', 'substrate-specific channel activity', 'ion gated channel activity', 'voltage-gated cation channel activity', 'transmembrane transporter activity', 'inorganic cation transmembrane transporter activity', 'ion binding', 'cation binding', 'metal ion binding', 'metal ion transmembrane transporter activity', 'Voltage-dependent calcium channel, alpha-1 subunit', 'Voltage-dependent calcium channel, L-type, alpha-1 subunit', 'Ion transport domain', 'Voltage-dependent calcium channel, alpha-1 subunit, IQ domain', 'Voltage-dependent channel domain superfamily', 'Voltage-dependent L-type calcium channel, IQ-associated domain', 'Voltage-gated calcium channel subunit alpha, C-terminal', 'Alternative splicing', 'Calcium', 'Calcium channel', 'Calcium transport', 'Cone-rod dystrophy', 'Disease mutation', 'Glycoprotein', 'Ion transport', 'Ion channel', 'Membrane', 'Metal-binding', 'Phosphoprotein', 'Polymorphism', 'Repeat', 'Sensory transduction', 'Transmembrane', 'Transport', 'Vision', 'Voltage-gated channel', 'Congenital stationary night blindness', 'Disulfide bond', 'Transmembrane helix', 'Disease', 'Ion transport protein', 'Polycystin cation channel', 'Voltage gated calcium channel IQ domain', 'Voltage-gated calcium channel subunit alpha, C-term', 'Voltage-dependent L-type calcium channel, IQ-associated', 'action potential', 'leukocyte homeostasis', 'lymphocyte homeostasis', 'immune system process', 'regulation of immune system process', 'system process', 'transport', 'ion transport', 'cation transport', 'calcium ion transport', 'sensory perception', 'visual perception', 'response to radiation', 'response to light stimulus', 'detection of external stimulus', 'detection of abiotic stimulus', 'detection of light stimulus', 'detection of visible light', 'response to external stimulus', 'response to abiotic stimulus', 'regulation of signal transduction', 'regulation of cell communication', 'regulation of metal ion transport', 'regulation of transmembrane transporter activity', 'regulation of signaling', 'metal ion transport', 'regulation of transporter activity', 'negative regulation of transporter activity', 'regulation of ion transmembrane transporter activity', 'negative regulation of ion transmembrane transporter activity', 'multicellular organismal process', 'regulation of localization', 'ion transmembrane transport', 'regulation of transmembrane transport', 'negative regulation of transmembrane transport', 'regulation of ion transmembrane transport', 'negative regulation of ion transmembrane transport', 'regulation of membrane potential', 'homeostatic process', 'T cell homeostasis', 'regulation of ion transport', 'negative regulation of ion transport', 'negative regulation of molecular function', 'negative regulation of biological process', 'regulation of response to stimulus', 'homeostasis of number of cells', 'regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'regulation of antigen receptor-mediated signaling pathway', 'regulation of T cell receptor signaling pathway', 'nervous system process', 'response to stimulus', 'detection of stimulus involved in sensory perception', 'detection of light stimulus involved in visual perception', 'sensory perception of light stimulus', 'detection of light stimulus involved in sensory perception', 'regulation of transport', 'negative regulation of transport', 'localization', 'establishment of localization', 'detection of stimulus', 'membrane depolarization', 'regulation of calcium ion transport', 'negative regulation of calcium ion transport', 'transmembrane transport', 'biological regulation', 'regulation of biological quality', 'regulation of molecular function', 'calcium ion transmembrane transport', 'divalent metal ion transport', 'divalent inorganic cation transport', 'membrane depolarization during action potential', 'cation transmembrane transport', 'inorganic ion transmembrane transport', 'inorganic cation transmembrane transport', 'regulation of calcium ion transmembrane transporter activity', 'negative regulation of calcium ion transmembrane transporter activity', 'regulation of voltage-gated calcium channel activity', 'negative regulation of voltage-gated calcium channel activity', 'regulation of calcium ion transmembrane transport', 'negative regulation of calcium ion transmembrane transport', 'regulation of cation transmembrane transport', 'negative regulation of cation transmembrane transport', 'regulation of cation channel activity', 'negative regulation of cation channel activity', 'Muscle contraction', 'Cardiac conduction', 'Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase', 'Voltage gated calcium channel IQ domain']",MSESEGGKDTTPEPSPANGAGPGPEWGLCPGPPAVEGESSGASGLGTPKRRNQHSKHKTVAVASAQRSPRALFCLTLANPLRRSCISIVEWKPFDILILLTIFANCVALGVYIPFPEDDSNTANHNLEQVEYVFLVIFTVETVLKIVAYGLVLHPSAYIRNGWNLLDFIIVVVGLFSVLLEQGPGRPGDAPHTGGKPGGFDVKALRAFRVLRPLRLVSGVPSLHIVLNSIMKALVPLLHIALLVLFVIIIYAIIGLELFLGRMHKTCYFLGSDMEAEEDPSPCASSGSGRACTLNQTECRGRWPGPNGGITNFDNFFFAMLTVFQCVTMEGWTDVLYWMQDAMGYELPWVYFVSLVIFGSFFVLNLVLGVLSGEFSKEREKAKARGDFQKQREKQQMEEDLRGYLDWITQAEELDMEDPSADDNLGSMAEEGRAGHRPQLAELTNRRRGRLRWFSHSTRSTHSTSSHASLPASDTGSMTETQGDEDEEEGALASCTRCLNKIMKTRVCRRLRRANRVLRARCRRAVKSNACYWAVLLLVFLNTLTIASEHHGQPVWLTQIQEYANKVLLCLFTVEMLLKLYGLGPSAYVSSFFNRFDCFVVCGGILETTLVEVGAMQPLGISVLRCVRLLRIFKVTRHWASLSNLVASLLNSMKSIASLLLLLFLFIIIFSLLGMQLFGGKFNFDQTHTKRSTFDTFPQALLTVFQILTGEDWNVVMYDGIMAYGGPFFPGMLVCIYFIILFICGNYILLNVFLAIAVDNLASGDAGTAKDKGGEKSNEKDLPQENEGLVPGVEKEEEEGARREGADMEEEEEEEEEEEEEEEEEGAGGVELLQEVVPKEKVVPIPEGSAFFCLSQTNPLRKGCHTLIHHHVFTNLILVFIILSSVSLAAEDPIRAHSFRNHILGYFDYAFTSIFTVEILLKMTVFGAFLHRGSFCRSWFNMLDLLVVSVSLISFGIHSSAISVVKILRVLRVLRPLRAINRAKGLKHVVQCVFVAIRTIGNIMIVTTLLQFMFACIGVQLFKGKFYTCTDEAKHTPQECKGSFLVYPDGDVSRPLVRERLWVNSDFNFDNVLSAMMALFTVSTFEGWPALLYKAIDAYAEDHGPIYNYRVEISVFFIVYIIIIAFFMMNIFVGFVIITFRAQGEQEYQNCELDKNQRQCVEYALKAQPLRRYIPKNPHQYRVWATVNSAAFEYLMFLLILLNTVALAMQHYEQTAPFNYAMDILNMVFTGLFTIEMVLKIIAFKPKHYFTDAWNTFDALIVVGSIVDIAVTEVNNGGHLGESSEDSSRISITFFRLFRVMRLVKLLSKGEGIRTLLWTFIKSFQALPYVALLIAMIFFIYAVIGMQMFGKVALQDGTQINRNNNFQTFPQAVLLLFRCATGEAWQEIMLASLPGNRCDPESDFGPGEEFTCGSNFAIAYFISFFMLCAFLIINLFVAVIMDNFDYLTRDWSILGPHHLDEFKRIWSEYDPGAKGRIKHLDVVALLRRIQPPLGFGKLCPHRVACKRLVAMNMPLNSDGTVTFNATLFALVRTSLKIKTEGNLEQANQELRIVIKKIWKRMKQKLLDEVIPPPDEEEVTVGKFYATFLIQDYFRKFRRRKEKGLLGNDAAPSTSSALQAGLRSLQDLGPEMRQALTCDTEEEEEEGQEGVEEEDEKDLETNKATMVSQPSARRGSGISVSLPVGDRLPDSLSFGPSDDDRGTPTSSQPSVPQAGSNTHRRGSGALIFTIPEEGNSQPKGTKGQNKQDEDEEVPDRLSYLDEQAGTPPCSVLLPPHRAQRYMDGHLVPRRRLLPPTPAGRKPSFTIQCLQRQGSCEDLPIPGTYHRGRNSGPNRAQVLISEGLGLFARDPRFVALAKQEIADACRLTLDEMDNAASDLLAQGTSSLYSDEESILSRFDEEDLGDEMACVHAL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=34

DOMAIN=transmembrane_domain
START=96
END=115
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=130
END=152
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=161
END=180
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=233
END=256
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=238
END=260
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=317
END=339
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=349
END=371
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=455
END=469
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=479
END=490
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=506
END=526
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=525
END=547
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=567
END=589
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=640
END=652
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=655
END=673
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=656
END=678
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=728
END=750
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=787
END=844
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=794
END=831
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=867
END=889
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=909
END=931
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=943
END=965
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=945
END=954
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=964
END=978
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=1000
END=1022
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1111
END=1132
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=1116
END=1138
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1183
END=1205
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1225
END=1244
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1326
END=1345
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1418
END=1440
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1567
END=1578
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=Ca_chan_IQ
START=1575
END=1609
EVALUE=8.6521700055717e-15
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1640
END=1659
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1785
END=1794
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chrX:49228030_T_C,3.223,-1,HGNC,C,protein_coding,HGNC:1393,ENST00000323022,ENSG00000102001,"['splice_region_variant', 'intron_variant']",CACNA1F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,15682424,15682425,C,T,CYP4F12,ENST00000550308,2017-06-13 00:00:00,Cgt/Tgt,R/C,188/524,MODERATE,MED,benign,".,.",None,None,".,.",rs2285888,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000186204,Cytochrome P450 family 4 subfamily F member 12,"['Predicted intracellular proteins', 'Predicted membrane proteins']",None,"{'intestine': '53.0', 'liver': '24.2'}",24.6,24.6,11.5,0.3,5.1,53,8,0,0,13.2,0,0,0.1,"FMO5,PPIG,UGT1A6,UGT1A6,CYP2J2,CYP2J2,CYP2J2,UGT1A5,POR,POR,POR,CYP4F12,CYP4F12,CYP4F12,CYP4F12,CYP4F12,CYP4F12,CYP4F12,CYP4F12,CYP4F8,CYP4F8,CYP4F8,CYP4F8,CYP4F8,FMO1,FMO1,FMO1,FMO1,FMO1,FMO1,FMO1","CYP4F2,CYP4F2,CYP4F2,PPIG,CYP4F2,FMO5,PPIG,PPIG,CYP4F2,PPIG,CYP2J2,CYP4F2,UGT2A3,FMO5,PPIG,UGT1A6,CYP2J2,UGT1A5,POR,CYP4F2,PPIG,CYP2J2,POR,CYP4F12,UGT2A3,PPIG,UGT1A6,CYP2J2,UGT1A5,CYP4F12,CYP4F8","[0.309, 0.672, 0.364, 0.704, 0.279346, 0.363, 0.739, 0.554, 0.474, 0.737, 0.562, 0.013547, 0.358, 0.414, 0.533, 0.407, 0.29651, 0.408, 0.544, 0.017119, 0.482, 0.197105, 0.538, 0.01554, 0.563, 0.443, 0.531, 0.387, 0.392, 0.425, 0.341]","['intracellular', 'cell', 'cytoplasm', 'endoplasmic reticulum', 'endoplasmic reticulum membrane', 'plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'apical plasma membrane', 'organelle membrane', 'intrinsic component of membrane', 'organelle subcompartment', 'nuclear outer membrane-endoplasmic reticulum membrane network', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle part', 'intracellular part', 'membrane part', 'endoplasmic reticulum part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'apical part of cell', 'cell periphery', 'plasma membrane region', 'endoplasmic reticulum subcompartment', 'catalytic activity', 'monooxygenase activity', 'binding', 'iron ion binding', 'arachidonic acid monooxygenase activity', 'arachidonic acid epoxygenase activity', 'oxidoreductase activity', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen', 'alkane 1-monooxygenase activity', 'heme binding', 'ion binding', 'cation binding', 'metal ion binding', 'tetrapyrrole binding', 'transition metal ion binding', 'cofactor binding', 'leukotriene-B4 20-monooxygenase activity', 'aromatase activity', 'organic cyclic compound binding', 'heterocyclic compound binding', 'Cytochrome P450', 'Cytochrome P450, E-class, group I', 'Cytochrome P450, conserved site', 'Cytochrome P450 superfamily', 'Alternative splicing', 'Endoplasmic reticulum', 'Heme', 'Iron', 'Membrane', 'Metal-binding', 'Microsome', 'Monooxygenase', 'Oxidoreductase', 'Polymorphism', 'Transmembrane', 'Transmembrane helix', 'Cytochrome P450', 'very long-chain fatty acid metabolic process', 'long-chain fatty acid metabolic process', 'renal system process involved in regulation of blood volume', 'system process', 'circulatory system process', 'renal system process', 'renal system process involved in regulation of systemic arterial blood pressure', 'regulation of systemic arterial blood pressure', 'renal water homeostasis', 'pressure natriuresis', 'organic acid metabolic process', 'lipid metabolic process', 'fatty acid metabolic process', 'icosanoid metabolic process', 'leukotriene metabolic process', 'vitamin metabolic process', 'fat-soluble vitamin metabolic process', 'blood circulation', 'metabolic process', 'regulation of blood pressure', 'catabolic process', 'fatty acid catabolic process', 'cellular process', 'lipid catabolic process', 'organic acid catabolic process', 'drug metabolic process', 'arachidonic acid metabolic process', 'epoxygenase P450 pathway', 'carboxylic acid metabolic process', 'water homeostasis', 'multicellular organismal process', 'monocarboxylic acid metabolic process', 'unsaturated fatty acid metabolic process', 'leukotriene catabolic process', 'leukotriene B4 catabolic process', 'leukotriene B4 metabolic process', 'vitamin E metabolic process', 'homeostatic process', 'long-chain fatty acid catabolic process', 'oxoacid metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular lipid catabolic process', 'cellular catabolic process', 'cellular lipid metabolic process', 'small molecule metabolic process', 'small molecule catabolic process', 'carboxylic acid catabolic process', 'heterocycle metabolic process', 'multicellular organismal homeostasis', 'chemical homeostasis', 'ion homeostasis', 'regulation of body fluid levels', 'multicellular organismal water homeostasis', 'metal ion homeostasis', 'monovalent inorganic cation homeostasis', 'sodium ion homeostasis', 'cation homeostasis', 'oxidation-reduction process', 'biological regulation', 'regulation of biological quality', 'organic substance metabolic process', 'monocarboxylic acid catabolic process', 'inorganic ion homeostasis', 'organic cyclic compound metabolic process', 'icosanoid catabolic process', 'fatty acid derivative metabolic process', 'fatty acid derivative catabolic process', 'organic substance catabolic process', 'organic hydroxy compound metabolic process', 'organic hydroxy compound catabolic process', 'Metabolism', 'Biological oxidations', 'Cytochrome P450 - arranged by substrate type', 'Fatty acids', 'Phase I - Functionalization of compounds', 'Eicosanoids']",MSLLSLPWLGLRPVATSPWLLLLLVVGSWLLARILAWTYAFYNNCRRLQCFPQPPKRNWFWGHLGLITPTEEGLKNSTQMSATYSQGFTLPLHPRIISSSGS,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=transmembrane_domain
START=15
END=37
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=19
END=31
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

-- FINISHED --
",chr19:15682425_C_T,20.3,1,HGNC,T,protein_coding,HGNC:18857,ENST00000550308,ENSG00000186204,['missense_variant'],CYP4F12,".,.",188,".,.",612,".,.",562,"0.281,0.323",0.711,".,.",benign,".,.",0.094,0.454,".,.",".,.",0.899,".,.",0.979,0.14,tolerated,612,".,.",R/C,188,".,.",Cgt/Tgt,"T,T",0.106,0,562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,57402386,57402387,T,C,DNAH12,ENST00000351747,,,,-/3092,LOW,MED,,,None,None,.,rs6445873,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000174844,Dynein axonemal heavy chain 12,"['Cancer-related genes', 'Predicted intracellular proteins']",['Ubl conjugation pathway'],"{'brain': '23.0', 'fallopian tube': '16.7', 'lung': '17.5', 'testis': '17.6'}",0.2,0.1,0.2,0.2,0.2,0.2,0.2,0.5,0.5,0,0,1.2,0.9,"DNAH9,DNAH5,DNAH5,DNAH12,DNAH12,DNAH12,DNAH6,DNAH6,DNAH6,DNAH6,DYNC2H1,DYNC2H1,DYNC2H1,DYNC2H1,DYNC2H1,DNAH14,DNAH14,DNAH14,DNAH14,DNAH14,DNAH14,DNAI2,DNAI2,DNAI2,DNAI2,DNAI2,DNAI2,DNAI2,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1","DNAL4,DNAL4,DNAH9,DNAL4,DNAH9,DNAH5,DNAL4,DNAH9,DNAH5,DNAH12,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAI2,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAI2,DNAH1,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAI2,DNAH1,DNAH2","[0.615, 0.542, 0.159258, 0.43, 0.552, 0.759, 0.487, 0.118816, 0.190322, 0.903, 0.162, 0.123375, 0.152086, 0.56, 0.111027, 0.421, 0.42, 0.759, 0.905, 0.390999, 0.213, 0.65, 0.757, 0.917, 0.479, 0.583, 0.442, 0.294, 0.484, 0.09504, 0.1518, 0.905, 0.109263, 0.1452, 0.905, 0.524, 0.558, 0.102808, 0.089355, 0.54, 0.06981, 0.06541, 0.397, 0.396, 0.082224, 0.63, 0.699, 0.899, 0.458, 0.609, 0.341, 0.267, 0.35399, 0.573, 0.44]","['intracellular', 'cell', 'cytoplasm', 'cytoskeleton', 'microtubule', 'microtubule associated complex', 'cilium', 'microtubule cytoskeleton', 'dynein complex', 'protein-containing complex', 'cell projection', 'organelle', 'non-membrane-bounded organelle', 'intracellular organelle', 'intracellular non-membrane-bounded organelle', 'organelle part', 'intracellular part', 'cytoskeletal part', 'intracellular organelle part', 'cell part', 'supramolecular complex', 'supramolecular polymer', 'supramolecular fiber', 'polymeric cytoskeletal fiber', 'plasma membrane bounded cell projection', 'catalytic complex', 'nucleotide binding', 'motor activity', 'microtubule motor activity', 'catalytic activity', 'binding', 'ATP binding', 'drug binding', 'pyrophosphatase activity', 'hydrolase activity', 'hydrolase activity, acting on acid anhydrides', 'hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides', 'ATPase activity', 'purine nucleotide binding', 'nucleoside-triphosphatase activity', 'adenyl nucleotide binding', 'ribonucleotide binding', 'purine ribonucleotide binding', 'adenyl ribonucleotide binding', 'purine ribonucleoside triphosphate binding', 'small molecule binding', 'ion binding', 'anion binding', 'organic cyclic compound binding', 'carbohydrate derivative binding', 'nucleoside phosphate binding', 'heterocyclic compound binding', 'Dynein heavy chain', 'Coiled coil', 'movement of cell or subcellular component', 'microtubule-based process', 'microtubule-based movement', 'cellular process']",MSDANKAAIAAEKEALNLKLPPIVHLPENIGVDTPTQSKLLKYRRSKEQQQKINQLVIDGAKRNLDRTLGKRTPLLPPPDYPQTMTSEMKKKGFNYIYMKQCVESSPLVPIQQEWLDHMLRLIPESLKEGKEREELLESLINEVSSDFENSMKRYLVQSVLVKPPVKSLEDEGGPLPESPVGLDYSNPWHSSYVQARNQIFSNLHIIHPTMKMLLDLGYTTFADTVLLDFTGIRAKGPIDCESLKTDLSIQTRNAEEKIMNTWYPKVINLFTKKEALEGVKPEKLDAFYSCVSTLMSNQLKDLLRRTVEGFVKLFDPKDQQRLPIFKIELTFDDDKMEFYPTFQDLEDNVLSLVERIAEALQNVQTIPSWLSGTSTPVNLDTELPEHVLHWAVDTLKAAVHRNLEGARKHYETYVEKYNWLLDGTAVENIETFQTEDHTFDEYTEELDCWVVWEVYF,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=low_complexity_region
START=4
END=20
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=125
END=140
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:57402387_T_C,7.327,-1,HGNC,C,protein_coding,HGNC:2943,ENST00000351747,ENSG00000174844,"['splice_region_variant', 'intron_variant']",DNAH12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr17,74866470,74866471,T,C,FDXR,ENST00000579893,2017-03-06 00:00:00,cAg/cGg,Q/R,72/164,MODERATE,MED,benign,".,.,.,.,.,.,.,.,.",None,None,"FAD/NAD(P)-binding domain,.,FAD/NAD(P)-binding domain,FAD/NAD(P)-binding domain,.,.,FAD/NAD(P)-binding domain,.,.",rs690514,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000161513,Ferredoxin reductase,"['Disease related genes', 'Enzymes', 'Potential drug targets', 'Predicted intracellular proteins']","['Cholesterol metabolism', 'Electron transport', 'Lipid metabolism', 'Steroid metabolism', 'Sterol metabolism', 'Transport']",{'adrenal gland': '93.9'},4.6,2.6,8.7,1.7,2.1,2.5,2.2,5.4,7.4,4.8,6.4,10,15.2,"FDX1,CYP11A1,CYP11A1,STAR,STAR,ISCU,NFS1,NFS1,FDX1L,FDX1L,FDX1L,FDX1L,FDX1L,NFU1,NFU1,NFU1,NFU1,FDXR,FDXR,FDXR,FDXR,FDXR,FDXR,FDXR,FDXR,FHIT,LYRM4,LYRM4,LYRM4,LYRM4,LYRM4,LYRM4","DECR1,DECR1,FDX1,FDX1,CYP11A1,FDX1,FDX1,ISCU,FDX1,CYP11A1,STAR,ISCU,NFS1,FDX1,ISCU,NFS1,FDX1L,DECR1,FDX1,CYP11A1,STAR,ISCU,NFS1,FDX1L,NFU1,FDXR,FDX1,ISCU,NFS1,FDX1L,NFU1,FDXR","[0.72, 0.515, 0.874, 0.711, 0.94, 0.879, 0.725, 0.967, 0.150591, 0.083, 0, 0.836, 0.796, 0.753, 0.919, 0.882, 0.826, 0.767, 0.975, 0.792, 0.534, 0.793, 0.853, 0.785, 0.798, 0.653, 0.777, 0.936, 0.981, 0.855, 0.893, 0.856]","['intracellular', 'cell', 'cytoplasm', 'mitochondrion', 'mitochondrial envelope', 'mitochondrial inner membrane', 'mitochondrial matrix', 'membrane', 'organelle inner membrane', 'organelle membrane', 'mitochondrial membrane', 'organelle envelope', 'membrane-enclosed lumen', 'envelope', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'mitochondrial part', 'cytoplasmic part', 'intracellular organelle part', 'cell part', 'intracellular organelle lumen', 'catalytic activity', 'oxidoreductase activity', 'FAD/NAD(P)-binding domain', 'FAD/NAD(P)-binding domain superfamily', 'Alternative splicing', 'Cholesterol metabolism', 'Deafness', 'Disease mutation', 'Electron transport', 'FAD', 'Flavoprotein', 'Lipid metabolism', 'Membrane', 'Mitochondrion', 'NADP', 'Oxidoreductase', 'Phosphoprotein', 'Polymorphism', 'Neuropathy', 'Steroid metabolism', 'Transit peptide', 'Transport', 'Mitochondrion inner membrane', 'Sterol metabolism', 'Disease', 'alcohol metabolic process', 'generation of precursor metabolites and energy', 'lipid metabolic process', 'steroid biosynthetic process', 'C21-steroid hormone biosynthetic process', 'coenzyme metabolic process', 'oxidoreduction coenzyme metabolic process', 'ubiquinone metabolic process', 'ubiquinone biosynthetic process', 'metabolic process', 'steroid metabolic process', 'cholesterol metabolic process', 'C21-steroid hormone metabolic process', 'lipid biosynthetic process', 'biosynthetic process', 'coenzyme biosynthetic process', 'cellular process', 'regulation of hormone levels', 'sterol metabolic process', 'cellular hormone metabolic process', 'cellular ketone metabolic process', 'ketone biosynthetic process', 'hormone metabolic process', 'hormone biosynthetic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'small molecule metabolic process', 'small molecule biosynthetic process', 'cofactor metabolic process', 'cofactor biosynthetic process', 'oxidation-reduction process', 'biological regulation', 'regulation of biological quality', 'organic substance metabolic process', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'organic hydroxy compound metabolic process', 'quinone metabolic process', 'quinone biosynthetic process', 'secondary alcohol metabolic process', 'Mitochondrial iron-sulfur cluster biogenesis', 'Metabolism', 'Disease', 'Metabolism of steroid hormones', 'Pregnenolone biosynthesis', 'Biological oxidations', 'Cytochrome P450 - arranged by substrate type', 'Phase I - Functionalization of compounds', 'Endogenous sterols', 'Electron transport from NADPH to Ferredoxin', 'Metabolism of lipids', 'Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)', 'Metabolic disorders of biological oxidation enzymes', 'Diseases of metabolism', 'Metabolism of steroids']",MASRCWRWWGWSAWPRTRLPPAGSTPSFCHHFSTQEKTPQICVVGSGPAGFYTAQHLLKHPQAHVDIYEKQPVPFGLVRFGVAPDHPEVKNVINTFTQTAHSGRCAFWGNVEVGRDVTVPELREAYHAVVLSYGAEDHRALEIPGEELPGVCSARAFVGWYNGLPENQELEPDLSCDTAVILGQGNVALDVARILLTPPEHLERTDITKAALGVLRQSRVKTVWLVGRRGPLQVAFTIKELREMIQLPGARPILDPVDFLGLQDKIKEVPRPRKRLTELLLRTATEKPGPAEAARQASASRAWGLRFFRSPQQVLPSPDGRRAAGVRLAVTRLEGVDEATRAVPTGDMEDLPCGLVLSSIGYKSRPVDPSVPFDSKLGVIPNVEGRVMDVPGLYCSGWVKRGPTGVIATTMTDSFLTGQMLLQDLKAGLLPSGPRPGYAAIQALLSSRGVRPVSFSDWEKLDAEEVARGQGTGKPREKLVDPQEMLRLLGH,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=low_complexity_region
START=270
END=287
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=291
END=302
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr17:74866471_T_C,3.064,-1,HGNC,C,protein_coding,HGNC:3642,ENST00000579893,ENSG00000161513,['missense_variant'],FDXR,".,.,.,.,.,.,.,.,.",72,".,.,.,.,.,.,.,.,.",281,".,.,.,.,.,.,.,.,.",215,"0.091,0.163,0.096,0.1,0.094,0.094,0.095,.,.",0.143,".,.,.,.,.,.,.,.,.",benign,".,.,.,.,.,.,.,.,.",0.001,-1.976,".,.,.,.,.,.,.,.,.",".,.,.,T,.,T,T,T,.",0.129,".,.,.,.,.,.,.,.,.",-2.291,1,tolerated,281,".,.,.,.,.,.,.,.,.",Q/R,72,".,.,.,.,.,.,.,.,.",cAg/cGg,"T,T,T,T,T,T,T,T,T",-1.299,0,215,['cds_end_NF'],ENSG00000161513,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr17,74866907,74866908,C,T,FDXR,ENST00000442102,2017-03-12 00:00:00,gGc/gAc,G/D,92/534,MODERATE,MED,benign,".,.",None,None,".,.",rs1688149,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000161513,Ferredoxin reductase,"['Disease related genes', 'Enzymes', 'Potential drug targets', 'Predicted intracellular proteins']","['Cholesterol metabolism', 'Electron transport', 'Lipid metabolism', 'Steroid metabolism', 'Sterol metabolism', 'Transport']",{'adrenal gland': '93.9'},4.6,2.6,8.7,1.7,2.1,2.5,2.2,5.4,7.4,4.8,6.4,10,15.2,"FDX1,CYP11A1,CYP11A1,STAR,STAR,ISCU,NFS1,NFS1,FDX1L,FDX1L,FDX1L,FDX1L,FDX1L,NFU1,NFU1,NFU1,NFU1,FDXR,FDXR,FDXR,FDXR,FDXR,FDXR,FDXR,FDXR,FHIT,LYRM4,LYRM4,LYRM4,LYRM4,LYRM4,LYRM4","DECR1,DECR1,FDX1,FDX1,CYP11A1,FDX1,FDX1,ISCU,FDX1,CYP11A1,STAR,ISCU,NFS1,FDX1,ISCU,NFS1,FDX1L,DECR1,FDX1,CYP11A1,STAR,ISCU,NFS1,FDX1L,NFU1,FDXR,FDX1,ISCU,NFS1,FDX1L,NFU1,FDXR","[0.72, 0.515, 0.874, 0.711, 0.94, 0.879, 0.725, 0.967, 0.150591, 0.083, 0, 0.836, 0.796, 0.753, 0.919, 0.882, 0.826, 0.767, 0.975, 0.792, 0.534, 0.793, 0.853, 0.785, 0.798, 0.653, 0.777, 0.936, 0.981, 0.855, 0.893, 0.856]","['intracellular', 'cell', 'cytoplasm', 'mitochondrion', 'mitochondrial envelope', 'mitochondrial inner membrane', 'mitochondrial matrix', 'membrane', 'organelle inner membrane', 'organelle membrane', 'mitochondrial membrane', 'organelle envelope', 'membrane-enclosed lumen', 'envelope', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'mitochondrial part', 'cytoplasmic part', 'intracellular organelle part', 'cell part', 'intracellular organelle lumen', 'catalytic activity', 'oxidoreductase activity', 'FAD/NAD(P)-binding domain', 'FAD/NAD(P)-binding domain superfamily', 'Alternative splicing', 'Cholesterol metabolism', 'Deafness', 'Disease mutation', 'Electron transport', 'FAD', 'Flavoprotein', 'Lipid metabolism', 'Membrane', 'Mitochondrion', 'NADP', 'Oxidoreductase', 'Phosphoprotein', 'Polymorphism', 'Neuropathy', 'Steroid metabolism', 'Transit peptide', 'Transport', 'Mitochondrion inner membrane', 'Sterol metabolism', 'Disease', 'alcohol metabolic process', 'generation of precursor metabolites and energy', 'lipid metabolic process', 'steroid biosynthetic process', 'C21-steroid hormone biosynthetic process', 'coenzyme metabolic process', 'oxidoreduction coenzyme metabolic process', 'ubiquinone metabolic process', 'ubiquinone biosynthetic process', 'metabolic process', 'steroid metabolic process', 'cholesterol metabolic process', 'C21-steroid hormone metabolic process', 'lipid biosynthetic process', 'biosynthetic process', 'coenzyme biosynthetic process', 'cellular process', 'regulation of hormone levels', 'sterol metabolic process', 'cellular hormone metabolic process', 'cellular ketone metabolic process', 'ketone biosynthetic process', 'hormone metabolic process', 'hormone biosynthetic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'small molecule metabolic process', 'small molecule biosynthetic process', 'cofactor metabolic process', 'cofactor biosynthetic process', 'oxidation-reduction process', 'biological regulation', 'regulation of biological quality', 'organic substance metabolic process', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'organic hydroxy compound metabolic process', 'quinone metabolic process', 'quinone biosynthetic process', 'secondary alcohol metabolic process', 'Mitochondrial iron-sulfur cluster biogenesis', 'Metabolism', 'Disease', 'Metabolism of steroid hormones', 'Pregnenolone biosynthesis', 'Biological oxidations', 'Cytochrome P450 - arranged by substrate type', 'Phase I - Functionalization of compounds', 'Endogenous sterols', 'Electron transport from NADPH to Ferredoxin', 'Metabolism of lipids', 'Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)', 'Metabolic disorders of biological oxidation enzymes', 'Diseases of metabolism', 'Metabolism of steroids']",MASRCWRWWGWSAWPRTRLPPAGSTPSFCHHFSTQEKTPQICVVGSGPAGFYTAQHLLKHPQAHVDIYEKQPVPFGLVRFGVAPDHPEVKNVINTFTQTAHSGRCAFWGNVEVGRDVTVPELREAYHAVVLSYGAEDHRALEIPGEELPGVCSARAFVGWYNGLPENQELEPDLSCDTAVILGQGNVALDVARILLTPPEHLERTDITKAALGVLRQSRVKTVWLVGRRGPLQVAFTIKELREMIQLPGARPILDPVDFLGLQDKIKEVPRPRKRLTELLLRTATEKPGPAEAARQASASRAWGLRFFRSPQQVLPSPDGRRAAGVRLAVTRLEGVDEATRAVPTGDMEDLPCGLVLSSIGYKSRPVDPSVPFDSKLGVIPNVEGRVMDVPGLYCSGWVKRGPTGVIATTMTDSFLTGQMLLQDLKAGLLPSGPRPGYAAIQALLSSRGVRPVSFSDWEKLDAEEVARGQGTGKPREKLVDPQEMLRLLGH,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=low_complexity_region
START=270
END=287
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=291
END=302
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr17:74866908_C_T,3.676,-1,HGNC,T,protein_coding,HGNC:3642,ENST00000442102,ENSG00000161513,['missense_variant'],FDXR,".,.",92,".,.",362,".,.",275,"0.177,.",0,".,.",benign,".,.",0.27,-0.313,".,.",".,.",0.005,".,.",-0.982,0.08,tolerated_low_confidence,362,".,.",G/D,92,".,.",gGc/gAc,"T,T",-0.936,0,275,,ENSG00000161513,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,22353227,22353228,A,T,IGLV5-48,ENST00000390293,2017-02-02 00:00:00,tAc/tTc,Y/F,55/105,MODERATE,MED,benign,tolerated,None,None,.,rs117042445,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MAWTPLLLLFLSHCTGSLSQAVLTQPTSLSASPGASARLTCTLRSGISVGSYRIYWYQQKPGSPPRYLLNYYSDSDKHQGSGVPSRFSGSKDASTNAGILFISGL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=0

-- FINISHED --
",chr22:22353228_A_T,0.001,1,HGNC,T,IG_V_gene,HGNC:5925,ENST00000390293,ENSG00000211647,['missense_variant'],IGLV5-48,,55,,164,,164,,,,benign,,0.003,,,,,,,0.41,tolerated,164,,Y/F,55,,tAc/tTc,,,,164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,21523491,21523492,G,C,SALL2,ENST00000450879,2017-03-04 00:00:00,Cgg/Ggg,R/G,609/906,MODERATE,MED,benign,".,.",None,None,".,.",rs1263810,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000165821,Spalt like transcription factor 2,"['Disease related genes', 'Predicted intracellular proteins', 'Transcription factors']","['Transcription', 'Transcription regulation']","{'brain': '30.9', 'parathyroid gland': '36.0'}",4.5,2.3,3.5,1.9,2.4,3.1,3.2,0.3,1.7,0,0,0.5,3.8,"NANOG,SOX2,SOX2,POU3F2,POU3F2,HECW1,CHD8,CHD8,CHD8,TOX4,TOX4,TOX4,TOX4,SALL2,SALL2,SALL2,SALL2,SALL2,SALL2,SALL2,SALL2,SALL2,SALL2","NGFR,NGFR,NANOG,NANOG,SOX2,STARD3NL,STARD3NL,METTL3,HECW1,STARD3NL,METTL3,HECW1,CHD8,STARD3NL,NGFR,NANOG,METTL3,SOX2,POU3F2,LHX6,HECW1,CHD8,TOX4","[0.448, 0.519, 0.966, 0.482, 0.701, 0.717, 0.665, 0.49, 0.65, 0.714, 0.556, 0.677, 0.683, 0.643, 0.508, 0.597, 0.684, 0.494, 0.69, 0, 0.658, 0.662, 0.68]","['histone deacetylase complex', 'nuclear chromosome', 'chromatin', 'nuclear chromatin', 'intracellular', 'cell', 'nucleus', 'nucleoplasm', 'chromosome', 'NuRD complex', 'transcriptional repressor complex', 'membrane-enclosed lumen', 'nuclear lumen', 'protein-containing complex', 'organelle', 'membrane-bounded organelle', 'non-membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular non-membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'chromosomal part', 'nuclear part', 'intracellular organelle part', 'nucleoplasm part', 'nuclear chromosome part', 'cell part', 'intracellular organelle lumen', 'SWI/SNF superfamily-type complex', 'CHD-type complex', 'nuclear transcriptional repressor complex', 'catalytic complex', 'ATPase complex', 'transcription regulatory region sequence-specific DNA binding', 'RNA polymerase II regulatory region sequence-specific DNA binding', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'RNA polymerase II regulatory region DNA binding', 'regulatory region nucleic acid binding', 'DNA-binding transcription activator activity', 'DNA-binding transcription activator activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'double-stranded DNA binding', 'DNA-binding transcription factor activity', 'binding', 'ion binding', 'cation binding', 'sequence-specific DNA binding', 'transcription regulatory region DNA binding', 'metal ion binding', 'organic cyclic compound binding', 'transcription regulator activity', 'heterocyclic compound binding', 'sequence-specific double-stranded DNA binding', 'Zinc finger C2H2-type', 'Zinc finger C2H2 superfamily', 'Alternative splicing', 'DNA-binding', 'Metal-binding', 'Nucleus', 'Phosphoprotein', 'Polymorphism', 'Repeat', 'Transcription', 'Transcription regulation', 'Ubl conjugation', 'Zinc', 'Zinc-finger', 'Isopeptide bond', 'Zinc finger, C2H2 type', 'Zinc-finger of C2H2 type', 'C2H2-type zinc finger', 'negative regulation of transcription by RNA polymerase II', 'eye development', 'nucleobase-containing compound metabolic process', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'cell communication', 'signal transduction', 'multicellular organism development', 'nervous system development', 'sensory organ development', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'embryo development', 'embryo development ending in birth or egg hatching', 'tissue development', 'regulation of biosynthetic process', 'negative regulation of biosynthetic process', 'positive regulation of biosynthetic process', 'negative regulation of metabolic process', 'positive regulation of metabolic process', 'cellular process', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'positive regulation of macromolecule biosynthetic process', 'negative regulation of macromolecule biosynthetic process', 'positive regulation of macromolecule metabolic process', 'negative regulation of macromolecule metabolic process', 'positive regulation of gene expression', 'negative regulation of gene expression', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'neural tube development', 'signaling', 'regulation of cellular metabolic process', 'negative regulation of cellular metabolic process', 'positive regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'negative regulation of cellular biosynthetic process', 'positive regulation of cellular biosynthetic process', 'multicellular organismal process', 'developmental process', 'RNA biosynthetic process', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'tube development', 'chordate embryonic development', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'negative regulation of transcription, DNA-templated', 'positive regulation of transcription, DNA-templated', 'negative regulation of nucleobase-containing compound metabolic process', 'positive regulation of nucleobase-containing compound metabolic process', 'positive regulation of transcription by RNA polymerase II', 'heterocycle metabolic process', 'animal organ development', 'positive regulation of biological process', 'negative regulation of biological process', 'positive regulation of cellular process', 'negative regulation of cellular process', 'system development', 'anatomical structure development', 'sensory system development', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'regulation of nitrogen compound metabolic process', 'negative regulation of nitrogen compound metabolic process', 'positive regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'negative regulation of RNA metabolic process', 'positive regulation of RNA metabolic process', 'cellular response to stimulus', 'regulation of macromolecule metabolic process', 'epithelium development', 'biological regulation', 'organic substance metabolic process', 'regulation of primary metabolic process', 'nucleic acid metabolic process', 'nucleic acid-templated transcription', 'visual system development', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'negative regulation of RNA biosynthetic process', 'positive regulation of RNA biosynthetic process', 'regulation of nucleic acid-templated transcription', 'negative regulation of nucleic acid-templated transcription', 'positive regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'negative regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'zinc finger']",MAHESERSSRLGVPCGEPAELGGDASEEDHPQVCAKCCAQFTDPTEFLAHQNACSTDPPVMVIIGGQENPNNSSASSEPRPEGHNNPQVMDTEHSNPPDSGSSVPTDPTWGPERRGEESPGHFLVAATEPVCGIPVKWPAHEALEFQLHLHYHSKPGPTSAVWPRNCGWEGASNNGIQGSQGEDSPPPISASCTQGSA,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=low_complexity_region
START=68
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr14:21523492_G_C,12.11,-1,HGNC,C,protein_coding,HGNC:10526,ENST00000450879,ENSG00000165821,['missense_variant'],SALL2,".,.",609,".,.",1925,".,.",1825,"0.048,0.05",0.354,".,.",benign,".,.",0,-0.174,".,.",".,T",0.602,".,.",0.128,1,tolerated,1925,".,.",R/G,609,".,.",Cgg/Ggg,"T,T",1.595,0.051,1825,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,72728895,72728896,C,T,TYW1B,ENST00000612372,2017-07-12 00:00:00,tGg/tAg,W/*,211/471,HIGH,HIGH,,".,.,.",None,None,"Radical SAM&Radical SAM,Radical SAM&Radical SAM,Radical SAM",rs3015858,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000277149,TRNA-yW synthesizing protein 1 homolog B,['Predicted membrane proteins'],None,None,2.9,1.5,3.4,2.4,4.4,2.9,3.1,7.5,5.4,5.7,3.5,2.4,3,"CDKAL1,COBLL1,MARC1,MARC1,KIAA0020,NMD3,NMD3,NMD3,BOP1,BOP1,BOP1,BOP1,TYW1B,TYW1B,TYW1B,TYW1B,TYW1B,TYW1B,TYW1B,TYW1B,TYW1B,DDX27,DDX27,DDX27,DDX27,DDX27","POLR3B,OSBPL7,OSBPL7,COBLL1,POLR3B,POLR3B,CDKAL1,KIAA0020,POLR3B,CDKAL1,KIAA0020,NMD3,OSBPL7,POLR3B,CDKAL1,COBLL1,MARC1,TYW3,KIAA0020,NMD3,BOP1,POLR3B,KIAA0020,NMD3,BOP1,TYW1B","[0, 0.511, 0.536, 0.441, 0, 0.057, 0, 0.426, 0.057, 0, 0.056, 0.515, 0.67, 0, 0.406, 0.586, 0.655, 0.542, 0, 0.269, 0.172, 0.086, 0.266, 0.091, 0.491, 0]","['nucleotide binding', 'catalytic activity', 'binding', 'FMN binding', 'lyase activity', 'carbon-carbon lyase activity', 'oxo-acid-lyase activity', 'ribonucleotide binding', 'small molecule binding', 'ion binding', 'anion binding', 'cation binding', 'metal ion binding', 'cofactor binding', 'coenzyme binding', 'iron-sulfur cluster binding', '4 iron, 4 sulfur cluster binding', 'metal cluster binding', 'organic cyclic compound binding', 'carbohydrate derivative binding', 'tRNA-4-demethylwyosine synthase activity', 'catalytic activity, acting on RNA', 'catalytic activity, acting on a tRNA', 'nucleoside phosphate binding', 'heterocyclic compound binding', 'Flavodoxin-like', 'Radical SAM', 'Flavodoxin/nitric oxide synthase', 'Aldolase-type TIM barrel', 'tRNA wybutosine-synthesis', 'Flavoprotein-like superfamily', 'S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase', '4Fe-4S', 'Alternative splicing', 'Iron', 'Iron-sulfur', 'Lyase', 'Metal-binding', 'Nucleotide-binding', 'tRNA processing', 'S-adenosyl-L-methionine', 'Flavodoxin', 'Radical SAM superfamily', 'Wyosine base formation', 'nucleobase-containing compound metabolic process', 'RNA processing', 'tRNA metabolic process', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'tRNA processing', 'metabolic process', 'cellular process', 'gene expression', 'RNA metabolic process', 'ncRNA processing', 'cellular nitrogen compound metabolic process', 'ncRNA metabolic process', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'heterocycle metabolic process', 'oxidation-reduction process', 'organic substance metabolic process', 'nucleic acid metabolic process', 'organic cyclic compound metabolic process']",MDQPEMILKEAIENHQNMIKQFKGVPGVKAERFEEGMTVKHCALSLVGEPIMYPEINRFLKLLHQCKISSFLVTNAQFPAEIRNLEPVTQLYVSVDASTKDSLKKIDRPLFKDFWQQFLDSLKALAVKQQRTVYRLMLVKAWNVDELQAYAQLVSLGNPDFIEVKGVTYCRESSASSLTMAHVPWHEEVVQFVRELVDLIPEYEIACEHEHSNCLLIAHRKFKIGGEWWTWIDYNRFQELIQEYEDSGGSKTFSAKDYMARTPHWALFGANERSFDPKDTRHQRKNKSKAISGC,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Sequence submitted into the processing queue</title>
<meta http-equiv=""refresh"" content=""3;url=job_status.pl?jobid=184147158237370871597370281wPSCIqRVxX"" />
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
<h2>Job 184147158237370871597370281wPSCIqRVxX entered our processing queue at <span style=""background:#ecdb7a;font-weight:bold"">position 8</span>.</h2>
You will be redirected to your job's status page in a few seconds. If your browser doesn't support redirection, <a href='job_status.pl?jobid=184147158237370871597370281wPSCIqRVxX'>click here</a>. 
",chr7:72728896_C_T,40,-1,HGNC,T,protein_coding,HGNC:33908,ENST00000612372,ENSG00000277149,['stop_gained'],TYW1B,".,.,.",211,".,.,.",731,".,.,.",632,"0.354,0.323,.",0.992,".,.,.",,".,.,.",,0.514,".,.,.",".,.,.",0.801,".,.,.",0.783,,,731,".,.,.",W/*,211,".,.,.",tGg/tAg,".,.,.",6.086,1,632,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,75738574,75738575,G,A,ZNF717,ENST00000478296,2017-04-04 00:00:00,Cgt/Tgt,R/C,300/864,MODERATE,MED,benign,T,None,None,Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type,rs1962893,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000227124,Zinc finger protein 717,['Predicted intracellular proteins'],None,None,6.7,6.9,7.7,6.2,8.9,7.3,10.1,9.5,6.2,6.8,5.3,4,10.2,"OR4C3,FAM104B,ZNF717,ZNF717,ZNF717,ZNF717,ZNF717,ZNF717,OR5M11,HNRNPCP5,HNRNPCP5,UBTFL1,UBTFL1,HNRNPCL2,HNRNPCL2","FRG2C,FRG2C,TRIM28,OR8U1,FRG2C,OR4C3,CDCP2,FAM104B,ZNF717,OR8U1,ZNF717,OR4C3,ZNF717,OR8U1,ZNF717","[0.544, 0.528, 0, 0.587, 0.648, 0.668, 0.493, 0.556, 0.479, 0.567, 0.514, 0.57, 0.45, 0.642, 0.569]","['intracellular', 'cell', 'nucleus', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular part', 'cell part', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'DNA-binding transcription factor activity', 'binding', 'ion binding', 'cation binding', 'metal ion binding', 'organic cyclic compound binding', 'transcription regulator activity', 'heterocyclic compound binding', 'Krueppel-associated box', 'KRAB domain superfamily', 'KRAB box', 'nucleobase-containing compound metabolic process', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'regulation of biosynthetic process', 'cellular process', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'RNA biosynthetic process', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'heterocycle metabolic process', 'regulation of biological process', 'regulation of cellular process', 'regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'regulation of macromolecule metabolic process', 'biological regulation', 'organic substance metabolic process', 'regulation of primary metabolic process', 'nucleic acid metabolic process', 'nucleic acid-templated transcription', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'krueppel associated box']",MLETYNSLVSLQELVSFEEVAVHFTWEEWQDLDDAQRTLYRDVMLETYSSLVSLGHCITKPEMIFKLEQGAEPWIVEETPNLRLSAVQIIDDLIERSHESHDRFFWQIVITNSNTSTQERVELGKTFNLNSNHVLNLIINNGNSSGMKPGQFNDCQNMLFPIKPGETQSGEKPHVCDITRRSHRHHEHLTQHHKIQTLLQTFQCNEQGKTFNTEAMFFIHKRVHIVQTFGKYNEYEKACNNSAVIVQVITQVGQPTCCRKSDFTKHQQTHTGEKPYECVECEKPSISKSDLMLQCKMPTEEKPYACNWCEKLFSYKSSLIIHQRIHTGEKPYGCNECGKTFRRKSFLTLHERTHTGDKPYKCIECGKTFHCKSLLTLHHRTHSGEKPYQCSECGKTFSQKSYLTIHHRTHTGEKPYACDHCEEAFSHKSRLTVHQRTHTGEKPYECNECGKPFINKSNLRLHQRTHTGEKPYECNECGKTFHRKSFLTIHQWTHTGEKPYECNECGKTFRCKSFLTVHQRTHAGEKPYACNECGKTYSHKSYLTVHHRTHTGEKPYECNECGKSFHCKSFLTIHQRTHAGKKPYECNECEKTFINKLNLGIHKITHTGERPYECNECGKTFRQKSNLSTHQGTHTGEKPYVCGKTFHRKSFLTIHQRTHTGKNRMDVMNVEKLFVRNHTLLYIRELTPGKSPMNVMNVENPFIRRQIFRSIKVFTRGRNPMNVANVEKPCQKSVLTVHHRTHTGEKPYECNECGKTFCHKSNLSTHQGTHSGEKPYECDECRKTFYDKTVLTIHQRTHTGEKPFECKECRKTFSQKSKLFVHHRTHTGEKPFRCNECRKTFSQKSGLSIHQRTHTGEKPYECKECGKTFCQKSHLSRHQQTHIGEKSDVAEAGYVFPQNHSFFP,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=20

DOMAIN=KRAB
START=15
END=75
EVALUE=1.21775277742491e-36
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=202
END=224
EVALUE=12.5893755426639
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=304
END=326
EVALUE=0.00169418808138012
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=332
END=354
EVALUE=0.00389222209314515
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=360
END=382
EVALUE=0.14307158491925
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=388
END=410
EVALUE=0.000299492972048714
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=416
END=438
EVALUE=0.00894197807485502
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=444
END=466
EVALUE=0.000184359549829924
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=472
END=494
EVALUE=0.266980907371989
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=500
END=522
EVALUE=0.00389222209314515
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=528
END=550
EVALUE=0.00834316057055673
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=556
END=578
EVALUE=0.0191675489413791
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=584
END=606
EVALUE=0.0205432702018928
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=612
END=634
EVALUE=0.000423547022613019
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=641
END=659
EVALUE=46.1756348010085
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=748
END=770
EVALUE=0.00275221664717456
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=776
END=798
EVALUE=0.00181578582533093
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=804
END=826
EVALUE=0.0220177317266696
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=832
END=854
EVALUE=0.000907892915921005
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=860
END=882
EVALUE=0.000973055533843017
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr3:75738575_G_A,16.95,-1,HGNC,C,protein_coding,HGNC:29448,ENST00000478296,ENSG00000227124,['missense_variant'],ZNF717,N,300,,1175,,898,0.089,0,T,benign,,0.428,-0.363,,,0,,-0.36,0.09,tolerated,1175,0.0666544352282,R/G,300,,Cgt/Ggt,T,-4.415,0,898,,,5.2461,0.6683549,N,0.8407198356,0,0.061,T,0.69289,T,T,"P,P,P,P",0.9999825725,,,,,,,,,,,,,,,
chr3,75741292,75741293,G,A,ZNF717,ENST00000477374,2017-04-06 00:00:00,cCa/cTa,P/L,87/114,MODERATE,MED,benign,"D,T,T,D",None,None,"Krueppel-associated box,Krueppel-associated box,Krueppel-associated box,Krueppel-associated box",rs1971517,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",AR,ENSG00000227124,Zinc finger protein 717,['Predicted intracellular proteins'],None,None,6.7,6.9,7.7,6.2,8.9,7.3,10.1,9.5,6.2,6.8,5.3,4,10.2,"OR4C3,FAM104B,ZNF717,ZNF717,ZNF717,ZNF717,ZNF717,ZNF717,OR5M11,HNRNPCP5,HNRNPCP5,UBTFL1,UBTFL1,HNRNPCL2,HNRNPCL2","FRG2C,FRG2C,TRIM28,OR8U1,FRG2C,OR4C3,CDCP2,FAM104B,ZNF717,OR8U1,ZNF717,OR4C3,ZNF717,OR8U1,ZNF717","[0.544, 0.528, 0, 0.587, 0.648, 0.668, 0.493, 0.556, 0.479, 0.567, 0.514, 0.57, 0.45, 0.642, 0.569]","['intracellular', 'cell', 'nucleus', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular part', 'cell part', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'DNA-binding transcription factor activity', 'binding', 'ion binding', 'cation binding', 'metal ion binding', 'organic cyclic compound binding', 'transcription regulator activity', 'heterocyclic compound binding', 'Krueppel-associated box', 'KRAB domain superfamily', 'KRAB box', 'nucleobase-containing compound metabolic process', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'regulation of biosynthetic process', 'cellular process', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'RNA biosynthetic process', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'heterocycle metabolic process', 'regulation of biological process', 'regulation of cellular process', 'regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'regulation of macromolecule metabolic process', 'biological regulation', 'organic substance metabolic process', 'regulation of primary metabolic process', 'nucleic acid metabolic process', 'nucleic acid-templated transcription', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'krueppel associated box']",MLETYNSLVSLQELVSFEEVAVHFTWEEWQDLDDAQRTLYRDVMLETYSSLVSLGHCITKPEMIFKLEQGAEPWIVEETPNLRLSAVQIIDDLIERSHESHDRFFWQIVITNSNTSTQERVELGKTFNLNSNHVLNLIINNGNSSGMKPGQFNDCQNMLFPIKPGETQSGEKPHVCDITRRSHRHHEHLTQHHKIQTLLQTFQCNEQGKTFNTEAMFFIHKRVHIVQTFGKYNEYEKACNNSAVIVQVITQVGQPTCCRKSDFTKHQQTHTGEKPYECVECEKPSISKSDLMLQCKMPTEEKPYACNWCEKLFSYKSSLIIHQRIHTGEKPYGCNECGKTFRRKSFLTLHERTHTGDKPYKCIECGKTFHCKSLLTLHHRTHSGEKPYQCSECGKTFSQKSYLTIHHRTHTGEKPYACDHCEEAFSHKSRLTVHQRTHTGEKPYECNECGKPFINKSNLRLHQRTHTGEKPYECNECGKTFHRKSFLTIHQWTHTGEKPYECNECGKTFRCKSFLTVHQRTHAGEKPYACNECGKTYSHKSYLTVHHRTHTGEKPYECNECGKSFHCKSFLTIHQRTHAGKKPYECNECEKTFINKLNLGIHKITHTGERPYECNECGKTFRQKSNLSTHQGTHTGEKPYVCGKTFHRKSFLTIHQRTHTGKNRMDVMNVEKLFVRNHTLLYIRELTPGKSPMNVMNVENPFIRRQIFRSIKVFTRGRNPMNVANVEKPCQKSVLTVHHRTHTGEKPYECNECGKTFCHKSNLSTHQGTHSGEKPYECDECRKTFYDKTVLTIHQRTHTGEKPFECKECRKTFSQKSKLFVHHRTHTGEKPFRCNECRKTFSQKSGLSIHQRTHTGEKPYECKECGKTFCQKSHLSRHQQTHIGEKSDVAEAGYVFPQNHSFFP,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=20

DOMAIN=KRAB
START=15
END=75
EVALUE=1.21775277742491e-36
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=202
END=224
EVALUE=12.5893755426639
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=304
END=326
EVALUE=0.00169418808138012
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=332
END=354
EVALUE=0.00389222209314515
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=360
END=382
EVALUE=0.14307158491925
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=388
END=410
EVALUE=0.000299492972048714
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=416
END=438
EVALUE=0.00894197807485502
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=444
END=466
EVALUE=0.000184359549829924
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=472
END=494
EVALUE=0.266980907371989
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=500
END=522
EVALUE=0.00389222209314515
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=528
END=550
EVALUE=0.00834316057055673
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=556
END=578
EVALUE=0.0191675489413791
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=584
END=606
EVALUE=0.0205432702018928
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=612
END=634
EVALUE=0.000423547022613019
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=641
END=659
EVALUE=46.1756348010085
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=748
END=770
EVALUE=0.00275221664717456
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=776
END=798
EVALUE=0.00181578582533093
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=804
END=826
EVALUE=0.0220177317266696
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=832
END=854
EVALUE=0.000907892915921005
TYPE=SMART
STATUS=visible|OK

DOMAIN=ZnF_C2H2
START=860
END=882
EVALUE=0.000973055533843017
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr3:75741293_G_A,8.838,-1,HGNC,C,protein_coding,HGNC:29448,ENST00000477374,ENSG00000227124,['missense_variant'],ZNF717,"D,N,N,D",87,".,.,.,.",432,".,.,.,.",260,"0.133,0.139,.,.",0.001,"T,T,T,T",possibly_damaging,".,.,.,.",0.497,0.56,".,.,.,.",".,.,.,.",0.002,".,.,.,.",0.561,0.05,tolerated,432,"0.0551355673512,0.0551355673512,0.0551355673512,0.0551355673512",P/R,87,".,.,.,.",cCa/cGa,"T,T,.,.",2.664,0.126,260,,,4.6233,0.7560664,N,0.3795863342,0,0.179,T,0.562547,T,T,"N,N,N,N",0.9999739685,N,0.425,T,,,,,,,,,,,,
chrX,49228029,49228030,T,C,CACNA1F,ENST00000323022,,,,-/1966,LOW,MED,,,None,None,.,rs6609854,None,None,None,0,None,None,None,None,None,"TSK_12005_014905,TSK_13246_014957",X-linked,ENSG00000102001,Calcium voltage-gated channel subunit alpha1 F,"['Disease related genes', 'FDA approved drug targets', 'Plasma proteins', 'Predicted intracellular proteins', 'Predicted membrane proteins', 'Transporters', 'Voltage-gated ion channels']","['Calcium transport', 'Ion transport', 'Sensory transduction', 'Transport', 'Vision']",{'retina': '55.8'},1,1.9,0.7,2.7,1.5,3.7,1,1.4,4.6,2,0.9,0.5,1,"CACNG8,CACNB3,CACNB3,CACNB2,CACNB2,CACNB2,CACNA2D1,CACNA2D1,CACNA2D1,CACNA2D1,CACNA1F,CACNA1F,CACNA1F,CACNA1F,CACNA1F,CACNA2D4,CACNA2D4,CACNA2D4,CACNA2D4,CACNA2D4,CACNA2D4,CACNB1,CACNB1,CACNB1,CACNB1,CACNB1,CACNB1,CACNB1,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D2,CACNA2D3,CACNA2D3,CACNA2D3,CACNA2D3,CACNA2D3,CACNA2D3,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4,CACNB4","CACNG1,CACNG1,CACNG8,CACNG1,CACNG8,CACNB3,CACNG1,CACNG8,CACNB3,CACNB2,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNA1F,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNA1F,CACNA2D4,CACNG1,CACNG8,CACNB3,CACNB2,CACNA1F,CACNA2D4,CACNB1,CACNG1,CACNG8,CACNB3,CACNB2,CACNA1F,CACNB1,CACNG1,CACNG8,CACNB3,CACNB2,CACNA2D1,CACNA1F,CACNA2D4,CACNB1,CACNA2D2,CACNA2D3","[0.761, 0.221, 0.241, 0.355, 0.459, 0.028796, 0.85, 0.552, 0.716, 0.794, 0.541, 0.31, 0.387, 0.532, 0.661, 0.63, 0.224, 0.757, 0.549, 0.20075, 0.698, 0.905, 0.645, 0.031234, 0.021924, 0.913, 0.542, 0.646, 0.758, 0.477, 0.514, 0.528, 0.502, 0.190938, 0.626, 0.629, 0.258, 0.498, 0.404, 0.318, 0.652, 0.642, 0.386, 0.028035, 0.01961, 0.673, 0.445, 0.591, 0.023199, 0.712, 0.507]","['photoreceptor outer segment', 'cell', 'plasma membrane', 'voltage-gated calcium channel complex', 'cilium', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'protein-containing complex', 'ion channel complex', 'cation channel complex', 'calcium channel complex', 'somatodendritic compartment', 'cell projection', 'neuron projection', 'neuronal cell body', 'perikaryon', 'organelle', 'cell body', 'organelle part', 'membrane part', 'ciliary part', 'plasma membrane part', 'cell projection part', 'cell part', 'cell periphery', 'neuron part', 'non-motile cilium', '9+0 non-motile cilium', 'photoreceptor cell cilium', 'membrane protein complex', 'plasma membrane protein complex', 'plasma membrane bounded cell projection', 'plasma membrane bounded cell projection part', 'transmembrane transporter complex', 'transporter complex', 'transporter activity', 'ion channel activity', 'voltage-gated ion channel activity', 'voltage-gated calcium channel activity', 'cation channel activity', 'calcium channel activity', 'binding', 'cation transmembrane transporter activity', 'high voltage-gated calcium channel activity', 'ion transmembrane transporter activity', 'calcium ion transmembrane transporter activity', 'channel activity', 'inorganic molecular entity transmembrane transporter activity', 'passive transmembrane transporter activity', 'voltage-gated channel activity', 'gated channel activity', 'substrate-specific channel activity', 'ion gated channel activity', 'voltage-gated cation channel activity', 'transmembrane transporter activity', 'inorganic cation transmembrane transporter activity', 'ion binding', 'cation binding', 'metal ion binding', 'metal ion transmembrane transporter activity', 'Voltage-dependent calcium channel, alpha-1 subunit', 'Voltage-dependent calcium channel, L-type, alpha-1 subunit', 'Ion transport domain', 'Voltage-dependent calcium channel, alpha-1 subunit, IQ domain', 'Voltage-dependent channel domain superfamily', 'Voltage-dependent L-type calcium channel, IQ-associated domain', 'Voltage-gated calcium channel subunit alpha, C-terminal', 'Alternative splicing', 'Calcium', 'Calcium channel', 'Calcium transport', 'Cone-rod dystrophy', 'Disease mutation', 'Glycoprotein', 'Ion transport', 'Ion channel', 'Membrane', 'Metal-binding', 'Phosphoprotein', 'Polymorphism', 'Repeat', 'Sensory transduction', 'Transmembrane', 'Transport', 'Vision', 'Voltage-gated channel', 'Congenital stationary night blindness', 'Disulfide bond', 'Transmembrane helix', 'Disease', 'Ion transport protein', 'Polycystin cation channel', 'Voltage gated calcium channel IQ domain', 'Voltage-gated calcium channel subunit alpha, C-term', 'Voltage-dependent L-type calcium channel, IQ-associated', 'action potential', 'leukocyte homeostasis', 'lymphocyte homeostasis', 'immune system process', 'regulation of immune system process', 'system process', 'transport', 'ion transport', 'cation transport', 'calcium ion transport', 'sensory perception', 'visual perception', 'response to radiation', 'response to light stimulus', 'detection of external stimulus', 'detection of abiotic stimulus', 'detection of light stimulus', 'detection of visible light', 'response to external stimulus', 'response to abiotic stimulus', 'regulation of signal transduction', 'regulation of cell communication', 'regulation of metal ion transport', 'regulation of transmembrane transporter activity', 'regulation of signaling', 'metal ion transport', 'regulation of transporter activity', 'negative regulation of transporter activity', 'regulation of ion transmembrane transporter activity', 'negative regulation of ion transmembrane transporter activity', 'multicellular organismal process', 'regulation of localization', 'ion transmembrane transport', 'regulation of transmembrane transport', 'negative regulation of transmembrane transport', 'regulation of ion transmembrane transport', 'negative regulation of ion transmembrane transport', 'regulation of membrane potential', 'homeostatic process', 'T cell homeostasis', 'regulation of ion transport', 'negative regulation of ion transport', 'negative regulation of molecular function', 'negative regulation of biological process', 'regulation of response to stimulus', 'homeostasis of number of cells', 'regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'regulation of antigen receptor-mediated signaling pathway', 'regulation of T cell receptor signaling pathway', 'nervous system process', 'response to stimulus', 'detection of stimulus involved in sensory perception', 'detection of light stimulus involved in visual perception', 'sensory perception of light stimulus', 'detection of light stimulus involved in sensory perception', 'regulation of transport', 'negative regulation of transport', 'localization', 'establishment of localization', 'detection of stimulus', 'membrane depolarization', 'regulation of calcium ion transport', 'negative regulation of calcium ion transport', 'transmembrane transport', 'biological regulation', 'regulation of biological quality', 'regulation of molecular function', 'calcium ion transmembrane transport', 'divalent metal ion transport', 'divalent inorganic cation transport', 'membrane depolarization during action potential', 'cation transmembrane transport', 'inorganic ion transmembrane transport', 'inorganic cation transmembrane transport', 'regulation of calcium ion transmembrane transporter activity', 'negative regulation of calcium ion transmembrane transporter activity', 'regulation of voltage-gated calcium channel activity', 'negative regulation of voltage-gated calcium channel activity', 'regulation of calcium ion transmembrane transport', 'negative regulation of calcium ion transmembrane transport', 'regulation of cation transmembrane transport', 'negative regulation of cation transmembrane transport', 'regulation of cation channel activity', 'negative regulation of cation channel activity', 'Muscle contraction', 'Cardiac conduction', 'Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase', 'Voltage gated calcium channel IQ domain']",MSESEGGKDTTPEPSPANGAGPGPEWGLCPGPPAVEGESSGASGLGTPKRRNQHSKHKTVAVASAQRSPRALFCLTLANPLRRSCISIVEWKPFDILILLTIFANCVALGVYIPFPEDDSNTANHNLEQVEYVFLVIFTVETVLKIVAYGLVLHPSAYIRNGWNLLDFIIVVVGLFSVLLEQGPGRPGDAPHTGGKPGGFDVKALRAFRVLRPLRLVSGVPSLHIVLNSIMKALVPLLHIALLVLFVIIIYAIIGLELFLGRMHKTCYFLGSDMEAEEDPSPCASSGSGRACTLNQTECRGRWPGPNGGITNFDNFFFAMLTVFQCVTMEGWTDVLYWMQDAMGYELPWVYFVSLVIFGSFFVLNLVLGVLSGEFSKEREKAKARGDFQKQREKQQMEEDLRGYLDWITQAEELDMEDPSADDNLGSMAEEGRAGHRPQLAELTNRRRGRLRWFSHSTRSTHSTSSHASLPASDTGSMTETQGDEDEEEGALASCTRCLNKIMKTRVCRRLRRANRVLRARCRRAVKSNACYWAVLLLVFLNTLTIASEHHGQPVWLTQIQEYANKVLLCLFTVEMLLKLYGLGPSAYVSSFFNRFDCFVVCGGILETTLVEVGAMQPLGISVLRCVRLLRIFKVTRHWASLSNLVASLLNSMKSIASLLLLLFLFIIIFSLLGMQLFGGKFNFDQTHTKRSTFDTFPQALLTVFQILTGEDWNVVMYDGIMAYGGPFFPGMLVCIYFIILFICGNYILLNVFLAIAVDNLASGDAGTAKDKGGEKSNEKDLPQENEGLVPGVEKEEEEGARREGADMEEEEEEEEEEEEEEEEEGAGGVELLQEVVPKEKVVPIPEGSAFFCLSQTNPLRKGCHTLIHHHVFTNLILVFIILSSVSLAAEDPIRAHSFRNHILGYFDYAFTSIFTVEILLKMTVFGAFLHRGSFCRSWFNMLDLLVVSVSLISFGIHSSAISVVKILRVLRVLRPLRAINRAKGLKHVVQCVFVAIRTIGNIMIVTTLLQFMFACIGVQLFKGKFYTCTDEAKHTPQECKGSFLVYPDGDVSRPLVRERLWVNSDFNFDNVLSAMMALFTVSTFEGWPALLYKAIDAYAEDHGPIYNYRVEISVFFIVYIIIIAFFMMNIFVGFVIITFRAQGEQEYQNCELDKNQRQCVEYALKAQPLRRYIPKNPHQYRVWATVNSAAFEYLMFLLILLNTVALAMQHYEQTAPFNYAMDILNMVFTGLFTIEMVLKIIAFKPKHYFTDAWNTFDALIVVGSIVDIAVTEVNNGGHLGESSEDSSRISITFFRLFRVMRLVKLLSKGEGIRTLLWTFIKSFQALPYVALLIAMIFFIYAVIGMQMFGKVALQDGTQINRNNNFQTFPQAVLLLFRCATGEAWQEIMLASLPGNRCDPESDFGPGEEFTCGSNFAIAYFISFFMLCAFLIINLFVAVIMDNFDYLTRDWSILGPHHLDEFKRIWSEYDPGAKGRIKHLDVVALLRRIQPPLGFGKLCPHRVACKRLVAMNMPLNSDGTVTFNATLFALVRTSLKIKTEGNLEQANQELRIVIKKIWKRMKQKLLDEVIPPPDEEEVTVGKFYATFLIQDYFRKFRRRKEKGLLGNDAAPSTSSALQAGLRSLQDLGPEMRQALTCDTEEEEEEGQEGVEEEDEKDLETNKATMVSQPSARRGSGISVSLPVGDRLPDSLSFGPSDDDRGTPTSSQPSVPQAGSNTHRRGSGALIFTIPEEGNSQPKGTKGQNKQDEDEEVPDRLSYLDEQAGTPPCSVLLPPHRAQRYMDGHLVPRRRLLPPTPAGRKPSFTIQCLQRQGSCEDLPIPGTYHRGRNSGPNRAQVLISEGLGLFARDPRFVALAKQEIADACRLTLDEMDNAASDLLAQGTSSLYSDEESILSRFDEEDLGDEMACVHAL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=34

DOMAIN=transmembrane_domain
START=96
END=115
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=130
END=152
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=161
END=180
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=233
END=256
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=238
END=260
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=317
END=339
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=349
END=371
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=455
END=469
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=479
END=490
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=506
END=526
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=525
END=547
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=567
END=589
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=640
END=652
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=655
END=673
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=656
END=678
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=728
END=750
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=787
END=844
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=794
END=831
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=867
END=889
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=909
END=931
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=943
END=965
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=945
END=954
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=964
END=978
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=1000
END=1022
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1111
END=1132
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=1116
END=1138
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1183
END=1205
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1225
END=1244
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1326
END=1345
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=1418
END=1440
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1567
END=1578
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=Ca_chan_IQ
START=1575
END=1609
EVALUE=8.6521700055717e-15
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1640
END=1659
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1785
END=1794
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chrX:49228030_T_C,3.223,-1,HGNC,C,protein_coding,HGNC:1393,ENST00000323022,ENSG00000102001,"['splice_region_variant', 'intron_variant']",CACNA1F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,39886004,39886005,T,G,FCGBP,ENST00000620799,2017-10-11 00:00:00,aAt/aCt,N/T,1590/1642,MODERATE,MED,benign,tolerated,None,0.00002649999988,"Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich",rs773341125,None,0.0008999999845,None,0.003100000089,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39886005_T_G,6.263,-1,HGNC,G,protein_coding,HGNC:13572,ENST00000620799,ENSG00000275395,['missense_variant'],FCGBP,,1590,,4769,,4769,,0.025,,benign,,0,-0.572,,T,0.654,,-0.774,1,tolerated,4769,0.126345400529,N/T,1590,,aAt/aCt,T,-3,0,4769,,,10.7931,0.02708623,N,0.2000233237,0,0.151,T,0.553676,T,T,N,0.7946265577,N,,T,,,,,,,,,,,,
chr19,39886268,39886269,G,A,FCGBP,ENST00000616721,16/28,cCg/cTg,P/L,2637/4204,MODERATE,MED,possibly_damaging,,21.39999962,0.0001999999949,"von Willebrand factor, type D domain",rs142784101,None,None,None,0.001500000013,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39886269_G_A,22.7,-1,HGNC,A,protein_coding,HGNC:13572,ENST00000616721,ENSG00000275395,['missense_variant'],FCGBP,,2637,,7918,,7910,,0.004,,probably_damaging,,0.995,0.345,,T,0.002,,1.085,0.28,tolerated,7918,0.277730125212,P/L,2637,,cCg/cTg,T,0.353,0,7910,,,3.5602,0.7797864,D,0.9908147216,0,0.087,T,0.553676,T,T,N,0.00003132946029,N,,T,,,,,,,,,,,,
chr19,39885667,39885668,C,T,FCGBP,ENST00000616721,,,,-/4204,splice_region_variant,MED,,,None,0.008999999613,.,.,None,0.01009999961,None,0.01730000041,None,1084,4,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39885668_C_T,16.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,39885667,39885668,C,T,FCGBP,ENST00000616721,,,,-/4204,splice_region_variant,MED,,,None,0.008999999613,.,.,None,0.01009999961,None,0.01730000041,None,1084,4,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39885668_C_T,16.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195779683,195779684,C,T,MUC4,ENST00000463781,2017-02-25 00:00:00,Gcc/Acc,A/T,3966/5412,MODERATE,MED,benign,"T,T",None,0.004300000146,".,.",rs368695884,None,0.0008999999845,None,0.008213000372,None,49,3,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779684_C_T,6.913,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",3966,".,.",12008,".,.",11896,"0.114,0.016",0.024,"T,T",benign,".,.",0.098,-2.738,".,.",".,.",0.001,".,.",0.201,0.16,tolerated_low_confidence,12008,".,.",A/T,3966,".,.",Gcc/Acc,"T,T",-0.282,0.001,11896,,,2.1866,0.01759409,N,0.1800033168,0,0.012,T,0.554377,,T,"N,N,N,N",0.0005174002113,N,,T,,,,,,,,,,,,
chr3,195780301,195780302,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,Cct/Tct,P/S,3760/5360,MODERATE,MED,unknown,"D,T",None,0.002400000114,".,.",rs200197178,None,0.0003000000142,None,0.004300000146,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195780302_G_A,0.002,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3760,".,.",11350,".,.",11278,"0.019,0.022",0.004,"T,T",possibly_damaging,".,.",0.65,-3.668,".,.",".,.",0,".,.",-1.484,0.15,tolerated_low_confidence,11350,"0.0138822411134,0.0138822411134",P/T,3760,".,.",Cct/Act,"T,T",-3.808,0,11278,,,5.844,0.1313842,N,0.317299563,0,0.043,T,0.615465,T,T,"D,D,N,N",0.00001241789726,N,0.276,T,U,,,,,,,,,,,
chr3,195781702,195781703,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,Gac/Cac,D/H,3293/5360,missense_variant,MED,benign,,None,0.0003000000142,.,.,None,0,None,0.001300000004,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781703_C_G,16.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195786975,195786976,A,G,MUC4,ENST00000463781,2017-02-25 00:00:00,aTg/aCg,M/T,1535/5412,MODERATE,MED,benign,"T,T",None,0.0007999999798,".,.",rs200019432,None,0.003899999894,None,0.009100000374,None,6,0,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195786976_A_G,0.226,-1,HGNC,G,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",1535,".,.",4716,".,.",4604,"0.062,0.046",0.004,"T,T",benign,".,.",0.044,-2.028,".,.",".,.",0.002,".,.",-1.929,1,tolerated_low_confidence,4716,"0.0138822411134,0.0138822411134",M/T,1535,".,.",aTg/aCg,"T,T",0.167,0,4604,,,4.7644,0.008794552,N,0.1836991067,0,0.017,T,0.554377,T,T,"N,N,N,N",0.0002144945718,N,0.175,T,,,,,,,,,,,,
chr3,195779686,195779687,G,C,MUC4,ENST00000475231,2017-02-24 00:00:00,Cac/Gac,H/D,3965/5360,MODERATE,MED,unknown,"T,T",None,0.00400000019,".,.",rs572850344,None,0.000699999975,None,0.007699999958,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779687_G_C,0.316,-1,HGNC,C,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3965,".,.",11965,".,.",11893,"0.22,0.237",0.019,"T,T",benign,".,.",0.234,-1.726,".,.",".,.",0.002,".,.",0.225,0.63,tolerated_low_confidence,11965,"0.0138822411134,0.0138822411134",H/D,3965,".,.",Cac/Gac,"T,T",-0.746,0,11893,,,5.4844,0.01055165,N,0.9199415131,0,0.007,T,0.554377,T,T,"N,N,N,N",0.0000122349357,N,0.159,T,,,,,,,,,,,,
chr3,195780884,195780885,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,caG/caC,Q/H,3565/5360,MODERATE,MED,unknown,"D,D",None,0.0005000000237,".,.",rs140571210,None,0.006300000008,None,0.00810000021,None,5,0,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195780885_C_G,7.291,-1,HGNC,G,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3693,".,.",11151,".,.",11079,"0.024,0.016",0.002,"T,T",benign,".,.",0.197,-1.935,".,.",".,.",0.002,".,.",-2.143,0.05,tolerated_low_confidence,11151,".,.",Q/H,3693,".,.",caG/caC,"T,T",0.05,0.003,11079,,,2.144,0.02084799,N,0.3056246934,0,0.015,T,0.554377,T,T,"P,P,P,P",0.0009933844741,N,0.127,T,,,,,,,,,,,,
chr3,195781236,195781237,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,tCa/tTa,S/L,3448/5360,missense_variant,MED,benign,,None,0.001200000057,.,.,None,0.0005000000237,None,0.004900000058,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781237_G_A,13.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195781702,195781703,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,Gac/Cac,D/H,3293/5360,missense_variant,MED,benign,,None,0.0003000000142,.,.,None,0,None,0.001300000004,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781703_C_G,16.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195779686,195779687,G,C,MUC4,ENST00000475231,2017-02-24 00:00:00,Cac/Gac,H/D,3965/5360,MODERATE,MED,unknown,"T,T",None,0.00400000019,".,.",rs572850344,None,0.000699999975,None,0.007699999958,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779687_G_C,0.316,-1,HGNC,C,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3965,".,.",11965,".,.",11893,"0.22,0.237",0.019,"T,T",benign,".,.",0.234,-1.726,".,.",".,.",0.002,".,.",0.225,0.63,tolerated_low_confidence,11965,"0.0138822411134,0.0138822411134",H/D,3965,".,.",Cac/Gac,"T,T",-0.746,0,11893,,,5.4844,0.01055165,N,0.9199415131,0,0.007,T,0.554377,T,T,"N,N,N,N",0.0000122349357,N,0.159,T,,,,,,,,,,,,
chr3,195782337,195782338,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,gCa/gTa,A/V,3081/5360,MODERATE,MED,benign,"T,T",None,0.001300000004,".,.",rs79077485,None,0.0000873099998,None,0.008546999656,None,25,1,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195782338_G_A,4.926,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3081,".,.",9314,".,.",9242,"0.107,0.084",0.001,"T,T",benign,".,.",0.197,-2.161,".,.",".,.",0.002,".,.",-1.697,0.02,deleterious_low_confidence,9314,"0.0138822411134,0.0138822411134",A/E,3081,".,.",gCa/gAa,"D,D",-4.185,0,9242,,,2.1444,0.08337291,N,0.7751790992,0,0.031,T,0.554377,T,T,"N,N,N,N",0.00002932456642,N,,T,,,,,,,,,,,,
chr3,195779683,195779684,C,T,MUC4,ENST00000463781,2017-02-25 00:00:00,Gcc/Acc,A/T,3966/5412,MODERATE,MED,benign,"T,T",None,0.004300000146,".,.",rs368695884,None,0.0008999999845,None,0.008213000372,None,49,3,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779684_C_T,6.913,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",3966,".,.",12008,".,.",11896,"0.114,0.016",0.024,"T,T",benign,".,.",0.098,-2.738,".,.",".,.",0.001,".,.",0.201,0.16,tolerated_low_confidence,12008,".,.",A/T,3966,".,.",Gcc/Acc,"T,T",-0.282,0.001,11896,,,2.1866,0.01759409,N,0.1800033168,0,0.012,T,0.554377,,T,"N,N,N,N",0.0005174002113,N,,T,,,,,,,,,,,,
chr3,195782337,195782338,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,gCa/gTa,A/V,3081/5360,MODERATE,MED,benign,"T,T",None,0.001300000004,".,.",rs79077485,None,0.0000873099998,None,0.008546999656,None,25,1,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195782338_G_A,4.926,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3081,".,.",9314,".,.",9242,"0.107,0.084",0.001,"T,T",benign,".,.",0.197,-2.161,".,.",".,.",0.002,".,.",-1.697,0.02,deleterious_low_confidence,9314,"0.0138822411134,0.0138822411134",A/E,3081,".,.",gCa/gAa,"D,D",-4.185,0,9242,,,2.1444,0.08337291,N,0.7751790992,0,0.031,T,0.554377,T,T,"N,N,N,N",0.00002932456642,N,,T,,,,,,,,,,,,
chr3,195779683,195779684,C,T,MUC4,ENST00000463781,2017-02-25 00:00:00,Gcc/Acc,A/T,3966/5412,MODERATE,MED,benign,"T,T",None,0.004300000146,".,.",rs368695884,None,0.0008999999845,None,0.008213000372,None,49,3,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779684_C_T,6.913,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",3966,".,.",12008,".,.",11896,"0.114,0.016",0.024,"T,T",benign,".,.",0.098,-2.738,".,.",".,.",0.001,".,.",0.201,0.16,tolerated_low_confidence,12008,".,.",A/T,3966,".,.",Gcc/Acc,"T,T",-0.282,0.001,11896,,,2.1866,0.01759409,N,0.1800033168,0,0.012,T,0.554377,,T,"N,N,N,N",0.0005174002113,N,,T,,,,,,,,,,,,
chr3,195781236,195781237,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,tCa/tTa,S/L,3448/5360,missense_variant,MED,benign,,None,0.001200000057,.,.,None,0.0005000000237,None,0.004900000058,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781237_G_A,13.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195779686,195779687,G,C,MUC4,ENST00000475231,2017-02-24 00:00:00,Cac/Gac,H/D,3965/5360,MODERATE,MED,unknown,"T,T",None,0.00400000019,".,.",rs572850344,None,0.000699999975,None,0.007699999958,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779687_G_C,0.316,-1,HGNC,C,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3965,".,.",11965,".,.",11893,"0.22,0.237",0.019,"T,T",benign,".,.",0.234,-1.726,".,.",".,.",0.002,".,.",0.225,0.63,tolerated_low_confidence,11965,"0.0138822411134,0.0138822411134",H/D,3965,".,.",Cac/Gac,"T,T",-0.746,0,11893,,,5.4844,0.01055165,N,0.9199415131,0,0.007,T,0.554377,T,T,"N,N,N,N",0.0000122349357,N,0.159,T,,,,,,,,,,,,
chr3,195780301,195780302,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,Cct/Tct,P/S,3760/5360,MODERATE,MED,unknown,"D,T",None,0.002400000114,".,.",rs200197178,None,0.0003000000142,None,0.004300000146,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195780302_G_A,0.002,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3760,".,.",11350,".,.",11278,"0.019,0.022",0.004,"T,T",possibly_damaging,".,.",0.65,-3.668,".,.",".,.",0,".,.",-1.484,0.15,tolerated_low_confidence,11350,"0.0138822411134,0.0138822411134",P/T,3760,".,.",Cct/Act,"T,T",-3.808,0,11278,,,5.844,0.1313842,N,0.317299563,0,0.043,T,0.615465,T,T,"D,D,N,N",0.00001241789726,N,0.276,T,U,,,,,,,,,,,
chr3,195779686,195779687,G,C,MUC4,ENST00000475231,2017-02-24 00:00:00,Cac/Gac,H/D,3965/5360,MODERATE,MED,unknown,"T,T",None,0.00400000019,".,.",rs572850344,None,0.000699999975,None,0.007699999958,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779687_G_C,0.316,-1,HGNC,C,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3965,".,.",11965,".,.",11893,"0.22,0.237",0.019,"T,T",benign,".,.",0.234,-1.726,".,.",".,.",0.002,".,.",0.225,0.63,tolerated_low_confidence,11965,"0.0138822411134,0.0138822411134",H/D,3965,".,.",Cac/Gac,"T,T",-0.746,0,11893,,,5.4844,0.01055165,N,0.9199415131,0,0.007,T,0.554377,T,T,"N,N,N,N",0.0000122349357,N,0.159,T,,,,,,,,,,,,
chr3,195786975,195786976,A,G,MUC4,ENST00000463781,2017-02-25 00:00:00,aTg/aCg,M/T,1535/5412,MODERATE,MED,benign,"T,T",None,0.0007999999798,".,.",rs200019432,None,0.003899999894,None,0.009100000374,None,6,0,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195786976_A_G,0.226,-1,HGNC,G,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",1535,".,.",4716,".,.",4604,"0.062,0.046",0.004,"T,T",benign,".,.",0.044,-2.028,".,.",".,.",0.002,".,.",-1.929,1,tolerated_low_confidence,4716,"0.0138822411134,0.0138822411134",M/T,1535,".,.",aTg/aCg,"T,T",0.167,0,4604,,,4.7644,0.008794552,N,0.1836991067,0,0.017,T,0.554377,T,T,"N,N,N,N",0.0002144945718,N,0.175,T,,,,,,,,,,,,
chr3,195779683,195779684,C,T,MUC4,ENST00000463781,2017-02-25 00:00:00,Gcc/Acc,A/T,3966/5412,MODERATE,MED,benign,"T,T",None,0.004300000146,".,.",rs368695884,None,0.0008999999845,None,0.008213000372,None,49,3,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779684_C_T,6.913,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",3966,".,.",12008,".,.",11896,"0.114,0.016",0.024,"T,T",benign,".,.",0.098,-2.738,".,.",".,.",0.001,".,.",0.201,0.16,tolerated_low_confidence,12008,".,.",A/T,3966,".,.",Gcc/Acc,"T,T",-0.282,0.001,11896,,,2.1866,0.01759409,N,0.1800033168,0,0.012,T,0.554377,,T,"N,N,N,N",0.0005174002113,N,,T,,,,,,,,,,,,
chr3,195780884,195780885,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,caG/caC,Q/H,3565/5360,MODERATE,MED,unknown,"D,D",None,0.0005000000237,".,.",rs140571210,None,0.006300000008,None,0.00810000021,None,5,0,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195780885_C_G,7.291,-1,HGNC,G,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3693,".,.",11151,".,.",11079,"0.024,0.016",0.002,"T,T",benign,".,.",0.197,-1.935,".,.",".,.",0.002,".,.",-2.143,0.05,tolerated_low_confidence,11151,".,.",Q/H,3693,".,.",caG/caC,"T,T",0.05,0.003,11079,,,2.144,0.02084799,N,0.3056246934,0,0.015,T,0.554377,T,T,"P,P,P,P",0.0009933844741,N,0.127,T,,,,,,,,,,,,
chr3,195781702,195781703,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,Gac/Cac,D/H,3293/5360,missense_variant,MED,benign,,None,0.0003000000142,.,.,None,0,None,0.001300000004,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781703_C_G,16.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195782337,195782338,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,gCa/gTa,A/V,3081/5360,MODERATE,MED,benign,"T,T",None,0.001300000004,".,.",rs79077485,None,0.0000873099998,None,0.008546999656,None,25,1,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195782338_G_A,4.926,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3081,".,.",9314,".,.",9242,"0.107,0.084",0.001,"T,T",benign,".,.",0.197,-2.161,".,.",".,.",0.002,".,.",-1.697,0.02,deleterious_low_confidence,9314,"0.0138822411134,0.0138822411134",A/E,3081,".,.",gCa/gAa,"D,D",-4.185,0,9242,,,2.1444,0.08337291,N,0.7751790992,0,0.031,T,0.554377,T,T,"N,N,N,N",0.00002932456642,N,,T,,,,,,,,,,,,
chr3,195779683,195779684,C,T,MUC4,ENST00000463781,2017-02-25 00:00:00,Gcc/Acc,A/T,3966/5412,MODERATE,MED,benign,"T,T",None,0.004300000146,".,.",rs368695884,None,0.0008999999845,None,0.008213000372,None,49,3,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779684_C_T,6.913,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",3966,".,.",12008,".,.",11896,"0.114,0.016",0.024,"T,T",benign,".,.",0.098,-2.738,".,.",".,.",0.001,".,.",0.201,0.16,tolerated_low_confidence,12008,".,.",A/T,3966,".,.",Gcc/Acc,"T,T",-0.282,0.001,11896,,,2.1866,0.01759409,N,0.1800033168,0,0.012,T,0.554377,,T,"N,N,N,N",0.0005174002113,N,,T,,,,,,,,,,,,
chr3,195786975,195786976,A,G,MUC4,ENST00000463781,2017-02-25 00:00:00,aTg/aCg,M/T,1535/5412,MODERATE,MED,benign,"T,T",None,0.0007999999798,".,.",rs200019432,None,0.003899999894,None,0.009100000374,None,6,0,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195786976_A_G,0.226,-1,HGNC,G,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",1535,".,.",4716,".,.",4604,"0.062,0.046",0.004,"T,T",benign,".,.",0.044,-2.028,".,.",".,.",0.002,".,.",-1.929,1,tolerated_low_confidence,4716,"0.0138822411134,0.0138822411134",M/T,1535,".,.",aTg/aCg,"T,T",0.167,0,4604,,,4.7644,0.008794552,N,0.1836991067,0,0.017,T,0.554377,T,T,"N,N,N,N",0.0002144945718,N,0.175,T,,,,,,,,,,,,
chr3,195780301,195780302,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,Cct/Tct,P/S,3760/5360,MODERATE,MED,unknown,"D,T",None,0.002400000114,".,.",rs200197178,None,0.0003000000142,None,0.004300000146,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195780302_G_A,0.002,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3760,".,.",11350,".,.",11278,"0.019,0.022",0.004,"T,T",possibly_damaging,".,.",0.65,-3.668,".,.",".,.",0,".,.",-1.484,0.15,tolerated_low_confidence,11350,"0.0138822411134,0.0138822411134",P/T,3760,".,.",Cct/Act,"T,T",-3.808,0,11278,,,5.844,0.1313842,N,0.317299563,0,0.043,T,0.615465,T,T,"D,D,N,N",0.00001241789726,N,0.276,T,U,,,,,,,,,,,
chr3,195781702,195781703,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,Gac/Cac,D/H,3293/5360,missense_variant,MED,benign,,None,0.0003000000142,.,.,None,0,None,0.001300000004,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781703_C_G,16.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195779686,195779687,G,C,MUC4,ENST00000475231,2017-02-24 00:00:00,Cac/Gac,H/D,3965/5360,MODERATE,MED,unknown,"T,T",None,0.00400000019,".,.",rs572850344,None,0.000699999975,None,0.007699999958,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779687_G_C,0.316,-1,HGNC,C,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3965,".,.",11965,".,.",11893,"0.22,0.237",0.019,"T,T",benign,".,.",0.234,-1.726,".,.",".,.",0.002,".,.",0.225,0.63,tolerated_low_confidence,11965,"0.0138822411134,0.0138822411134",H/D,3965,".,.",Cac/Gac,"T,T",-0.746,0,11893,,,5.4844,0.01055165,N,0.9199415131,0,0.007,T,0.554377,T,T,"N,N,N,N",0.0000122349357,N,0.159,T,,,,,,,,,,,,
chr3,195781236,195781237,G,A,MUC4,ENST00000475231,2017-02-24 00:00:00,tCa/tTa,S/L,3448/5360,missense_variant,MED,benign,,None,0.001200000057,.,.,None,0.0005000000237,None,0.004900000058,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781237_G_A,13.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195780884,195780885,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,caG/caC,Q/H,3565/5360,MODERATE,MED,unknown,"D,D",None,0.0005000000237,".,.",rs140571210,None,0.006300000008,None,0.00810000021,None,5,0,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195780885_C_G,7.291,-1,HGNC,G,protein_coding,HGNC:7514,ENST00000475231,ENSG00000145113,['missense_variant'],MUC4,"N,N",3693,".,.",11151,".,.",11079,"0.024,0.016",0.002,"T,T",benign,".,.",0.197,-1.935,".,.",".,.",0.002,".,.",-2.143,0.05,tolerated_low_confidence,11151,".,.",Q/H,3693,".,.",caG/caC,"T,T",0.05,0.003,11079,,,2.144,0.02084799,N,0.3056246934,0,0.015,T,0.554377,T,T,"P,P,P,P",0.0009933844741,N,0.127,T,,,,,,,,,,,,
chr3,195781702,195781703,C,G,MUC4,ENST00000475231,2017-02-24 00:00:00,Gac/Cac,D/H,3293/5360,missense_variant,MED,benign,,None,0.0003000000142,.,.,None,0,None,0.001300000004,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",CH,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195781703_C_G,16.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,54806085,54806086,T,C,KIR2DL4,ENST00000396284,2017-04-08 00:00:00,cTt/cCt,L/P,205/416,MODERATE,MED,benign,".,T,T,T,T,T",None,None,"Immunoglobulin&Immunoglobulin subtype,Immunoglobulin&Immunoglobulin subtype,.,.,.,Immunoglobulin",rs112694450,None,None,rs11672983,0,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",DN,ENSG00000117281,CD160 molecule,"['CD markers', 'Predicted intracellular proteins']","['Adaptive immunity', 'Angiogenesis', 'Immunity', 'Innate immunity']","{'blood': '33.9', 'brain': '15.2', 'intestine': '19.9', 'lymphoid tissue': '17.4'}",9.3,5.6,0.9,6,1,19.9,0.8,0.2,0.3,2.7,0.4,23.2,33.9,"KIR2DL4,PTPN11,BAG6,HLA-C,HLA-C,HLA-E,HLA-E,HLA-E,HLA-A,HLA-A,HLA-A,HLA-A,PTPN6,PTPN6,PTPN6,HLA-B,HLA-B,HLA-B,HLA-B,HLA-B,HLA-G,HLA-G,HLA-G,HLA-G,HLA-G,HLA-G,B2M,B2M,B2M,B2M,B2M,B2M,B2M,B2M","HLA-F,KIR2DL4,KIR2DL4,HLA-F,KIR2DL4,HLA-F,KIR2DL4,HLA-C,HLA-F,KIR2DL4,HLA-C,HLA-E,KIR2DL4,PTPN11,HLA-A,HLA-F,KIR2DL4,HLA-C,HLA-E,HLA-A,HLA-F,KIR2DL4,HLA-C,HLA-E,HLA-A,HLA-B,HLA-F,KIR2DL4,HLA-C,HLA-E,HLA-A,PTPN6,HLA-B,HLA-G","[0.473, 0.348, 0.862, 0.018278, 0.731, 0.022176, 0.707, 0.019176, 0.016813, 0.676, 0.01844, 0.017556, 0.386, 0.032304, 0.221, 0.016123, 0.67, 0.016632, 0.016126, 0.017208, 0.017468, 0.889, 0.016548, 0.020086, 0.01501, 0.01442, 0.11039, 0.317, 0.647, 0.64, 0.955, 0.095, 0.699, 0.631]","['cell', 'plasma membrane', 'integral component of plasma membrane', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane part', 'plasma membrane part', 'cell part', 'cell periphery', 'transmembrane signaling receptor activity', 'signaling receptor activity', 'molecular transducer activity', 'Immunoglobulin subtype', 'Immunoglobulin-like domain', 'Immunoglobulin', 'Immunoglobulin-like fold', 'Immunoglobulin-like domain superfamily', 'Alternative splicing', 'Glycoprotein', 'Immunoglobulin domain', 'Membrane', 'Polymorphism', 'Receptor', 'Repeat', 'Signal', 'Transmembrane', 'Endosome', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'Immunoglobulin domain', 'Immunoglobulin domain', 'regulation of immune system process', 'response to stress', 'defense response', 'cellular defense response', 'cell communication', 'signal transduction', 'cellular process', 'signaling', 'regulation of response to stimulus', 'regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'biological regulation', 'Adaptive Immune System', 'Immune System', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Immunoglobulin', 'Immunoglobulin like']",MSMSPTVIILACLGFFLDQSVWAHVGLYEKPSLTARPGPTVRAGENVTLSCSSQSSFDIYHLSREGEAHELRLPAVPSINGTFQADFPLGPATHGETYRCFGSFHGSPYEWSDPSDPLPVSVTDAAVMNQEPAGHRTVNREDSDEQDPQEVTYAQLDHCIFTQRKITGPSQRSKRPSTDTSVCIELPNAEPRALSPAHEHHSQALMGSSRETTALSQTQLASSNVPAAGI,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=0

-- FINISHED --
",chr19:54806086_T_C,0.11,1,HGNC,C,protein_coding,HGNC:6332,ENST00000396284,ENSG00000189013,['missense_variant'],KIR2DL4,".,D,D,D,D,N",205,".,.,2.22587521974,.,.,.",614,".,.,B,B,.,B",614,"0.048,0.084,0.079,0.088,0.099,0.098",0,".,T,T,T,T,T",benign,".,.,.,.,.,.",0.017,-1.727,".,.,L,L,.,.",".,.,.,.,.,.",0.001,".,.,B,B,.,B",-1.561,0.22,tolerated,614,"0.043077524339,0.043077524339,0.043077524339,0.043077524339,0.043077524339,0.043077524339",L/P,205,".,.,.,.,.,.",cTt/cCt,"T,T,T,T,T,T",-4.522,0,614,,,0.2444,0.0218348,N,0.3054616353,0,0.084,T,0.487112,T,T,"N,N,N,N,N,N,N,N,N,N",0.0004004680851,N,,T,,,,,,,,,,,,
chr19,54806108,54806109,A,G,KIR2DL4,ENST00000396293,2017-03-05 00:00:00,Atc/Gtc,I/V,79/230,MODERATE,MED,benign,".,T,T,T,T,T",None,None,"Immunoglobulin&Immunoglobulin subtype,Immunoglobulin&Immunoglobulin subtype,.,.,.,Immunoglobulin",rs200435373,None,0,rs11672983,0,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",DN,ENSG00000117281,CD160 molecule,"['CD markers', 'Predicted intracellular proteins']","['Adaptive immunity', 'Angiogenesis', 'Immunity', 'Innate immunity']","{'blood': '33.9', 'brain': '15.2', 'intestine': '19.9', 'lymphoid tissue': '17.4'}",9.3,5.6,0.9,6,1,19.9,0.8,0.2,0.3,2.7,0.4,23.2,33.9,"KIR2DL4,PTPN11,BAG6,HLA-C,HLA-C,HLA-E,HLA-E,HLA-E,HLA-A,HLA-A,HLA-A,HLA-A,PTPN6,PTPN6,PTPN6,HLA-B,HLA-B,HLA-B,HLA-B,HLA-B,HLA-G,HLA-G,HLA-G,HLA-G,HLA-G,HLA-G,B2M,B2M,B2M,B2M,B2M,B2M,B2M,B2M","HLA-F,KIR2DL4,KIR2DL4,HLA-F,KIR2DL4,HLA-F,KIR2DL4,HLA-C,HLA-F,KIR2DL4,HLA-C,HLA-E,KIR2DL4,PTPN11,HLA-A,HLA-F,KIR2DL4,HLA-C,HLA-E,HLA-A,HLA-F,KIR2DL4,HLA-C,HLA-E,HLA-A,HLA-B,HLA-F,KIR2DL4,HLA-C,HLA-E,HLA-A,PTPN6,HLA-B,HLA-G","[0.473, 0.348, 0.862, 0.018278, 0.731, 0.022176, 0.707, 0.019176, 0.016813, 0.676, 0.01844, 0.017556, 0.386, 0.032304, 0.221, 0.016123, 0.67, 0.016632, 0.016126, 0.017208, 0.017468, 0.889, 0.016548, 0.020086, 0.01501, 0.01442, 0.11039, 0.317, 0.647, 0.64, 0.955, 0.095, 0.699, 0.631]","['cell', 'plasma membrane', 'integral component of plasma membrane', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane part', 'plasma membrane part', 'cell part', 'cell periphery', 'transmembrane signaling receptor activity', 'signaling receptor activity', 'molecular transducer activity', 'Immunoglobulin subtype', 'Immunoglobulin-like domain', 'Immunoglobulin', 'Immunoglobulin-like fold', 'Immunoglobulin-like domain superfamily', 'Alternative splicing', 'Glycoprotein', 'Immunoglobulin domain', 'Membrane', 'Polymorphism', 'Receptor', 'Repeat', 'Signal', 'Transmembrane', 'Endosome', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'Immunoglobulin domain', 'Immunoglobulin domain', 'regulation of immune system process', 'response to stress', 'defense response', 'cellular defense response', 'cell communication', 'signal transduction', 'cellular process', 'signaling', 'regulation of response to stimulus', 'regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'biological regulation', 'Adaptive Immune System', 'Immune System', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Immunoglobulin', 'Immunoglobulin like']",MSMSPTVIILACLGFFLDQSVWAHVGLYEKPSLTARPGPTVRAGENVTLSCSSQSSFDIYHLSREGEAHELRLPAVPSINGTFQADFPLGPATHGETYRCFGSFHGSPYEWSDPSDPLPVSVTDAAVMNQEPAGHRTVNREDSDEQDPQEVTYAQLDHCIFTQRKITGPSQRSKRPSTDTSVCIELPNAEPRALSPAHEHHSQALMGSSRETTALSQTQLASSNVPAAGI,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=0

-- FINISHED --
",chr19:54806109_A_G,0.001,1,HGNC,G,protein_coding,HGNC:6332,ENST00000396293,ENSG00000189013,['missense_variant'],KIR2DL4,".,N,N,N,N,N",79,".,.,1.30891436969,.,.,.",246,".,.,B,B,.,B",235,"0.064,0.095,0.099,0.1,0.108,0.099",0,".,T,T,T,T,T",benign,".,.,.,.,.,.",0,-2.92,".,.,N,N,.,.",".,.,.,.,.,.",0,".,.,B,B,.,B",-4.17,0.54,tolerated,246,"0.043077524339,0.043077524339,0.043077524339,0.043077524339,0.043077524339,0.043077524339",I/V,79,".,.,.,.,.,.",Atc/Gtc,"T,T,T,T,T,T",-0.997,0,235,,,,0.0009431019,N,0.1675746182,0,0.047,T,0.487112,T,T,"N,N,N,N,N,N,N,N,N,N",0.04316146659,N,,T,N,,,,,,,,,,,
chr17,41226774,41226775,G,T,KRTAP9-2,ENST00000455970,2017-03-03 00:00:00,Gcc/Tcc,A/S,37/170,missense_variant,MED,unknown,tolerated,None,0.001000000048,.,rs71371478,None,0.003000000026,None,0.007000000216,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",DN,ENSG00000239886,Keratin associated protein 9-2,['Predicted intracellular proteins'],None,{'skin 1': '23.6'},0,0,0,0,0,0,0,0,0,0,0,0,0,"KRTAP8-1,KRTAP9-4,KRTAP9-4,KRTAP9-4,KRTAP13-1,KRTAP13-1,KRTAP13-1,KRTAP9-2,KRTAP9-2,KRTAP9-2,KRTAP9-2,KRTAP9-2,KRTAP1-4,KRTAP1-4,KRTAP1-4,KRTAP1-4,KRTAP1-4,KRTAP1-4,KRTAP13-3,KRTAP13-3,KRTAP13-3,KRTAP13-3,KRTAP13-3,KRTAP3-3,KRTAP3-3,KRTAP3-3,KRTAP3-3,KRTAP3-3,KRTAP3-2,KRTAP3-2,KRTAP3-2,KRTAP3-2,KRTAP3-2,KRTAP3-2,KRTAP3-2,KRTAP3-2,KRTAP7-1,KRTAP7-1,KRTAP7-1,KRTAP7-1,KRTAP7-1,KRTAP7-1,KRTAP7-1,KRTAP7-1,KRTAP7-1,KRTAP7-1","KRTAP11-1,KRT27,KRTAP11-1,KRTAP8-1,KRT27,KRTAP8-1,KRTAP9-4,KRT27,KRTAP11-1,KRTAP8-1,KRTAP9-4,KRTAP13-1,KRT27,KRTAP11-1,KRTAP8-1,KRTAP9-4,KRTAP13-1,KRTAP9-2,KRTAP11-1,KRTAP8-1,KRTAP9-4,KRTAP9-2,KRTAP1-4,KRTAP11-1,KRTAP8-1,KRTAP9-4,KRTAP9-2,KRTAP13-3,KRT27,KRTAP11-1,KRTAP8-1,KRTAP9-4,KRTAP13-1,KRTAP9-2,KRTAP1-4,KRTAP13-3,KRT27,KRTAP11-1,KRTAP8-1,KRTAP9-4,KRTAP13-1,KRTAP9-2,KRTAP1-4,KRTAP13-3,KRTAP3-3,KRTAP3-2","[0.752, 0.511, 0.423, 0.383, 0.443, 0.617, 0.412, 0.558, 0.471, 0.567, 0.00990000000000001, 0.586, 0.53, 0.567, 0.54, 0.465, 0.465, 0.531, 0.723, 0.533, 0.574, 0.493, 0.497, 0.546, 0.365, 0.418, 0.473, 0.412, 0.474, 0.616, 0.37, 0.418, 0.43, 0.473, 0.616, 0.567, 0.55, 0.773, 0.778, 0.443, 0.669, 0.496, 0.538, 0.622, 0.441, 0.57]","['intracellular', 'cell', 'cytoplasm', 'cytosol', 'cytoskeleton', 'intermediate filament', 'organelle', 'non-membrane-bounded organelle', 'intracellular organelle', 'intracellular non-membrane-bounded organelle', 'organelle part', 'intracellular part', 'cytoskeletal part', 'cytoplasmic part', 'intracellular organelle part', 'cell part', 'keratin filament', 'intermediate filament cytoskeleton', 'supramolecular complex', 'supramolecular polymer', 'supramolecular fiber', 'polymeric cytoskeletal fiber', 'binding', 'protein binding', 'identical protein binding', 'Keratin-associated protein', 'Keratin', 'Polymorphism', 'Repeat', 'Keratin, high sulfur B2 protein', 'multicellular organism development', 'epidermis development', 'tissue development', 'epidermal cell differentiation', 'cellular process', 'cell differentiation', 'keratinocyte differentiation', 'epithelial cell differentiation', 'keratinization', 'multicellular organismal process', 'developmental process', 'skin development', 'animal organ development', 'system development', 'anatomical structure development', 'cellular developmental process', 'epithelium development', 'Developmental Biology', 'Keratinization']",MTHCCSPCCQPTCCRTTCCRTTCWKPTTVTTCSSTPCCQPACCVSSCCQPCCRPTCCQNTCCRTTCCQPTCVTSCCQPSCCSTPCCQPTCCGSSCCGQTSCGSSCGQSSSCAPVYCRRTCYYPTTVCLPGCLNQSCGSNCCQPCCRPACCETTCCRTTCFQPTCVSSCCQPSCC,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=low_complexity_region
START=2
END=111
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=140
END=159
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr17:41226775_G_T,0.001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195779188,195779189,C,G,MUC4,ENST00000463781,2017-02-25 00:00:00,Gtc/Ctc,V/L,4131/5412,missense_variant,MED,unknown,,None,0.00005147000047,.,.,None,0.00009999999747,None,0.0008999999845,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",DN,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195779189_C_G,18.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,195780811,195780812,C,T,MUC4,ENST00000463781,2017-02-25 00:00:00,Gct/Act,A/T,3590/5412,MODERATE,MED,benign,"D,T",None,0.006399999838,".,.",rs71187742,None,0,None,0.016818,None,26,2,None,None,"TSK_9693_015374,TSK_12136_016021",DN,ENSG00000145113,"Mucin 4, cell surface associated","['Predicted membrane proteins', 'Predicted secreted proteins']",['Cell adhesion'],"{'intestine': '21.5', 'lymphoid tissue': '57.2'}",21.5,0.4,13,0.4,1.9,1.7,2.4,0,0,0,0,0,0,"MUC21,MUC16,MUC16,MUC6,MUC6,MUC6,MUC7,MUC7,MUC7,MUC7,MUC20,MUC20,MUC20,MUC20,MUC20,MUC15,MUC15,MUC15,MUC15,MUC15,MUC15,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,MUC4,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,GALNT6,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC1,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13,MUC13","B3GNT5,B3GNT5,MUC21,B3GNT5,MUC21,MUC16,B3GNT5,MUC21,MUC16,MUC6,B3GNT5,MUC21,MUC16,MUC6,MUC7,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,B3GNT5,MUC21,MUC16,MUC6,MUC7,MUC20,MUC15,MUC4,GALNT6,MUC1","[0, 0.118, 0.672, 0.089, 0.619, 0.758, 0.043, 0.669, 0.703, 0.793, 0.617, 0.769, 0.759, 0.717, 0.671, 0, 0.767, 0.734, 0.677, 0.71, 0.819, 0.501, 0.655, 0.867, 0.851, 0.796, 0.789, 0.724, 0, 0.214, 0.284, 0.187, 0.251, 0, 0.594, 0.085, 0.58, 0.797, 0.86, 0.734, 0.669, 0.711, 0.867, 0.53, 0.526, 0.688, 0.735, 0.731, 0.702, 0.801, 0.8, 0.799, 0.19, 0.703]","['extracellular region', 'intracellular', 'cell', 'cytoplasm', 'Golgi apparatus', 'Golgi lumen', 'plasma membrane', 'integral component of plasma membrane', 'endomembrane system', 'membrane', 'integral component of membrane', 'extracellular matrix', 'intrinsic component of membrane', 'intrinsic component of plasma membrane', 'membrane-enclosed lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'extracellular region part', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'cytoplasmic part', 'intracellular organelle part', 'plasma membrane part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'signaling receptor binding', 'ErbB-2 class receptor binding', 'structural molecule activity', 'extracellular matrix structural constituent', 'binding', 'protein binding', 'extracellular matrix constituent, lubricant activity', 'EGF-like domain', 'von Willebrand factor, type D domain', 'NIDO domain', 'AMOP domain', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'von Willebrand factor type D domain', 'Nidogen-like', 'tissue homeostasis', 'activation of innate immune response', 'innate immune response activating cell surface receptor signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'activation of immune response', 'immune system process', 'immune response-activating cell surface receptor signaling pathway', 'regulation of immune system process', 'positive regulation of immune system process', 'immune response-activating signal transduction', 'innate immune response-activating signal transduction', 'immune response-regulating signaling pathway', 'immune response-regulating cell surface receptor signaling pathway', 'system process', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'cell communication', 'cell adhesion', 'cell-matrix adhesion', 'signal transduction', 'cell surface receptor signaling pathway', 'digestion', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'epithelial structure maintenance', 'O-glycan processing', 'protein metabolic process', 'digestive system process', 'biological adhesion', 'signaling', 'maintenance of gastrointestinal epithelium', 'regulation of defense response', 'positive regulation of defense response', 'cell-substrate adhesion', 'multicellular organismal process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'homeostatic process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'regulation of innate immune response', 'positive regulation of innate immune response', 'positive regulation of biological process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'multicellular organismal homeostasis', 'regulation of immune response', 'positive regulation of immune response', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'cellular response to stimulus', 'anatomical structure homeostasis', 'biological regulation', 'regulation of biological quality', 'glycosylation', 'organic substance metabolic process', 'regulation of response to stress', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Disease', 'Innate Immune System', 'Immune System', 'Diseases of glycosylation', 'Diseases associated with O-glycosylation of proteins', 'Metabolism of proteins', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'O-linked glycosylation', 'Dectin-2 family', 'C-type lectin receptors (CLRs)', 'Post-translational protein modification', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'EGF domain, unclasssified subfamily', 'Epidermal growth factor-like domain.', 'von Willebrand factor (vWF) type D domain', 'Extracellular domain of unknown function in nidogen (entactin) and hypothetical proteins.', 'Adhesion-associated domain present in MUC4 and other proteins']",KAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTGTAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVTQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTQAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGDGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTRTSRGSDTISLASQATDTFSTVPPTPPSITSTGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTYASSASTGHTTPLHVTDASSVSTGHATPLPVTSPSSVSTGHTTPL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=low_complexity_region
START=49
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=70
END=82
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=119
END=142
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=258
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=350
END=364
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=534
END=546
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=624
END=636
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=675
END=690
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=709
END=747
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=804
END=822
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=848
END=869
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=926
END=943
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:195780812_C_T,8.762,-1,HGNC,T,protein_coding,HGNC:7514,ENST00000463781,ENSG00000145113,['missense_variant'],MUC4,"N,N",3590,".,.",10880,".,.",10768,"0.022,0.017",0.001,"T,T",possibly_damaging,".,.",0.494,0.084,".,.",".,.",0.009,".,.",-1.23,0.51,tolerated_low_confidence,10880,".,.",A/T,3590,".,.",Gct/Act,"T,T",-3.281,0,10768,,,3.5185,0.01301163,N,0.8777053343,0,0.028,T,0.554377,T,T,"N,N,N,N",0.0004363864377,N,0.176,T,,,,,,,,,,,,
chr6,31629691,31629692,A,C,PRRC2A,ENST00000376007,14/31,Aag/Cag,K/Q,701/2157,MODERATE,MED,benign,"D,D",22.70000076,0.00007434000145,".,.",rs751599629,None,0.0001999999949,None,0.001700000023,None,None,None,None,None,"TSK_9693_015374,TSK_12136_016021",DN,ENSG00000204469,Proline rich coiled-coil 2A,"['Plasma proteins', 'Predicted intracellular proteins']",None,None,24.6,4.8,47.2,14.9,7.1,23,34.6,0.5,0,0,0,0,0,"ZBTB12,VARS,GPANK1,PRRC2A,PRRC2A,PRRC2A,PRRC2A,PRRC2A,ABHD16A,ABHD16A,ABHD16A,ABHD16A,UBAP2L,KMT2B,KMT2B,CIC,CPSF1","SKIV2L,ZBTB12,ZBTB12,SRCAP,SKIV2L,ZBTB12,VARS,GPANK1,ZBTB12,VARS,GPANK1,PRRC2A,PRRC2A,SRCAP,PRRC2A,PRRC2A,PRRC2A","[0.683, 0.543, 0.804, 0, 0.642, 0.794, 0.644, 0.794, 0.755, 0.484, 0.883, 0.748, 0, 0.254, 0.049, 0, 0]","['intracellular', 'cell', 'nucleus', 'nucleoplasm', 'cytoplasm', 'cytosol', 'plasma membrane', 'membrane', 'membrane-enclosed lumen', 'nuclear lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'nuclear part', 'cytoplasmic part', 'intracellular organelle part', 'cell part', 'intracellular organelle lumen', 'cell periphery', 'BAT2, N-terminal', 'Protein PRRC2', 'Acetylation', 'Alternative splicing', 'Methylation', 'Nucleus', 'Phosphoprotein', 'Polymorphism', 'Repeat', 'Cytoplasm', 'BAT2 N-terminus', 'cellular process', 'cell differentiation', 'developmental process', 'cellular developmental process']",MSDRSGPTAKGKDGKKYSSLNLFDTYKGKSLEIQKPAVAPRHGLQSLGKVAIARRMPPPANLPSLKAENKGNDPNVSLVPKDGTGWASKQEQSDPKSSDASTAQPPESQPLPASQTPASNQPKRPPAAPENTPLVPSGVKSWAQASVTHGAHGDGGRASSLLSRFSREEFPTLQAAGDQDKAAKERESAEQSSGPGPSLRPQNSTTWRDGGGRGPDELEGPDSKLHHGHDPRGGLQPSGPPQFPPYRGMMPPFMYPPYLPFPPPYGPQGPYRYPTPDGPSRFPRVAGPRGSGPPMRLVEPVGRPSILKEDNLKEFDQLDQENDDGWAGAHEEVDYTEKLKFSDEEDGRDSDEEGAEGHRDSQSASGEERPPEADGKKGNSPNSEPPTPKTAWAETSRPPETEPGPPAPKPPLPPPHRGPAGNWGPPGDYPDRGGPPCKPPAPEDEDEAWRQRRKQSSSEISLAVERARRRREEEERRMQEERRAACAEKLKRLDEKFGAPDKRLKAEPAAPPAAPSTPAPPPAVPKELPAPPAPPPASAPTPETEPEEPAQAPPAQSTPTPGVAAAPTLVSGGGSTSSTSSGSFEASPVEPQLPSKEGPEPPEEVPPPTTPPVPKVEPKGDGIGPTRQPPSQGLGYPKYQKSLPPRFQRQQQEQLLKQQQQHQWQQHQQGSAPPTPVPPSPPQPVTLGAVPAPQAPPPPPKALYPGALGRPPPMPPMNFDPRWMMIPPYVDPRLLQGRPPLDFYPPGVHPSGLVPRERSDSGGSSSEPFDRHAPAMLRERGTPPVDPKLAWVGDVFTATPAEPRPLTSPLRQAADEDDKGMRSETPPVPPPPPSSSAVFRLDQVIHSNPAGIQQALAQLSSRQGSVTAPGGHPRHKPGLPQAPQGPSPRPPTRYEPQRVNSGLSSDPHFEEPGPMVRGVGGTPRDSAGVSPFPPKRRERPPRKPELLQEESLPPPHSSGFLGSKPEGPGPQAESRDTGTEALTPHIWNRLHTATSRKSYRPSSMEPWMEPLSPFEDVAGTEMSQSDSGVDLSGDSQVSSGPCSQRSSPDGGLKGAAEGPPKRPGGSSPLNAVPCEGPPGSEPPRRPPPAPHDGDRKELPREQPLPPGPIGTERSQRTDRGTEPGPIRPSHRPGPPVQFGTSDKDSDLRLVVGDSLKAEKELTASVTEAIPVSRDWELLPSAAASAEPQSKNLDSGHCVPEPSSSGQRLYPEVFYGSAGPSSSQISGGAMDSQLHPNSGGFRPGTPSLHPYRSQPLYLPPGPAPPSALLSGLALKGQFLDFSTMQATELGKLPAGGVLYPPPSFLYSPAFCPSPLPDTSLLQVRQDLPSPSDFYSTPLQPGGQSGFLPSGAPAQQMLLPMVDSQLPVVNFGSLPPAPPPAPPPLSLLPVGPALQPPSLAVRPPPAPATRVLPSPARPFPASLGRAELHPVELKPFQDYQKLSSNLGGPGSSRTPPTGRSFSGLNSRLKATPSTYSGVFRTQRVDLYQQASPPDALRWIPKPWERTGPPPREGPSRRAEEPGSRGDKEPGLPPPR,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=22

DOMAIN=low_complexity_region
START=243
END=276
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=343
END=357
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=397
END=420
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=424
END=436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=coiled_coil_region
START=457
END=496
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=465
END=488
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=506
END=561
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=571
END=583
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=596
END=620
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=648
END=669
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=673
END=686
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=687
END=709
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=711
END=717
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=755
END=770
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=826
END=836
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=880
END=891
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=933
END=958
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1073
END=1090
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1254
END=1273
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1370
END=1392
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1394
END=1413
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1445
END=1458
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr6:31629692_A_C,20.8,1,HGNC,G,protein_coding,HGNC:13918,ENST00000376007,ENSG00000204469,['missense_variant'],PRRC2A,"N,N",701,".,0.34683869306",2303,"D,D",2101,"0.523,0.531",0.949,"T,T",possibly_damaging,".,.",0.824,0.742,"L,L","T,T",0.713,"P,P",1.297,0.01,deleterious,2303,"0.0934897674506,0.0934897674506",K/E,701,".,.",Aag/Gag,"T,T",0.721,0.851,2101,,,11.0312,4.564447,D,0.961266098,0,0.138,T,0.67177,T,T,"N,N",0.9999956225,N,0.3,T,D,,,,,,,,,,,SKIV2
chrX,77682660,77682661,G,C,ATRX,ENST00000624032,2017-10-10 00:00:00,caC/caG,H/Q,836/954,MODERATE,MED,benign,"T,T,.,.",None,0.008600000292,".,.,.,.",rs61752455,None,0.009399999864,None,0.01400000043,None,462,2,None,None,"TSK_9693_015374,TSK_12136_016021",X-linked,ENSG00000085224,"ATRX, chromatin remodeler","['Cancer-related genes', 'Disease related genes', 'Enzymes', 'Potential drug targets', 'Predicted intracellular proteins', 'Transcription factors']","['DNA damage', 'DNA repair', 'Transcription', 'Transcription regulation']",None,15.4,10.2,13.5,18.6,12.6,13.5,15.6,21.9,12.8,21.5,11.5,14.6,17.7,"BPTF,BPTF,RAD52,H3F3A,H3F3A,SCAF11,SCAF11,ATRX,ATRX,ATRX,ATRX,ATRX,ATRX,ATRX,DAXX,DAXX,DAXX,RAD51,RAD51,RAD51,MECP2","H3F3B,PHIP,MUS81,H3F3B,BPTF,PHIP,BPTF,H3F3B,PHIP,BPTF,MUS81,RAD52,H3F3A,SCAF11,H3F3B,H3F3A,ATRX,MUS81,RAD52,ATRX,ATRX","[0.199, 0.061446, 0.932, 0.00601500000000001, 0.417, 0, 0.092, 0.769, 0.094, 0.378, 0.835, 0.899, 0.769, 0.043, 0.736, 0.736, 0.93, 0.893, 0.983, 0.928, 0.916]","['nuclear chromosome', 'chromosome, centromeric region', 'condensed chromosome, centromeric region', 'condensed nuclear chromosome, centromeric region', 'chromosome, telomeric region', 'nuclear chromosome, telomeric region', 'chromatin', 'nuclear chromatin', 'heterochromatin', 'condensed chromosome', 'condensed nuclear chromosome', 'intracellular', 'cell', 'nucleus', 'nucleoplasm', 'chromosome', 'nuclear heterochromatin', 'pericentric heterochromatin', 'nuclear body', 'PML body', 'nuclear pericentric heterochromatin', 'telomeric heterochromatin', 'membrane-enclosed lumen', 'nuclear lumen', 'organelle', 'membrane-bounded organelle', 'non-membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular non-membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'chromosomal part', 'nuclear part', 'intracellular organelle part', 'nucleoplasm part', 'nuclear chromosome part', 'cell part', 'intracellular organelle lumen', 'chromosomal region', 'nucleotide binding', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'DNA helicase activity', 'chromatin binding', 'DNA-binding transcription factor activity', 'catalytic activity', 'helicase activity', 'binding', 'protein binding', 'ATP binding', 'DNA-dependent ATPase activity', 'drug binding', 'DNA translocase activity', 'pyrophosphatase activity', 'hydrolase activity', 'hydrolase activity, acting on acid anhydrides', 'hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides', 'ATPase activity', 'purine nucleotide binding', 'nucleoside-triphosphatase activity', 'protein domain specific binding', 'adenyl nucleotide binding', 'ribonucleotide binding', 'purine ribonucleotide binding', 'adenyl ribonucleotide binding', 'methylated histone binding', 'purine ribonucleoside triphosphate binding', 'small molecule binding', 'histone binding', 'ATPase activity, coupled', 'ion binding', 'anion binding', 'cation binding', 'metal ion binding', 'chromo shadow domain binding', 'organic cyclic compound binding', 'carbohydrate derivative binding', 'modification-dependent protein binding', 'methylation-dependent protein binding', 'catalytic activity, acting on DNA', 'transcription regulator activity', 'nucleoside phosphate binding', 'heterocyclic compound binding', 'SNF2-related, N-terminal domain', 'Helicase, C-terminal', 'Zinc finger, FYVE/PHD-type', 'Zinc finger, RING/FYVE/PHD-type', 'Helicase superfamily 1/2, ATP-binding domain', 'ADD domain', 'P-loop containing nucleoside triphosphate hydrolase', 'SNF2-like, N-terminal domain superfamily', 'Acetylation', 'Alternative splicing', 'ATP-binding', 'Chromatin regulator', 'Chromosome', 'Disease mutation', 'DNA damage', 'DNA repair', 'DNA-binding', 'Helicase', 'Hydrolase', 'Metal-binding', 'Methylation', 'Nucleus', 'Nucleotide-binding', 'Phosphoprotein', 'Polymorphism', 'Telomere', 'Transcription', 'Transcription regulation', 'Ubl conjugation', 'Zinc', 'Zinc-finger', 'Mental retardation', 'Isopeptide bond', 'Disease', 'SNF2 family N-terminal domain', 'Helicase conserved C-terminal domain', 'reproduction', 'negative regulation of transcription by RNA polymerase II', 'meiotic spindle organization', 'microtubule cytoskeleton organization', 'epithelial cell development', 'developmental process involved in reproduction', 'nucleobase-containing compound metabolic process', 'DNA metabolic process', 'DNA replication', 'DNA-dependent DNA replication', 'regulation of DNA replication', 'DNA repair', 'DNA modification', 'DNA alkylation', 'DNA methylation', 'DNA recombination', 'DNA packaging', 'chromatin organization', 'chromatin assembly or disassembly', 'nucleosome assembly', 'DNA replication-independent nucleosome assembly', 'chromatin remodeling', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'response to stress', 'cellular response to DNA damage stimulus', 'organelle organization', 'cytoskeleton organization', 'microtubule-based process', 'cell cycle', 'spindle organization', 'regulation of sister chromatid cohesion', 'regulation of mitotic nuclear division', 'cell communication', 'signal transduction', 'multicellular organism development', 'gamete generation', 'spermatogenesis', 'regulation of mitotic cell cycle', 'nervous system development', 'central nervous system development', 'brain development', 'sex differentiation', 'protein localization', 'metabolic process', 'gonad development', 'male gonad development', 'biosynthetic process', 'macromolecule biosynthetic process', 'anatomical structure morphogenesis', 'post-embryonic development', 'post-embryonic animal morphogenesis', 'tissue development', 'regulation of biosynthetic process', 'negative regulation of biosynthetic process', 'positive regulation of biosynthetic process', 'negative regulation of metabolic process', 'positive regulation of metabolic process', 'cellular process', 'response to organic substance', 'response to inorganic substance', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'positive regulation of macromolecule biosynthetic process', 'negative regulation of macromolecule biosynthetic process', 'regulation of cell cycle process', 'positive regulation of nuclear cell cycle DNA replication', 'positive regulation of macromolecule metabolic process', 'negative regulation of macromolecule metabolic process', 'positive regulation of gene expression', 'negative regulation of gene expression', 'positive regulation of organelle organization', 'negative regulation of organelle organization', 'negative regulation of cell cycle process', 'cellular component organization', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'sexual reproduction', 'cell cycle process', 'reproductive process', 'cellular component assembly', 'signaling', 'cell differentiation', 'DNA damage response, signal transduction by p53 class mediator', 'epithelial cell differentiation', 'forebrain development', 'regulation of histone modification', 'regulation of histone methylation', 'replication fork processing', 'regulation of cellular metabolic process', 'negative regulation of cellular metabolic process', 'positive regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'negative regulation of cellular biosynthetic process', 'positive regulation of cellular biosynthetic process', 'regulation of protein modification process', 'chromatin assembly', 'regulation of telomere maintenance', 'positive regulation of telomere maintenance', 'methylation', 'regulation of cellular protein metabolic process', 'DNA geometric change', 'multicellular organismal process', 'developmental process', 'multicellular organism reproduction', 'DNA duplex unwinding', 'RNA biosynthetic process', 'macromolecule localization', 'regulation of organelle organization', 'regulation of chromosome organization', 'regulation of sister chromatid segregation', 'negative regulation of sister chromatid segregation', 'regulation of mitotic sister chromatid segregation', 'negative regulation of mitotic sister chromatid segregation', 'regulation of nuclear cell cycle DNA replication', 'protein localization to organelle', 'cellular response to stress', 'regulation of maintenance of sister chromatid cohesion', 'negative regulation of maintenance of sister chromatid cohesion', 'regulation of maintenance of mitotic sister chromatid cohesion', 'negative regulation of maintenance of mitotic sister chromatid cohesion', 'protein localization to chromosome', 'cellular protein localization', 'cellular protein-containing complex assembly', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'DNA replication-independent nucleosome organization', 'nucleosome organization', 'appendage morphogenesis', 'limb morphogenesis', 'forelimb morphogenesis', 'multicellular organism growth', 'tube development', 'intracellular signal transduction', 'cellular response to drug', 'growth', 'response to chemical', 'response to drug', 'signal transduction in response to DNA damage', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule methylation', 'protein-containing complex subunit organization', 'cellular component biogenesis', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'multi-organism reproductive process', 'DNA methylation or demethylation', 'DNA-dependent DNA replication maintenance of fidelity', 'development of primary sexual characteristics', 'positive regulation of DNA replication', 'negative regulation of cell cycle', 'positive regulation of cell cycle', 'negative regulation of mitotic nuclear division', 'negative regulation of sister chromatid cohesion', 'negative regulation of transcription, DNA-templated', 'positive regulation of transcription, DNA-templated', 'negative regulation of mitotic cell cycle', 'negative regulation of nucleobase-containing compound metabolic process', 'positive regulation of nucleobase-containing compound metabolic process', 'positive regulation of transcription by RNA polymerase II', 'heterocycle metabolic process', 'development of primary male sexual characteristics', 'male sex differentiation', 'male gamete generation', 'cell development', 'animal organ development', 'positive regulation of biological process', 'negative regulation of biological process', 'positive regulation of cellular process', 'negative regulation of cellular process', 'developmental growth', 'reproductive structure development', 'multicellular organismal reproductive process', 'system development', 'appendage development', 'anatomical structure development', 'cellular developmental process', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'regulation of DNA metabolic process', 'positive regulation of DNA metabolic process', 'regulation of cellular component organization', 'negative regulation of cellular component organization', 'positive regulation of cellular component organization', 'regulation of nitrogen compound metabolic process', 'negative regulation of nitrogen compound metabolic process', 'positive regulation of nitrogen compound metabolic process', 'localization', 'regulation of protein metabolic process', 'regulation of RNA metabolic process', 'negative regulation of RNA metabolic process', 'positive regulation of RNA metabolic process', 'chromosome organization', 'meiotic cell cycle', 'regulation of histone H3-K9 methylation', 'cellular localization', 'multi-organism process', 'cellular response to stimulus', 'regulation of cell cycle', 'regulation of nuclear division', 'negative regulation of nuclear division', 'regulation of chromosome segregation', 'negative regulation of chromosome segregation', 'Sertoli cell differentiation', 'Sertoli cell development', 'limb development', 'regulation of macromolecule metabolic process', 'head development', 'epithelium development', 'reproductive system development', 'protein-containing complex assembly', 'protein-DNA complex assembly', 'biological regulation', 'regulation of biological quality', 'chromosome organization involved in meiotic cell cycle', 'protein localization to chromosome, telomeric region', 'cellular macromolecule localization', 'cellular response to chemical stimulus', 'DNA conformation change', 'cellular response to inorganic substance', 'organic substance metabolic process', 'protein-DNA complex subunit organization', 'cellular component organization or biogenesis', 'signal transduction by p53 class mediator', 'seminiferous tubule development', 'response to hydroxyurea', 'cellular response to hydroxyurea', 'regulation of primary metabolic process', 'positive regulation of cell cycle process', 'nucleic acid metabolic process', 'regulation of DNA-dependent DNA replication', 'response to antineoplastic agent', 'response to antimetabolite', 'nucleic acid-templated transcription', 'regulation of histone H3-K9 trimethylation', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'response to nitrogen compound', 'cellular response to nitrogen compound', 'regulation of chromatin organization', 'negative regulation of RNA biosynthetic process', 'positive regulation of RNA biosynthetic process', 'meiotic cell cycle process', 'regulation of nucleic acid-templated transcription', 'negative regulation of nucleic acid-templated transcription', 'positive regulation of nucleic acid-templated transcription', 'regulation of maintenance of mitotic sister chromatid cohesion, telomeric', 'negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric', 'positive regulation of DNA-dependent DNA replication', 'regulation of cellular macromolecule biosynthetic process', 'negative regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'negative regulation of chromosome organization', 'positive regulation of chromosome organization', 'Ring finger', 'DEAD-like helicases superfamily', 'helicase superfamily c-terminal domain']",MTAEPMSESKLNTLVQKLHDFLAHSSEESEETSSPPRLAMNQNTDKISGSGSNSDMMENSKEEGTSSSEKSKSSGSSRSKRKPSIVNKND,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=low_complexity_region
START=25
END=34
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=60
END=84
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chrX:77682661_G_C,0.023,-1,HGNC,C,protein_coding,HGNC:886,ENST00000624032,ENSG00000085224,['missense_variant'],ATRX,"N,N,.,.",836,"0.0241181193551,.,.,.",2715,"B,.,.,.",2508,"0.01,0.024,.,.",0.036,"D,D,.,.",benign,".,.,.,.",0,-0.209,".,.,.,.",".,.,T,T",0.901,"B,.,.,.",-1.63,1,tolerated_low_confidence,2715,"0.196089822672,0.196089822672,0.196089822672,0.196089822672",H/Q,836,".,.,.,.",caC/caG,"T,T,T,.",0.003,0.004,2508,['cds_end_NF'],,1.3467,,N,0.427496122,,0.152,T,,,T,"N,N",0.986266758,,,,N,301040,ATR-X_syndrome&History_of_neurodevelopmental_disorder&not_specified&not_provided,"criteria_provided,_multiple_submitters,_no_conflicts",C1845055&C2711754&CN169374&CN517202,ORPHA847,Benign,93134,,,,
chr6,31693101,31693102,C,A,ABHD16A,ENST00000440843,2017-05-18 00:00:00,cGc/cTc,R/L,151/525,MODERATE,MED,benign,"D,D",26.29999924,0.001500000013,".,.",rs139667935,None,0.0007999999798,None,0.002400000114,None,181,1,None,None,TSK_13633_015415,AR,ENSG00000204427,Abhydrolase domain containing 16A,['Predicted membrane proteins'],['Lipid metabolism'],None,8.5,5.5,18.8,7.8,5.5,10,7.5,0.2,0.4,4.3,0.3,0.1,0.3,"GPANK1,PRRC2A,PRRC2A,LY6G5C,LY6G5C,ABHD16A,ABHD16A,ABHD16A,ABHD16A,ABHD16A,ABHD16A,ABHD16A,ABHD16A,DDX39B,DDX39B,DDX39B,LTA,LTA,LTA","ZBTB12,ZBTB12,GPANK1,GPANK1,PRRC2A,RNF5,ZBTB12,ABHD13,GPANK1,PRRC2A,LST1,ABHD12,LY6G5C,PRRC2A,LST1,ABHD16A,ZBTB12,LST1,ABHD16A","[0.804, 0.794, 0.794, 0.536, 0.425, 0.211, 0.755, 0.656, 0.883, 0.748, 0.711, 0.6, 0.595, 0.39, 0.641, 0.648, 0.415, 0.641, 0.54]","['membrane', 'integral component of membrane', 'intrinsic component of membrane', 'membrane part', 'catalytic activity', 'lipase activity', 'hydrolase activity', 'hydrolase activity, acting on ester bonds', 'acylglycerol lipase activity', 'carboxylic ester hydrolase activity', 'Alpha/beta hydrolase fold-1', 'Alpha/Beta hydrolase fold', 'Alternative splicing', 'Hydrolase', 'Membrane', 'Transmembrane', 'Transmembrane helix', 'alpha/beta hydrolase fold', 'organic acid metabolic process', 'lipid metabolic process', 'fatty acid metabolic process', 'neutral lipid metabolic process', 'acylglycerol metabolic process', 'icosanoid metabolic process', 'prostanoid metabolic process', 'prostaglandin metabolic process', 'metabolic process', 'catabolic process', 'fatty acid catabolic process', 'cellular process', 'lipid catabolic process', 'organic acid catabolic process', 'carboxylic acid metabolic process', 'monocarboxylic acid metabolic process', 'unsaturated fatty acid metabolic process', 'oxoacid metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular lipid catabolic process', 'cellular catabolic process', 'cellular lipid metabolic process', 'small molecule metabolic process', 'small molecule catabolic process', 'carboxylic acid catabolic process', 'neutral lipid catabolic process', 'monoacylglycerol metabolic process', 'acylglycerol catabolic process', 'glycerolipid metabolic process', 'glycerolipid catabolic process', 'monoacylglycerol catabolic process', 'organic substance metabolic process', 'monocarboxylic acid catabolic process', 'icosanoid catabolic process', 'fatty acid derivative metabolic process', 'fatty acid derivative catabolic process', 'organic substance catabolic process']",MPPPALFLSSLYPRLEFQNDFYRSCIRRSSPQPPPNLAWRPESLYSGELAGGGYLSLSKVVPFSHYAGTLLLLLAGVACLRGIGRWTNPQYRQFITILEATHRNQSSENKRQLANYNFDFRSWPVDFHWEEPSSRKESRGGPSRRGVALLRPEPLHRGTADTLLNRVKKLPCQITSYLVAHTLGRRMLYPGSVYLLQKALMPVLLQGQARLVEECNGRRAKLLACDGNEIDTMFVDRRGTAEPQGQKLVICCEGNAGFYEVGCVSTPLEAGYSVLGWNHPGFAGSTGVPFPQNEANAMDVVVQFAIHRLGFQPQDIIIYAWSIGGFTATWAAMSYPDVSAMILDASFDDLVPLALKVMPDSWRGLVTRTVRQHLNLNNAEQLCRYQGPVLLIRRTKDEIITTTVPEDIMSNRGNDLLLKLLQHRYPRVMAEEGLRVVRQWLEASSQLEEASIYSRWEVEEDWCLSVLRSYQAEHGPDFPWSVGEDMSADGRRQLALFLARKHLHNFEATHCTPLPAQNFQMPWHL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=0

-- FINISHED --
",chr6:31693102_C_A,22,-1,HGNC,T,protein_coding,HGNC:13921,ENST00000440843,ENSG00000204427,['missense_variant'],ABHD16A,"N,N",151,"0.930341573795,.",754,"D,.",452,"0.108,0.164",1,".,.",benign,".,.",0.431,0.596,"L,.","T,.",0.999,"P,.",1.022,0.04,deleterious,754,"0.209943299407,0.209943299407",R/H,151,".,.",cGc/cAc,"D,D",1.358,0.996,452,,,10.5908,5.393491,D,0.9995221287,0,0.115,T,0.732398,T,T,"D,D,D,N",0.99999994,N,,T,D,,,,,,,,,,,
chr10,45826905,45826906,G,C,AGAP4,ENST00000311652,2017-07-07 00:00:00,aCc/aGc,T/S,334/663,missense_variant,MED,benign,tolerated,None,None,Pleckstrin_homology_domain,.,None,0.001300000004,None,0.005100000184,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000188234,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 4",['Predicted intracellular proteins'],None,None,4.1,8.4,2.6,5.8,4.3,4.8,4.4,1.5,1.3,4.8,1.4,2.3,2.2,"ZNF620,RFX6,AGAP4,AGAP4,AGAP4,AGAP4,AGAP4,AGAP4,AGAP4,AGAP4,AGAP4,GRAMD1A,GRAMD1A,GRAMD1A","ANKRD31,C2orf43,C2orf43,HDHD3,ANKRD31,ZPLD1,ZNF620,RFX6,PLEKHS1,AHDC1,CXorf36,ANKRD31,ZNF620,AGAP4","[0.575, 0.601, 0.587, 0.477, 0.532, 0.446, 0.51, 0.444, 0.422, 0.473, 0.453, 0.559, 0.559, 0.5]","['GTPase activator activity', 'binding', 'enzyme activator activity', 'enzyme regulator activity', 'GTPase regulator activity', 'ion binding', 'cation binding', 'metal ion binding', 'nucleoside-triphosphatase regulator activity', 'molecular function regulator', 'Arf GTPase activating protein', 'Pleckstrin homology domain', 'Ankyrin repeat', 'Ankyrin repeat-containing domain', 'Ankyrin repeat-containing domain superfamily', 'ARFGAP/RecO-like zinc finger', 'ArfGAP domain superfamily', 'ANK repeat', 'GTPase activation', 'Metal-binding', 'Polymorphism', 'Repeat', 'Zinc', 'Zinc-finger', 'Ankyrin repeat', 'Putative GTPase activating protein for Arf', 'Ankyrin repeats (3 copies)', 'Ankyrin repeats (many copies)', 'positive regulation of catalytic activity', 'regulation of GTPase activity', 'positive regulation of GTPase activity', 'positive regulation of molecular function', 'regulation of catalytic activity', 'regulation of hydrolase activity', 'positive regulation of hydrolase activity', 'biological regulation', 'regulation of molecular function', 'Putative GTP-ase activating proteins for the small GTPase, ARF', 'Pleckstrin homology domain.', 'ankyrin repeats']",MGNILTCRVHPSVSLEFDQQQGSVCPSESEIYEAGAGDRMAGAPMAAAVQPAEVTVEVGEDLHMHHVRDREMPEALEFNPSANPEASTIFQRNSQTDVVEIRRSNCTNHVSTVRFSQQYSLCSTIFLDDSTAIQHYLTMTIISVTLEIPHHITQRDADRSLSIPDEQLHSFAVSTVHIMKKRNGGGSLNNYSSSIPSTPSTSQEDPQFSVPPTANTPTPVCKRSMRWSNLFTSEKGSDPDKERKAPENHADTIGSGRAIPIKQGMLLKRSGKWLKTWKKKYVTLCSNGVLTYYSSLGDYMKNIHKKEIDLQTSTIKVPGKWPSLATSACTPISTSKSNGLSKDMDTGLGDSICFSPSISSTTSPKLNPPPSPHANKKKHLKKKSTNNFMIVSATGQTWHFEATTYEERDAWVQAIQSQILASLQSCESSKSKSQLTSQSKAMALQSIQNMRGNAHCVDCETQNPKWASLNLGVLMCIECSGIHRSLGTRLSRVRSLELDDWPVELRKVMSSIGNDLANSIWEGSSQGQTKPSEKSTREEKERWIRSKYEEKLFLAPLPCTELSLGQQLLRATADEDLQTAILLLAHGSREEVNETCGEGDGCTALHLACRKGNVVLAQLLIWYGVDVMARDAHGNTALTYARQASSQECINVLLQYGCPDKCV,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=8

DOMAIN=low_complexity_region
START=34
END=52
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=183
END=202
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=PH
START=260
END=422
EVALUE=2.04496891130558e-19
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=376
END=383
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=420
END=440
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=ArfGap
START=441
END=561
EVALUE=8.17450112301981e-48
TYPE=SMART
STATUS=visible|OK

DOMAIN=ANK
START=600
END=629
EVALUE=0.0027673773755512
TYPE=SMART
STATUS=visible|OK

DOMAIN=ANK
START=633
END=663
EVALUE=4.93380041890177
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr10:45826906_G_C,0.264,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr9,64411377,64411378,A,G,ANKRD20A4,ENST00000357336,15/15,Aac/Gac,N/D,698/823,MODERATE,MED,benign,T,None,0.00001480999981,"CCDC144C-like, coiled-coil domain",rs773492536,None,0.0008999999845,None,0.01180000044,None,1,0,None,None,TSK_13633_015415,AR,ENSG00000172014,Ankyrin repeat domain 20 family member A4,['Predicted intracellular proteins'],None,None,0.9,0.6,1.7,0.1,1.4,1.2,0.9,0,1.4,1.7,0,0,0.8,"CBWD3,FAM72B,FAM72B,FAM182B,FAM182B,CBWD7,CBWD7,CBWD7,CBWD1,CBWD1,CBWD1,FAM72D,FAM72D,FAM72D,FAM72D,FAM72D,ZNF492,ZNF492,ZNF492,ZNF492,ZNF492,FAM72C,FAM72C,FAM72C,FAM72C,FAM72C,FAM72C,NBPF9,NBPF9,NBPF9,NBPF19,NBPF19,NBPF19,NBPF19","ANKRD20A4,ANKRD20A4,CBWD3,ANKRD20A4,FAM72B,ANKRD20A4,FAM72B,FAM182B,ANKRD20A4,FAM72B,CBWD7,ANKRD20A4,CBWD3,FAM182B,CBWD7,CBWD1,ANKRD20A4,FAM72B,FAM182B,CBWD7,FAM72D,ANKRD20A4,CBWD3,FAM182B,CBWD7,CBWD1,ZNF492,ANKRD20A4,FAM72B,CBWD7,ANKRD20A4,FAM72B,FAM182B,CBWD7","[0.53, 0.629, 0.419, 0.644, 0.53, 0.7, 0.623, 0.642, 0.555, 0.445, 0.00781200000000001, 0.632, 0.425, 0.527, 0.634, 0.448, 0.641, 0.537, 0.541, 0.641, 0.527, 0.673, 0.514, 0.587, 0.674, 0.536, 0.595, 0.53, 0.4, 0.53, 0.63, 0.511, 0.53, 0.63]","['Ankyrin repeat', 'Ankyrin repeat-containing domain', 'Ankyrin repeat-containing domain superfamily', 'ANK repeat', 'Coiled coil', 'Repeat', 'Ankyrin repeat', 'Ankyrin repeats (3 copies)', 'Ankyrin repeats (many copies)', 'Ankyrin repeats (many copies)', 'CCDC144C protein coiled-coil region', 'ankyrin repeats']",MKLFGFGSRRGQTAQGSIDHVYTGSGYRIRDSELQKIHRAAVKGDAAEVERCLARRSGELDALDKQHRTALHLACASGHVQVVTLLVNRKCQIDVCDKENRTPLIQAVHCQEEACAVILLEHGANPNLKDIYGNTALHYAVYSESTSLAEKLLSHGAHIEALDKDNNTPLLFAIICKKEKMVEFLLKKKASSHAVDRLRRSALMLAVYYDSPGIVNILLKQNIDVFAQDMCGRDAEDYAISHHLTKIQQQILEHKKKILKKEKSDVGSSDESAVSIFHELRVDSLPASDDKDLNVATKQCVPEKVSEPLPGSSHEKGNRIVNGQGEGPPAKHPSLKPSTEVEDPAVKGAVQRKNVQTLRAEQALPVASEEEQQRHERSEKKQPQVKEGNNTNKSEKIQLSENICDSTSSAAAGRLTQQRKIGKTYPQQFPKKLKEEHDRCTLKQENEEKTNVNMLYKKNREELERKEKQYKKEVEAKQLEPTVQSLEMKSKTARNTPNWDFHNHEEMKGLMDENCILKADIAILRQEICTMKNDNLEKENKYLKDIKIVKETNAALEKYIKLNEEMITETAFRYQQELNDLKAENTRLNAELLKEKESKKRLEADIESYQSRLAAAISKHSESVKTERNLKLALERTQDVSVQVEMSSAISKVKDENEFLTEQLSETQIKFNALKDKFRKTRDSLRKKSLALETVQNNLSQTQQQTQEMKEMYQNAEAKVNNSTGKWNCVEERICHLQRENAWLVQQLDDVHQKEDHKEIVTNIQRGFIESGKKDFVLEEKSKKLMNECDHLKESLFQYEREKTEVVVSIKEDKYFQTSRKKI,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=15

DOMAIN=ANK
START=66
END=95
EVALUE=0.000301142745913236
TYPE=SMART
STATUS=visible|OK

DOMAIN=ANK
START=99
END=128
EVALUE=0.0949120080130251
TYPE=SMART
STATUS=visible|OK

DOMAIN=ANK
START=132
END=161
EVALUE=0.000370750209058496
TYPE=SMART
STATUS=visible|OK

DOMAIN=ANK
START=165
END=194
EVALUE=0.125237126292203
TYPE=SMART
STATUS=visible|OK

DOMAIN=ANK
START=198
END=227
EVALUE=0.354223677223745
TYPE=SMART
STATUS=visible|OK

DOMAIN=ANK
START=231
END=260
EVALUE=1839.528102082
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=246
END=263
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=368
END=381
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=coiled_coil_region
START=440
END=480
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=457
END=468
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=563
END=622
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=588
END=603
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=645
END=725
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=701
END=707
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=776
END=806
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr9:64411378_A_G,12.05,1,HGNC,G,protein_coding,HGNC:31982,ENST00000357336,ENSG00000172014,['missense_variant'],ANKRD20A4P,N,698,,2373,B,2092,0.056,0,T,benign,,0,-1.84,N,T,0,B,-1.267,1,tolerated,2373,0.213573922156,N/D,698,,Aac/Gac,T,2.431,1,2092,,,3.4494,0.02045089,N,0.1600184261,0,0.085,T,0.553676,T,T,N,0.5234207464,N,0.224,T,,,,,,,,,,,,
chr1,235484314,235484315,T,G,B3GALNT2,ENST00000366600,,,,-/500,LOW,MED,,,None,None,.,rs291387,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000162885,"Beta-1,3-N-acetylgalactosaminyltransferase 2","['Disease related genes', 'Enzymes', 'Potential drug targets', 'Predicted intracellular proteins']",None,{'pancreas': '35.7'},7.6,3.3,10.3,3.1,5.8,6.9,9.2,1.5,5.7,2.4,2.7,1.9,1.9,"GMPPB,B3GNT1,B3GNT1,FKRP,FKRP,FKRP,POMK,POMK,POMK,POMK,POMGNT2,POMGNT2,POMGNT2,POMGNT2,POMGNT2,B3GALNT2,B3GALNT2,B3GALNT2,B3GALNT2,B3GALNT2,B3GALNT2,B3GALNT2,POMT1,POMT1,POMT1,POMT1,POMT1,POMT1,POMT1,ISPD,ISPD,ISPD,ISPD,ISPD,ISPD,ISPD,ISPD,DAG1,DAG1,DAG1,DAG1,DAG1,DAG1,DAG1,DAG1,DAG1","TMEM5,TMEM5,GMPPB,TMEM5,GMPPB,B3GNT1,TMEM5,GMPPB,B3GNT1,FKRP,TMEM5,GMPPB,B3GNT1,FKRP,POMK,TMEM5,GMPPB,B3GNT1,FKRP,POMK,B4GALNT1,POMGNT2,TMEM5,GMPPB,B3GNT1,FKRP,POMK,POMGNT2,B3GALNT2,TMEM5,GMPPB,B3GNT1,FKRP,POMK,POMGNT2,B3GALNT2,POMT1,TMEM5,GMPPB,B3GNT1,FKRP,POMK,POMGNT2,B3GALNT2,POMT1,ISPD","[0.822, 0.791, 0.573, 0.859, 0.74, 0.736, 0.896, 0.817, 0.812, 0.814, 0.896, 0.813, 0.788, 0.82, 0.919, 0.875, 0.816, 0.824, 0.81, 0.92, 0.802, 0.893, 0.842, 0.776, 0.733, 0.927, 0.834, 0.857, 0.844, 0.877, 0.819, 0.663, 0.855, 0.823, 0.873, 0.851, 0.916, 0.666, 0.672, 0.496, 0.841, 0.684, 0.672, 0.664, 0.895, 0.663]","['Golgi membrane', 'intracellular', 'cell', 'cytoplasm', 'endoplasmic reticulum', 'endoplasmic reticulum membrane', 'Golgi apparatus', 'endomembrane system', 'membrane', 'integral component of membrane', 'organelle membrane', 'intrinsic component of membrane', 'organelle subcompartment', 'nuclear outer membrane-endoplasmic reticulum membrane network', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle part', 'intracellular part', 'membrane part', 'Golgi apparatus part', 'endoplasmic reticulum part', 'cytoplasmic part', 'intracellular organelle part', 'cell part', 'bounding membrane of organelle', 'Golgi subcompartment', 'endoplasmic reticulum subcompartment', 'catalytic activity', 'UDP-glycosyltransferase activity', 'acetylglucosaminyltransferase activity', 'acetylgalactosaminyltransferase activity', 'galactosyltransferase activity', 'transferase activity', 'transferase activity, transferring glycosyl groups', 'transferase activity, transferring hexosyl groups', 'Glycosyl transferase, family 31', 'Alternative splicing', 'Disease mutation', 'Endoplasmic reticulum', 'Glycoprotein', 'Glycosyltransferase', 'Golgi apparatus', 'Lissencephaly', 'Membrane', 'Polymorphism', 'Signal-anchor', 'Transferase', 'Transmembrane', 'Congenital muscular dystrophy', 'Transmembrane helix', 'Dystroglycanopathy', 'Disease', 'Galactosyltransferase', 'cellular protein modification process', 'protein glycosylation', 'protein O-linked glycosylation', 'nitrogen compound metabolic process', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'glycoprotein metabolic process', 'glycoprotein biosynthetic process', 'cellular process', 'protein metabolic process', 'cellular macromolecule biosynthetic process', 'protein modification process', 'macromolecule metabolic process', 'macromolecule modification', 'macromolecule glycosylation', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'glycosylation', 'organic substance metabolic process', 'carbohydrate derivative metabolic process', 'carbohydrate derivative biosynthetic process', 'organonitrogen compound metabolic process', 'organonitrogen compound biosynthetic process', 'organic substance biosynthetic process', 'Metabolism of proteins', 'O-linked glycosylation', 'Post-translational protein modification']",MRNWLVLLCPCVLGAALHLWLRLRSPPPACASGAGPAGGVSLLLPRLECNGAVSAHPNLHLPGSRDSPASASQVAGITDQLALFPQWKSTHYDVVVGVLSARNNHELRNVIRSTWMRHLLQHPTLSQRVLVKFIIGAHGCEVPVEDREDPYSCKLLNITNPVLNQEIEAFSLSEDTSSGLPEDRVVSVSFRVLYPIVITSLGVFYDANDVGFQRNITVKLYQAEQEEALFIARFSPPSCGVQVNKLWYKPVEQFILPESFEGTIVWESQDLHGLVSRNLHKVTVNDGGGVLRVITAGEGALPHEFLEGVEGVAGGFIYTIQGKFAS,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=low_complexity_region
START=25
END=39
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr1:235484315_T_G,5.849,-1,HGNC,G,protein_coding,HGNC:28596,ENST00000366600,ENSG00000162885,"['splice_region_variant', 'intron_variant']",B3GALNT2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr17,36013243,36013244,T,C,CCL23,ENST00000612516,2017-04-04 00:00:00,Atg/Gtg,M/V,106/120,MODERATE,MED,benign,".,.",None,None,".,.",rs1003645,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000274736,C-C motif chemokine ligand 23,"['Cancer-related genes', 'Plasma proteins', 'Predicted secreted proteins']","['Chemotaxis', 'Inflammatory response']",{'blood': '50.3'},2,0,1.3,8,7.2,1,0,0.2,0.1,50.3,0.2,0,0.1,"CCL21,CCR1,CCR1,CCL19,CCL19,CCL19,CCL20,CCL20,CCL20,CCL20,HBS1L,CCL7,CCL7,CCL7,CCL7,CCL24,CCL24,CCL24,CCL24,CCL24,CCL16,CCL16,CCL16,CCL16,CCL23,CCL23,CCL23,CCL23,CCL23,CCL23,CCL23,CCL23,CCL23,CCL23","IL4,IL4,CCL21,IL4,CCL21,CCR1,IL4,CCL21,CCR1,CCL19,TFAP4,IL4,CCR1,CCL19,CCL20,IL4,CCL21,CCR1,CCL19,CCL20,CCL21,CCR1,CCL19,CCL20,TFAP4,IL4,CCL21,CCR1,CCL19,CCL20,HBS1L,CCL7,CCL24,CCL16","[0.556, 0.518, 0.723, 0.56, 0.143832, 0.802, 0.63, 0.14212, 0.603, 0.711, 0.742, 0.657, 0.83, 0.662, 0.725, 0.669, 0.518, 0.513, 0.517, 0.563, 0.114464, 0.711, 0.473, 0.446, 0.641, 0.61, 0.543, 0.582, 0.589, 0.633, 0.641, 0.63, 0.64, 0.642]","['extracellular region', 'extracellular space', 'cell', 'extracellular region part', 'G protein-coupled receptor binding', 'signaling receptor binding', 'cytokine activity', 'cytokine receptor binding', 'binding', 'protein binding', 'glycosaminoglycan binding', 'chemokine activity', 'heparin binding', 'receptor regulator activity', 'CCR1 chemokine receptor binding', 'chemokine receptor binding', 'ion binding', 'anion binding', 'receptor ligand activity', 'CCR chemokine receptor binding', 'carbohydrate derivative binding', 'molecular function regulator', 'sulfur compound binding', 'Small cytokines (intecrine/chemokine), interleukin-8 like', 'regulation of protein phosphorylation', 'positive regulation of protein phosphorylation', 'immune system process', 'monocyte chemotaxis', 'cellular ion homeostasis', 'cellular calcium ion homeostasis', 'cellular metal ion homeostasis', 'movement of cell or subcellular component', 'chemotaxis', 'response to stress', 'defense response', 'inflammatory response', 'immune response', 'cell communication', 'signal transduction', 'cell surface receptor signaling pathway', 'G protein-coupled receptor signaling pathway', 'cell-cell signaling', 'negative regulation of cell population proliferation', 'response to external stimulus', 'positive regulation of metabolic process', 'regulation of signal transduction', 'positive regulation of signal transduction', 'cellular process', 'response to organic substance', 'regulation of signaling receptor activity', 'positive regulation of phosphorus metabolic process', 'positive regulation of macromolecule metabolic process', 'regulation of cell communication', 'positive regulation of cell communication', 'cell migration', 'regulation of phosphate metabolic process', 'cytokine-mediated signaling pathway', 'regulation of metabolic process', 'cellular homeostasis', 'regulation of signaling', 'signaling', 'positive regulation of signaling', 'cellular cation homeostasis', 'neutrophil chemotaxis', 'leukocyte chemotaxis', 'regulation of cellular metabolic process', 'positive regulation of cellular metabolic process', 'regulation of protein modification process', 'positive regulation of protein modification process', 'negative regulation of protein binding', 'regulation of cellular protein metabolic process', 'positive regulation of cellular protein metabolic process', 'response to cytokine', 'response to interferon-gamma', 'response to tumor necrosis factor', 'locomotion', 'regulation of cell population proliferation', 'response to chemical', 'regulation of phosphorylation', 'positive regulation of phosphorylation', 'taxis', 'homeostatic process', 'positive regulation of catalytic activity', 'regulation of GTPase activity', 'regulation of protein binding', 'regulation of MAPK cascade', 'positive regulation of MAPK cascade', 'positive regulation of GTPase activity', 'negative regulation of molecular function', 'positive regulation of molecular function', 'innate immune response', 'positive regulation of phosphate metabolic process', 'lymphocyte chemotaxis', 'positive regulation of biological process', 'negative regulation of biological process', 'positive regulation of cellular process', 'negative regulation of cellular process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'cell motility', 'chemical homeostasis', 'regulation of biological process', 'regulation of catalytic activity', 'regulation of cellular process', 'ion homeostasis', 'response to stimulus', 'leukocyte migration', 'regulation of binding', 'negative regulation of binding', 'regulation of nitrogen compound metabolic process', 'positive regulation of nitrogen compound metabolic process', 'regulation of phosphorus metabolic process', 'localization', 'regulation of protein metabolic process', 'positive regulation of protein metabolic process', 'regulation of hydrolase activity', 'positive regulation of hydrolase activity', 'localization of cell', 'cellular response to stimulus', 'metal ion homeostasis', 'calcium ion homeostasis', 'cation homeostasis', 'cellular chemical homeostasis', 'regulation of macromolecule metabolic process', 'cell chemotaxis', 'biological regulation', 'regulation of biological quality', 'regulation of molecular function', 'chemokine-mediated signaling pathway', 'regulation of ERK1 and ERK2 cascade', 'positive regulation of ERK1 and ERK2 cascade', 'response to interleukin-1', 'cellular response to chemical stimulus', 'cellular response to organic substance', 'cellular response to cytokine stimulus', 'cellular response to interferon-gamma', 'cellular response to interleukin-1', 'cellular response to tumor necrosis factor', 'granulocyte chemotaxis', 'mononuclear cell migration', 'cellular divalent inorganic cation homeostasis', 'divalent inorganic cation homeostasis', 'lymphocyte migration', 'regulation of primary metabolic process', 'myeloid leukocyte migration', 'granulocyte migration', 'inorganic ion homeostasis', 'regulation of intracellular signal transduction', 'positive regulation of intracellular signal transduction', 'neutrophil migration', 'response to chemokine', 'cellular response to chemokine', 'Intercrine alpha family (small cytokine C-X-C) (chemokine CXC).']",MKVSVAALSCLMLVTALGSQARVTKDAETEFMMSKLPLENPVLLDMLWRRKIGPQMTLSHAAGFHATSADCCISYTPRSIPCSLLESYFETNSECSKPGVIFLTKKGRRFCANPSDKQVQVCVRMLKLDTRIKTRKN,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=SCY
START=68
END=126
EVALUE=5.20285351145266e-26
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr17:36013244_T_C,7.068,-1,HGNC,C,protein_coding,HGNC:10622,ENST00000612516,ENSG00000274736,['missense_variant'],CCL23,".,.",106,".,.",381,".,.",316,"0.074,0.105",0.048,".,.",benign,".,.",0.21,0.566,".,.",".,.",0.011,".,.",1.028,0.42,tolerated,381,".,.",M/V,106,".,.",Atg/Gtg,"T,T",-0.098,0.057,316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr17,36212479,36212480,G,A,CCL4L2,ENST00000620250,,,,-/92,HIGH,HIGH,,,None,0.002600000007,.,rs4796195,None,0.009300000034,None,0.0195000004,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000276070,C-C motif chemokine ligand 4 like 2,['Predicted secreted proteins'],"['Chemotaxis', 'Inflammatory response']","{'blood': '41.8', 'bone marrow': '18.7', 'lung': '15.2'}",0.4,0.6,0.1,8.1,0.8,0.5,0,0,0,41.8,0.1,0.3,5.6,"CCR2,CCR5,CCR5,CCR1,CCR1,CCR1,CXCL10,CXCL10,CXCL10,CXCL10,CXCL8,CXCL8,CXCL8,CXCL8,CXCL8,CXCL9,CXCL9,CXCL9,CXCL9,CXCL9,CXCL9,CXCL1,CXCL1,CXCL1,CXCL1,CXCL1,CXCL1,CXCL1,CXCR4,CXCR4,CXCR4,CXCR4,CXCR4,CXCR4,CXCR4,CXCR4,CCR3,CCR3,CCR3,CCR3,CCR3,CCR3,CCR3,CCR3,CCR3,CCL4L1,CCL4L1,CCL4L1,CCL4L1,CCL4L1,CCL4L1,CCL4L1,CCL4L1,CCL4L1,CCL4L1","CXCL13,CXCL13,CCR2,CXCL13,CCR2,CCR5,CXCL13,CCR2,CCR5,CCR1,CXCL13,CCR2,CCR5,CCR1,CXCL10,CXCL13,CCR2,CCR5,CCR1,CXCL10,CXCL8,CXCL13,CCR2,CCR5,CCR1,CXCL10,CXCL8,CXCL9,CXCL13,CCR2,CCR5,CCR1,CXCL10,CXCL8,CXCL9,CXCL1,CXCL13,CCR2,CCR5,CCR1,CXCL10,CXCL8,CXCL9,CXCL1,CXCR4,CXCL13,CCR2,CCR5,CCR1,CXCL10,CXCL8,CXCL9,CXCL1,CXCR4,CCR3","[0.538, 0.562, 0.029984, 0.586, 0.04644, 0.039204, 0.7, 0.716, 0.744, 0.701, 0.126616, 0.675, 0.674, 0.596, 0.869, 0.704, 0.679, 0.716, 0.653, 0.131238, 0.744, 0.665, 0.675, 0.606, 0.594, 0.863, 0.111996, 0.123915, 0.668, 0.134736, 0.17208, 0.153272, 0.669, 0.812, 0.584, 0.657, 0.523, 0.059214, 0.04785, 0.03024, 0.682, 0.593, 0.608, 0.54, 0.1377, 0.381, 0.579, 0.77, 0.609, 0.763, 0.746, 0.634, 0.577, 0.561, 0.564]","['extracellular region', 'extracellular space', 'extracellular region part', 'G protein-coupled receptor binding', 'signaling receptor binding', 'cytokine activity', 'cytokine receptor binding', 'binding', 'protein binding', 'chemokine activity', 'receptor regulator activity', 'chemokine receptor binding', 'receptor ligand activity', 'CCR chemokine receptor binding', 'molecular function regulator', 'CC chemokine, conserved site', 'Chemokine interleukin-8-like domain', 'Chemokine interleukin-8-like superfamily', 'Alternative splicing', 'Chemotaxis', 'Cytokine', 'Inflammatory response', 'Signal', 'Secreted', 'Disulfide bond', 'Small cytokines (intecrine/chemokine), interleukin-8 like', 'regulation of protein phosphorylation', 'positive regulation of protein phosphorylation', 'immune system process', 'monocyte chemotaxis', 'movement of cell or subcellular component', 'chemotaxis', 'response to stress', 'defense response', 'inflammatory response', 'immune response', 'cell communication', 'signal transduction', 'cell surface receptor signaling pathway', 'G protein-coupled receptor signaling pathway', 'response to external stimulus', 'positive regulation of metabolic process', 'regulation of signal transduction', 'positive regulation of signal transduction', 'cellular process', 'response to organic substance', 'regulation of signaling receptor activity', 'positive regulation of phosphorus metabolic process', 'positive regulation of macromolecule metabolic process', 'regulation of cell communication', 'positive regulation of cell communication', 'cell migration', 'regulation of phosphate metabolic process', 'cytokine-mediated signaling pathway', 'regulation of metabolic process', 'regulation of signaling', 'signaling', 'positive regulation of signaling', 'neutrophil chemotaxis', 'leukocyte chemotaxis', 'regulation of cellular metabolic process', 'positive regulation of cellular metabolic process', 'regulation of protein modification process', 'positive regulation of protein modification process', 'regulation of cellular protein metabolic process', 'positive regulation of cellular protein metabolic process', 'response to cytokine', 'response to interferon-gamma', 'response to tumor necrosis factor', 'locomotion', 'response to chemical', 'regulation of phosphorylation', 'positive regulation of phosphorylation', 'taxis', 'positive regulation of catalytic activity', 'regulation of GTPase activity', 'regulation of MAPK cascade', 'positive regulation of MAPK cascade', 'positive regulation of GTPase activity', 'positive regulation of molecular function', 'innate immune response', 'positive regulation of phosphate metabolic process', 'lymphocyte chemotaxis', 'positive regulation of biological process', 'positive regulation of cellular process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'cell motility', 'regulation of biological process', 'regulation of catalytic activity', 'regulation of cellular process', 'response to stimulus', 'leukocyte migration', 'regulation of nitrogen compound metabolic process', 'positive regulation of nitrogen compound metabolic process', 'regulation of phosphorus metabolic process', 'localization', 'regulation of protein metabolic process', 'positive regulation of protein metabolic process', 'regulation of hydrolase activity', 'positive regulation of hydrolase activity', 'localization of cell', 'cellular response to stimulus', 'regulation of macromolecule metabolic process', 'cell chemotaxis', 'biological regulation', 'regulation of molecular function', 'chemokine-mediated signaling pathway', 'regulation of ERK1 and ERK2 cascade', 'positive regulation of ERK1 and ERK2 cascade', 'response to interleukin-1', 'cellular response to chemical stimulus', 'cellular response to organic substance', 'cellular response to cytokine stimulus', 'cellular response to interferon-gamma', 'cellular response to interleukin-1', 'cellular response to tumor necrosis factor', 'granulocyte chemotaxis', 'mononuclear cell migration', 'lymphocyte migration', 'regulation of primary metabolic process', 'myeloid leukocyte migration', 'granulocyte migration', 'regulation of intracellular signal transduction', 'positive regulation of intracellular signal transduction', 'neutrophil migration', 'response to chemokine', 'cellular response to chemokine', 'Signal Transduction', 'Signaling by GPCR', 'GPCR downstream signalling', 'G alpha (i) signalling events', 'Intercrine alpha family (small cytokine C-X-C) (chemokine CXC).']",MKLCVTVLSLLVLVAAFCSLALSAPTKSSEWKLQGVCFQCCSGKDPIHQSCPTWTMVRQRKMPTTGKG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=low_complexity_region
START=3
END=24
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=7
END=26
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr17:36212480_G_A,15.36,1,HGNC,A,protein_coding,HGNC:24066,ENST00000620250,ENSG00000276070,['splice_acceptor_variant'],CCL4L2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,27382529,27382530,C,T,CD164L2,ENST00000374030,2017-02-06 00:00:00,Gtg/Atg,V/M,76/174,MODERATE,MED,benign,".,.",None,None,".,.",rs2504779,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000174950,CD164 molecule like 2,['Predicted membrane proteins'],None,{'fallopian tube': '26.8'},0.4,0,13.4,0.1,0.2,0.1,0.2,0,0,0,0,0,0.5,"CLEC12B,RPRD2,RPRD2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,TEKT3,STRC,STRC","HPS3,HPS3,CLEC12B,HPS3,DCTN5,GPR113,SLC19A1,ABHD12B,CLEC12B,TMC2,RPRD2,CD164L2,TMC2,CD164L2","[0.487, 0.537, 0.539, 0.634, 0.589, 0.673, 0, 0.539, 0.692, 0.603, 0.718, 0.639, 0.44, 0.665]","['intracellular', 'cell', 'cytoplasm', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'cytoplasmic vesicle', 'vesicle', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular part', 'membrane part', 'cytoplasmic part', 'cell part', 'intracellular vesicle', 'CD164-related protein', 'Alternative splicing', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Signal', 'Transmembrane', 'Transmembrane helix', 'Multi-glycosylated core protein 24 (MGC-24), sialomucin']",MEAPGPRALRTALCGGCCCLLLCAQLAVAGKGARGFGRGALIRLNIWPAVQGACKQLEVCEHCVEGDGARNLSSCVWEQCRPEEPGHCVAQSEVVKEGCSIYNRSEACPAAHHHPTYEPKTVTTGSPPVPEAHSPGFDGASFIGGVVLVLSLQAVAFFVLHFLKAKDSTYQTL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=3

DOMAIN=transmembrane_domain
START=7
END=29
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=8
END=40
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=141
END=163
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr1:27382530_C_T,9.724,-1,HGNC,T,protein_coding,HGNC:32043,ENST00000374030,ENSG00000174950,['missense_variant'],CD164L2,".,.",76,".,.",320,".,.",226,"0.203,0.213",0.165,".,.",benign,".,.",0.113,-0.18,".,.",".,.",0.177,".,.",-0.238,0.05,tolerated,320,".,.",V/M,76,".,.",Gtg/Atg,"T,T",0.439,0.767,226,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,27382553,27382554,C,T,CD164L2,ENST00000374030,2017-02-06 00:00:00,Gga/Aga,G/R,68/174,MODERATE,MED,benign,".,.",None,None,".,.",rs2474297,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000174950,CD164 molecule like 2,['Predicted membrane proteins'],None,{'fallopian tube': '26.8'},0.4,0,13.4,0.1,0.2,0.1,0.2,0,0,0,0,0,0.5,"CLEC12B,RPRD2,RPRD2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,CD164L2,TEKT3,STRC,STRC","HPS3,HPS3,CLEC12B,HPS3,DCTN5,GPR113,SLC19A1,ABHD12B,CLEC12B,TMC2,RPRD2,CD164L2,TMC2,CD164L2","[0.487, 0.537, 0.539, 0.634, 0.589, 0.673, 0, 0.539, 0.692, 0.603, 0.718, 0.639, 0.44, 0.665]","['intracellular', 'cell', 'cytoplasm', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'cytoplasmic vesicle', 'vesicle', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular part', 'membrane part', 'cytoplasmic part', 'cell part', 'intracellular vesicle', 'CD164-related protein', 'Alternative splicing', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Signal', 'Transmembrane', 'Transmembrane helix', 'Multi-glycosylated core protein 24 (MGC-24), sialomucin']",MEAPGPRALRTALCGGCCCLLLCAQLAVAGKGARGFGRGALIRLNIWPAVQGACKQLEVCEHCVEGDGARNLSSCVWEQCRPEEPGHCVAQSEVVKEGCSIYNRSEACPAAHHHPTYEPKTVTTGSPPVPEAHSPGFDGASFIGGVVLVLSLQAVAFFVLHFLKAKDSTYQTL,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=3

DOMAIN=transmembrane_domain
START=7
END=29
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=8
END=40
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=141
END=163
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr1:27382554_C_T,2.845,-1,HGNC,T,protein_coding,HGNC:32043,ENST00000374030,ENSG00000174950,['missense_variant'],CD164L2,".,.",68,".,.",296,".,.",202,"0.087,0.089",0.446,".,.",benign,".,.",0,-0.108,".,.",".,.",0.084,".,.",0.207,1,tolerated,296,".,.",G/R,68,".,.",Gga/Aga,"T,T",-0.724,0,202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,44513189,44513190,C,T,CEACAM20,ENST00000614577,2017-06-11 00:00:00,tGc/tAc,C/Y,377/503,MODERATE,MED,unknown,".,.,.,.,.,.",None,None,".,.,.,.,.,.",rs1465723,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000273777,Carcinoembryonic antigen related cell adhesion molecule 20,['Predicted membrane proteins'],None,{'intestine': '64.6'},25,23.9,0,0,0,64.6,0,0,0,0,0,0,0,"LHFPL1,CEACAM19,LIN52,LIN52,SMAGP,CEACAM20,CEACAM20,CEACAM20,CEACAM20,CEACAM20,CEACAM20,CEACAM20,CEACAM20,CEACAM20,CEACAM20","CHRDL2,CEACAM18,CHRDL2,LHFPL1,PCDHGA9,CEACAM4,CHRDL2,CEACAM3,LHFPL1,PTPRH,CEACAM18,CEACAM19,LIN52,PCDHGA9,SMAGP","[0.444, 0.854, 0.415, 0.496, 0.473, 0.641, 0.484, 0.643, 0.55, 0.447, 0.3321, 0.838, 0.551, 0.473, 0.499]","['cell', 'plasma membrane', 'microvillus', 'membrane', 'integral component of membrane', 'apical plasma membrane', 'intrinsic component of membrane', 'cell projection membrane', 'microvillus membrane', 'cell projection', 'membrane part', 'plasma membrane part', 'cell projection part', 'cell part', 'apical part of cell', 'cell periphery', 'plasma membrane region', 'actin-based cell projection', 'plasma membrane bounded cell projection', 'plasma membrane bounded cell projection part', 'Immunoglobulin subtype 2', 'Immunoglobulin subtype', 'Immunoglobulin-like domain', 'Immunoglobulin-like fold', 'Immunoglobulin-like domain superfamily', 'Alternative splicing', 'Glycoprotein', 'Immunity', 'Immunoglobulin domain', 'Membrane', 'Phosphoprotein', 'Polymorphism', 'Repeat', 'Signal', 'Transmembrane', 'Cell projection', 'Cell membrane', 'Disulfide bond', 'Transmembrane helix', 'Immunoglobulin domain', 'Immunoglobulin I-set domain', 'Immunoglobulin domain', 'Immunoglobulin domain', 'immune system process', 'Immunoglobulin C-2 Type', 'Immunoglobulin']",MGPADSWGHHWMGILLSASLCTVWSPPAAAQLTLNANPLDATQSEDVVLPVFGTPRTPQIHGRSRELAKPSIAVSPGTAIEQKDMVTFYCTTKDVNITIHWVSNNLSIVFHERMQLSKDGKILTILIVQREDSGTYQCEARDALLSQRSDPIFLDVKYGPDPVEIKLESGVASGEVVEVMEGSSMTFLAETKSHPPCAYTWFLLDSILSHTTRTFTIHAVSREHEGLYRCLVSNSATHLSSLGTLKVRVLETLTMPQVVPSSLNLVENARSVDLTCQTVNQSVNVQWFLSGQPLLPSEHLQLSADNRTLIIHGLQRNDTGPYACEVWNWGSRARSEPLELTINYGPDQVHITRESASEMISTIEAELNSSLTLQCWAESKPGAEYRWTLEHSTGEHLGEQLIIRALTWEHDGIYNCTASNSLTGLARSTSVLVKVVGPQSSSLSSGAIAGIVIGILAVIAVASELGYFLCIRNARRPSRKTTEDPSHETSQPIPKEEHPTEPSSESLSPEYRNISQLQGRIRVELMQPPDLPEETYETKLPSASRRGNSFSPWKPPPKPLMPPLRLVSTVPKNMESIYEVLGMQQ,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=9

DOMAIN=IGc2
START=81
END=145
EVALUE=5.24005145919661e-07
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=168
END=185
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=IG
START=174
END=250
EVALUE=8.38408231572261e-06
TYPE=SMART
STATUS=visible|OK

DOMAIN=IG
START=261
END=343
EVALUE=8.25761286597779e-05
TYPE=SMART
STATUS=visible|OK

DOMAIN=IGc2
START=366
END=423
EVALUE=1.03220161022271e-05
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=440
END=463
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=449
END=471
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=494
END=510
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=552
END=564
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr19:44513190_C_T,8.019,-1,HGNC,T,protein_coding,HGNC:24879,ENST00000614577,ENSG00000273777,['missense_variant'],CEACAM20,".,.,.,.,.,.",377,".,.,.,.,.,.",1146,".,.,.,.,.,.",1130,"0.06,0.059,0.028,0.029,0.059,0.038",0.006,".,.,.,.,.,.",benign,".,.,.,.,.,.",0,-0.862,".,.,.,.,.,.",".,.,.,T,.,.",0.008,".,.,.,.,.,.",-1.37,0.49,tolerated,1146,".,.,.,.,.,.",C/Y,377,".,.,.,.,.,.",tGc/tAc,"T,T,T,T,T,T",-0.143,0.022,1130,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr21,34670178,34670179,T,A,CLIC6,ENST00000349499,2017-01-06 00:00:00,gTc/gAc,V/D,264/686,MODERATE,MED,benign,"T,T",None,0,".,.",rs13049745,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000159212,Chloride intracellular channel 6,"['Predicted intracellular proteins', 'Transporters']","['Ion transport', 'Transport']","{'brain': '63.3', 'retina': '85.1', 'stomach 1': '45.1'}",1.8,0.9,1.2,0.4,1.3,1.1,45.1,0.3,0.1,0.4,0,0.2,0.5,"CLIC6,BEST3,BEST3,ANO1,ANO1,ANO1,BEST4,BEST4,BEST4,BEST4,CLIC4,CLIC4,CLIC4,CLIC4,CLIC4,NIPAL3,NIPAL3,TPRN,TPRN,BEST1,BEST1,BEST1,BEST1,BEST1,BEST1,GABRP,GABRP,GABRP,GABRP,GABRP,GABRP,GABRP,BEST2,BEST2,BEST2,BEST2,BEST2,BEST2,BEST2,BEST2","CFTR,CFTR,CLIC6,CFTR,CLIC6,BEST3,CFTR,CLIC6,BEST3,ANO1,CFTR,CLIC6,BEST3,ANO1,BEST4,CLIC6,CLIC4,CLIC6,CLIC4,CFTR,CLIC6,BEST3,ANO1,BEST4,CLIC4,CFTR,CLIC6,BEST3,ANO1,BEST4,CLIC4,BEST1,CFTR,CLIC6,BEST3,ANO1,BEST4,CLIC4,BEST1,GABRP","[0.194, 0.447, 0.207, 0.709, 0.175, 0.679, 0.471, 0.232, 0.049734, 0.677, 0.216, 0.0162, 0.238, 0.157, 0.172, 0.634, 0.63, 0.66, 0.092, 0.474, 0.247, 0.083018, 0.675, 0.066174, 0.149, 0, 0.39, 0, 0, 0, 0.157, 0, 0.53, 0.273, 0.0522120000000001, 0.72, 0.043287, 0.129, 0.063258, 0]","['intracellular', 'cell', 'nucleus', 'cytoplasm', 'plasma membrane', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'protein-containing complex', 'ion channel complex', 'chloride channel complex', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular part', 'membrane part', 'cell part', 'cell periphery', 'membrane protein complex', 'transmembrane transporter complex', 'transporter complex', 'transporter activity', 'ion channel activity', 'voltage-gated ion channel activity', 'anion channel activity', 'chloride channel activity', 'anion transmembrane transporter activity', 'ion transmembrane transporter activity', 'inorganic anion transmembrane transporter activity', 'chloride transmembrane transporter activity', 'channel activity', 'inorganic molecular entity transmembrane transporter activity', 'passive transmembrane transporter activity', 'voltage-gated channel activity', 'gated channel activity', 'substrate-specific channel activity', 'ion gated channel activity', 'transmembrane transporter activity', 'Intracellular chloride channel', 'Glutathione S-transferase, C-terminal-like', 'Thioredoxin-like superfamily', 'Glutathione S-transferase, C-terminal domain superfamily', 'Glutathione Transferase family', 'Alternative splicing', 'Ion transport', 'Ion channel', 'Membrane', 'Phosphoprotein', 'Polymorphism', 'Repeat', 'Transmembrane', 'Transport', 'Voltage-gated channel', 'Chloride', 'Chloride channel', 'Cytoplasm', 'Cell membrane', 'Transmembrane helix', 'Glutathione S-transferase, C-terminal domain', 'transport', 'ion transport', 'anion transport', 'chloride transport', 'inorganic anion transport', 'regulation of localization', 'ion transmembrane transport', 'regulation of transmembrane transport', 'regulation of ion transmembrane transport', 'regulation of ion transport', 'regulation of biological process', 'regulation of transport', 'localization', 'establishment of localization', 'transmembrane transport', 'biological regulation', 'anion transmembrane transport', 'inorganic ion transmembrane transport', 'inorganic anion transmembrane transport', 'chloride transmembrane transport']",MAEAAEPEGVAPGPQGPPEVPAPLAERPGEPGAAGGEAEGPEGSEGAEEAPRGAAAVKEAGGGGPDRGPEAEARGTRGAHGETEAEEGAPEGAEVPQGGEETSGAQQVEGASPGRGAQGEPRGEAQREPEDSAAPERQEEAEQRPEVPEGSASGEAGDSVDAEGPLGDNIEAEGPAGDSVEAEGRVGDSVDAEGPAGDSVDAEGPLGDNIQAEGPAGDSVDAEGRVGDSVDAEGPAGDSVDAEGRVGDSVEAGDPAGDGVEAGVPAGDSVEAEGPAGDSMDAEGPAGRARRVSGEPQQSGDGSLSPQAEAIEVAAGESAGRSPGELAWDAAEEAEVPGVKGSEEAAPGDARADAGEDRVGDGPQQEPGEDEERRERSPEGPREEEAAGGEEESPDSSPHGEASRGAAEPEAQLSNHLAEEGPAEGSGEAARVNGRREDGEASEPRALGQEHDITLFVKAGYDGESIGNCPFSQRLFMILWLKGVIFNVTTVDLKRKPADLQNLAPGTNPPFMTFDGEVKTDVNKIEEFLEEKLAPPRYPKLGTQHPESNSAGNDVFAKFSAFIKNTKKDANEIHEKNLLKALRKLDNYLNSPLPDEIDAYSTEDVTVSGRKFLDGDELTLADCNLLPKLHIIKIVAKKYRDFEFPSEMTGIWRYLNNAYARDEFTNTCPADQEIEHAYSDVAKRMK,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=5

DOMAIN=low_complexity_region
START=2
END=64
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=75
END=101
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=133
END=149
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=360
END=398
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=418
END=430
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr21:34670179_T_A,0.59,1,HGNC,G,protein_coding,HGNC:2065,ENST00000349499,ENSG00000159212,['missense_variant'],CLIC6,"N,N",264,".,1.94421044628",791,"B,B",791,"0.099,0.077",0,"T,T",benign,".,.",0,-4.397,"N,N","T,.",0,"B,B",-2.388,0.07,tolerated_low_confidence,791,"0.0986583533028,0.0986583533028",V/G,264,".,.",gTc/gGc,"T,T",-4.245,0,791,,,3.1929,0.002153216,N,0.2322082172,0,0.006,T,0.59774,T,T,"N,N",0.9999999065,N,,T,N,,,,,,,,,,,
chr9,41996326,41996327,A,T,CNTNAP3B,ENST00000612828,2017-07-23 00:00:00,Tca/Aca,S/T,317/1207,MODERATE,MED,benign,".,.,.,.,T",None,None,"Laminin G domain&Laminin G domain&Laminin G domain,Laminin G domain&Laminin G domain&Laminin G domain,Laminin G domain&Laminin G domain&Laminin G domain,Laminin G domain&Laminin G domain&Laminin G domain,Laminin G domain&Laminin G domain&Laminin G domain",rs62554986,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000154529,Contactin associated protein like 3B,"['Predicted intracellular proteins', 'Predicted membrane proteins']",['Cell adhesion'],None,1.1,0.4,7.3,0,1.7,0.6,0.5,0,0,7.5,0,0,0,"SERTAD4,C9orf66,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,SPATA31A3","IMMP1L,CCDC144NL,IMMP1L,CCDC144NL,EPB41,SERTAD4,C9orf84,SPATA31A1,C9orf66,MCTP1,KIAA1958,CNTNAP3B","[0.506, 0.453, 0.466, 0.574, 0.549, 0.479, 0.504, 0.519, 0.473, 0.462, 0.56, 0.633]","['membrane', 'integral component of membrane', 'intrinsic component of membrane', 'membrane part', 'Coagulation factor 5/8 C-terminal domain', 'EGF-like domain', 'Laminin G domain', 'Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain', 'Galactose-binding-like domain superfamily', 'Concanavalin A-like lectin/glucanase domain superfamily', 'Contactin-associated protein-like 3', 'Fibrinogen-like, C-terminal', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Repeat', 'Signal', 'Transmembrane', 'Disulfide bond', 'Transmembrane helix', 'Laminin G domain', 'F5/8 type C domain', 'Laminin G domain', 'cell adhesion', 'biological adhesion', 'Epidermal growth factor-like domain.', 'Coagulation factor 5/8 C-terminal domain, discoidin domain', 'Laminin G domain']",MASVAWAVLKVLLLLPTQTWSPVGAGNPPDCDSPLASALPRSSFSSSSELSSSHGPGFSRLNRRDGAGGWTPLVSNKYQWLQIDLGERMEVTAVATQGGYGSSDWVTSYLLMFSDGGRNWKQYRREESIWGFPGNTNADSVVHYRLQPPFEARFLRFLPLAWNPRGRIGMRIEVYGCAYKSEVVYFDGQSALLYTLDKKPLKPIRDVISLKFKAMQSNGILLHREGQHGNHITLELIKGKLVFFLNSGNAKLPSTIAPVTLTLGSLLDDQHWHSVLIELLDTQVNFTVDKHTHHFQAKGDSSNLDLNFEISFGGILSPGRSRAFTRKSFHGCLENLYYNGVDVTELAKKHKPQILMMGNVSFSCPQPQTVPVTFLSSRSYLALPGNSGEDKVSVTFQFRTWNRAGHLLFGELQRGSGSFVLFLKDGKLKLSLFQAGQSPRNVTAGAGLNDGQWHSVSFSAKWSHMNVVVDDDTAVQPLVAVLIDSGDTYYFGALYEQSCEAHKHRGNPSGLYYIDADGSGPLGPFLVYCNMTDSAWTVVRHGGPDAVTLRGAPSGHPLSAVSFAYAAGAGQLRAAVNLAERCEQRLALRCGTARRPDSRGLVTQ,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=6

DOMAIN=low_complexity_region
START=2
END=15
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FA58C
START=30
END=177
EVALUE=1.92081609661916e-24
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=33
END=59
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=LamG
START=204
END=341
EVALUE=6.94231199242173e-22
TYPE=SMART
STATUS=visible|OK

DOMAIN=LamG
START=390
END=517
EVALUE=6.29500327798018e-11
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=564
END=575
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr9:41996327_A_T,5.64,-1,HGNC,T,protein_coding,HGNC:32035,ENST00000612828,ENSG00000154529,['missense_variant'],CNTNAP3B,".,.,.,.,N",317,".,.,.,.,.",1105,".,.,.,.,.",949,"0.142,0.132,0.128,0.109,0.107",0,".,.,.,.,T",benign,".,.,.,.,.",0,-0.656,".,.,.,.,.",".,T,.,.,.",0.009,".,.,.,.,.",-0.54,0.45,tolerated,1105,".,.,.,.,.",S/T,317,".,.,.,.,.",Tca/Aca,"T,T,T,T,T",0.192,0,949,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr9,42129031,42129032,G,T,CNTNAP3B,ENST00000377561,2017-01-24 00:00:00,agC/agA,S/R,21/1288,MODERATE,MED,possibly_damaging,".,.,.,.,T",None,None,".,.,.,.,.",rs372133350,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000154529,Contactin associated protein like 3B,"['Predicted intracellular proteins', 'Predicted membrane proteins']",['Cell adhesion'],None,1.1,0.4,7.3,0,1.7,0.6,0.5,0,0,7.5,0,0,0,"SERTAD4,C9orf66,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,CNTNAP3B,SPATA31A3","IMMP1L,CCDC144NL,IMMP1L,CCDC144NL,EPB41,SERTAD4,C9orf84,SPATA31A1,C9orf66,MCTP1,KIAA1958,CNTNAP3B","[0.506, 0.453, 0.466, 0.574, 0.549, 0.479, 0.504, 0.519, 0.473, 0.462, 0.56, 0.633]","['membrane', 'integral component of membrane', 'intrinsic component of membrane', 'membrane part', 'Coagulation factor 5/8 C-terminal domain', 'EGF-like domain', 'Laminin G domain', 'Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain', 'Galactose-binding-like domain superfamily', 'Concanavalin A-like lectin/glucanase domain superfamily', 'Contactin-associated protein-like 3', 'Fibrinogen-like, C-terminal', 'Alternative splicing', 'Cell adhesion', 'EGF-like domain', 'Glycoprotein', 'Membrane', 'Repeat', 'Signal', 'Transmembrane', 'Disulfide bond', 'Transmembrane helix', 'Laminin G domain', 'F5/8 type C domain', 'Laminin G domain', 'cell adhesion', 'biological adhesion', 'Epidermal growth factor-like domain.', 'Coagulation factor 5/8 C-terminal domain, discoidin domain', 'Laminin G domain']",MASVAWAVLKVLLLLPTQTWSPVGAGNPPDCDSPLASALPRSSFSSSSELSSSHGPGFSRLNRRDGAGGWTPLVSNKYQWLQIDLGERMEVTAVATQGGYGSSDWVTSYLLMFSDGGRNWKQYRREESIWGFPGNTNADSVVHYRLQPPFEARFLRFLPLAWNPRGRIGMRIEVYGCAYKSEVVYFDGQSALLYTLDKKPLKPIRDVISLKFKAMQSNGILLHREGQHGNHITLELIKGKLVFFLNSGNAKLPSTIAPVTLTLGSLLDDQHWHSVLIELLDTQVNFTVDKHTHHFQAKGDSSNLDLNFEISFGGILSPGRSRAFTRKSFHGCLENLYYNGVDVTELAKKHKPQILMMGNVSFSCPQPQTVPVTFLSSRSYLALPGNSGEDKVSVTFQFRTWNRAGHLLFGELQRGSGSFVLFLKDGKLKLSLFQAGQSPRNVTAGAGLNDGQWHSVSFSAKWSHMNVVVDDDTAVQPLVAVLIDSGDTYYFGALYEQSCEAHKHRGNPSGLYYIDADGSGPLGPFLVYCNMTDSAWTVVRHGGPDAVTLRGAPSGHPLSAVSFAYAAGAGQLRAAVNLAERCEQRLALRCGTARRPDSRGLVTQ,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=6

DOMAIN=low_complexity_region
START=2
END=15
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FA58C
START=30
END=177
EVALUE=1.92081609661916e-24
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=33
END=59
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=LamG
START=204
END=341
EVALUE=6.94231199242173e-22
TYPE=SMART
STATUS=visible|OK

DOMAIN=LamG
START=390
END=517
EVALUE=6.29500327798018e-11
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=564
END=575
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr9:42129032_G_T,9.682,-1,HGNC,T,protein_coding,HGNC:32035,ENST00000377561,ENSG00000154529,['missense_variant'],CNTNAP3B,".,.,.,.,N",21,".,.,.,.,.",395,".,.,.,.,.",63,"0.17,0.057,0.125,0.111,0.087",0.011,".,.,.,.,D",benign,".,.,.,.,.",0.006,0.469,".,.,.,.,.",".,T,.,.,.",0.233,".,.,.,.,.",0.981,0.57,tolerated,395,"0.693599896802,0.693599896802,0.693599896802,0.693599896802,0.693599896802",S/R,21,".,.,.,.,.",agC/agA,"T,T,T,T,T",1.769,0.087,63,,,6.7643,,N,0.8138283469,0,,,0.256391,,,,0.3805104658,,,,,,,,,,,,,,,
chr10,46337331,46337332,G,A,CTGLF11P,ENST00000624701,2017-01-09 00:00:00,Gag/Aag,E/K,37/685,missense_variant,MED,benign,deleterious_low_confidence,32,None,.,rs531000967,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"AGAP14,AGAP14,AGAP14,AGAP14","GALNT10,NANOS3,INO80,CYP4X1","[0.512, 0.471, 0.58, 0.517]","['Ankyrin repeat', 'Putative GTPase activating protein for Arf', 'Ankyrin repeats (3 copies)', 'Ankyrin repeats (many copies)', 'Putative GTP-ase activating proteins for the small GTPase, ARF', 'Pleckstrin homology domain.', 'ankyrin repeats']",,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Error</title>
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
Looks like you submited a DNA or RNA sequence. SMART annotates PROTEIN domains. Please resubmit the corresponding protein sequence.<p></div><div id=""footer"">
<div style=""float:left"">&copy; 2019 EMBL | <a href='https://www.embl.de/aboutus/privacy_policy/index.html'>Privacy Policy</a></div>Send comments to <a href=""http://www.letunic.com"">Ivica Letunic</a></div>
<script type=""text/javascript"">
  var _paq = _paq || [];
  _paq.push(['trackPageView']);
  _paq.push(['enableLinkTracking']);
  (function() {
    var u=""//tr-denbi.embl.de/heimdall/"";
    _paq.push(['setTrackerUrl', u+'p.php']);
    _paq.push(['setSiteId', '5']);
    var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
    g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'p.js'; s.parentNode.insertBefore(g,s);
  })();
</script>
</body></html>
",chr10:46337332_G_A,9.525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,46357707,46357708,C,G,CTGLF11P,ENST00000624701,2017-09-09 00:00:00,tCt/tGt,S/C,351/685,MODIFIER,MED,benign,tolerated,None,None,.,rs199654828,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"AGAP14,AGAP14,AGAP14,AGAP14","GALNT10,NANOS3,INO80,CYP4X1","[0.512, 0.471, 0.58, 0.517]","['Ankyrin repeat', 'Putative GTPase activating protein for Arf', 'Ankyrin repeats (3 copies)', 'Ankyrin repeats (many copies)', 'Putative GTP-ase activating proteins for the small GTPase, ARF', 'Pleckstrin homology domain.', 'ankyrin repeats']",,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Error</title>
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
Looks like you submited a DNA or RNA sequence. SMART annotates PROTEIN domains. Please resubmit the corresponding protein sequence.<p></div><div id=""footer"">
<div style=""float:left"">&copy; 2019 EMBL | <a href='https://www.embl.de/aboutus/privacy_policy/index.html'>Privacy Policy</a></div>Send comments to <a href=""http://www.letunic.com"">Ivica Letunic</a></div>
<script type=""text/javascript"">
  var _paq = _paq || [];
  _paq.push(['trackPageView']);
  _paq.push(['enableLinkTracking']);
  (function() {
    var u=""//tr-denbi.embl.de/heimdall/"";
    _paq.push(['setTrackerUrl', u+'p.php']);
    _paq.push(['setSiteId', '5']);
    var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
    g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'p.js'; s.parentNode.insertBefore(g,s);
  })();
</script>
</body></html>
",chr10:46357708_C_G,0.299,1,HGNC,T,unprocessed_pseudogene,HGNC:23660,ENST00000624701,ENSG00000279058,['non_coding_transcript_exon_variant'],AGAP14P,,,,1054,,,,,,,,,,,,,,,,,1054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126610,42126611,C,G,CYP2D6,ENST00000389970,2017-10-10 00:00:00,aGc/aCc,S/T,483/494,MODERATE,MED,benign,".,.,.,.,.",None,None,".,.,.,.,.",rs1135840,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000100197,Cytochrome P450 family 2 subfamily D member 6,"['Enzymes', 'Predicted intracellular proteins', 'Predicted membrane proteins']","['Cholesterol metabolism', 'Fatty acid metabolism', 'Lipid metabolism', 'Steroid metabolism', 'Sterol metabolism']",{'liver': '78.0'},2.2,3.5,0.1,0.1,0,11.2,0.1,0.1,0,0,0,0,0.8,"CYP3A4,CYP3A4,CYP3A4,MAOA,CYP2D6,CYP2D6,CYP2D6,CYP2D6,CYP2D6,HSD11B1,HSD11B1,FMO4,FMO4,FMO3,FMO3,MAOB,MAOB,MAOB,FMO1,FMO1,FMO1","FMO2,FMO5,CBR3,CYP3A4,FMO2,FMO5,CBR3,CYP3A4,MAOA,CYP3A4,CYP2D6,CYP3A4,CYP2D6,CYP3A4,CYP2D6,CYP3A4,MAOA,CYP2D6,CBR3,CYP3A4,CYP2D6","[0.226, 0.48, 0.232, 0.34, 0.253, 0.439, 0.387, 0.358105, 0.522, 0.255, 0.163, 0.385, 0.238, 0.617, 0.58, 0.267, 0.022344, 0.479, 0.675, 0.576, 0.558]","['intracellular', 'cell', 'cytoplasm', 'mitochondrion', 'endoplasmic reticulum', 'endoplasmic reticulum membrane', 'endomembrane system', 'membrane', 'organelle membrane', 'organelle subcompartment', 'nuclear outer membrane-endoplasmic reticulum membrane network', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle part', 'intracellular part', 'membrane part', 'endoplasmic reticulum part', 'cytoplasmic part', 'intracellular organelle part', 'cell part', 'endoplasmic reticulum subcompartment', 'catalytic activity', 'monooxygenase activity', 'binding', 'iron ion binding', 'drug binding', 'steroid hydroxylase activity', 'oxidoreductase activity', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen', 'heme binding', 'ion binding', 'cation binding', 'metal ion binding', 'tetrapyrrole binding', 'transition metal ion binding', 'cofactor binding', 'aromatase activity', 'organic cyclic compound binding', 'heterocyclic compound binding', 'Cytochrome P450', 'Cytochrome P450, E-class, group I', 'Cytochrome P450, E-class, group I, CYP2D-like', 'Cytochrome P450, conserved site', 'Cytochrome P450 superfamily', 'Alternative splicing', 'Endoplasmic reticulum', 'Heme', 'Iron', 'Lipid metabolism', 'Membrane', 'Metal-binding', 'Microsome', 'Monooxygenase', 'Oxidoreductase', 'Polymorphism', 'Steroid metabolism', 'Sterol metabolism', 'Cytochrome P450', 'long-chain fatty acid metabolic process', 'organic acid metabolic process', 'lipid metabolic process', 'fatty acid metabolic process', 'fatty acid biosynthetic process', 'icosanoid metabolic process', 'isoprenoid metabolic process', 'terpenoid metabolic process', 'cellular aromatic compound metabolic process', 'xenobiotic metabolic process', 'nitrogen compound metabolic process', 'metabolic process', 'steroid metabolic process', 'lipid biosynthetic process', 'catabolic process', 'biosynthetic process', 'response to xenobiotic stimulus', 'phenylpropanoid metabolic process', 'coumarin metabolic process', 'alkaloid metabolic process', 'alkaloid catabolic process', 'negative regulation of metabolic process', 'cellular process', 'organic acid biosynthetic process', 'monoterpenoid metabolic process', 'drug metabolic process', 'regulation of metabolic process', 'arachidonic acid metabolic process', 'secondary metabolic process', 'carboxylic acid metabolic process', 'regulation of cellular metabolic process', 'negative regulation of cellular metabolic process', 'monocarboxylic acid metabolic process', 'isoquinoline alkaloid metabolic process', 'unsaturated fatty acid metabolic process', 'cellular nitrogen compound metabolic process', 'response to chemical', 'drug catabolic process', 'long-chain fatty acid biosynthetic process', 'oxoacid metabolic process', 'negative regulation of molecular function', 'cellular metabolic process', 'primary metabolic process', 'cellular catabolic process', 'cellular biosynthetic process', 'cellular lipid metabolic process', 'cellular nitrogen compound catabolic process', 'small molecule metabolic process', 'small molecule biosynthetic process', 'carboxylic acid biosynthetic process', 'heterocycle metabolic process', 'negative regulation of biological process', 'negative regulation of cellular process', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'regulation of binding', 'negative regulation of binding', 'cellular response to stimulus', 'oxidation-reduction process', 'biological regulation', 'regulation of molecular function', 'cellular response to chemical stimulus', 'demethylation', 'oxidative demethylation', 'cellular response to xenobiotic stimulus', 'organic substance metabolic process', 'monocarboxylic acid biosynthetic process', 'organic cyclic compound metabolic process', 'organonitrogen compound metabolic process', 'organonitrogen compound catabolic process', 'fatty acid derivative metabolic process', 'organic substance catabolic process', 'organic substance biosynthetic process', 'Metabolism', 'Biological oxidations', 'Cytochrome P450 - arranged by substrate type', 'Fatty acids', 'Phase I - Functionalization of compounds', 'Miscellaneous substrates', 'Xenobiotics', 'CYP2E1 reactions', 'Metabolism of lipids', 'Biosynthesis of DHA-derived SPMs', 'Biosynthesis of specialized proresolving mediators (SPMs)', 'Biosynthesis of maresins', 'Biosynthesis of maresin-like SPMs']",MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYSPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVPEALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVTPSPYELCAVPR,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=3

DOMAIN=low_complexity_region
START=3
END=22
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=5
END=24
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=35
END=47
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr22:42126611_C_G,0.8,-1,HGNC,G,protein_coding,HGNC:2625,ENST00000389970,ENSG00000100197,['missense_variant'],CYP2D6,".,.,.,.,.",483,".,.,.,.,.",1604,".,.,.,.,.",1448,".,.,0.112,0.103,0.145",0,".,.,.,.,.",benign,".,.,.,.,.",0.001,-0.799,".,.,.,.,.","T,T,T,T,.",0.001,".,.,.,.,.",-0.7,1,tolerated,1604,".,.,.,.,.",S/T,483,".,.,.,.,.",aGc/aCc,".,.,T,T,T",-0.805,0,1448,,"ENSG00000183172,ENSG00000100147,ENSG00000198951,ENSG00000182057",,,,,,,,,,,,,,,,,,not_specified&not_provided,"criteria_provided,_multiple_submitters,_no_conflicts",CN169374&CN517202,,"Benign,_other",242701,,,,
chr22,42141586,42141587,G,A,CYP2D7,ENST00000614967,2017-06-09 00:00:00,tCg/tTg,S/L,260/446,HIGH,MED,benign,".,.",None,None,".,.",rs1800754,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000100197,Cytochrome P450 family 2 subfamily D member 6,"['Enzymes', 'Predicted intracellular proteins', 'Predicted membrane proteins']","['Cholesterol metabolism', 'Fatty acid metabolism', 'Lipid metabolism', 'Steroid metabolism', 'Sterol metabolism']",{'liver': '78.0'},2.2,3.5,0.1,0.1,0,11.2,0.1,0.1,0,0,0,0,0.8,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",DPAQPPRDLTEAFLAKKEKAKGSPESSFNDENLRIVSVSNRRSTT,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=0

-- FINISHED --
",chr22:42141587_G_A,19.59,-1,HGNC,T,protein_coding,HGNC:2624,ENST00000614967,ENSG00000205702,['stop_gained'],CYP2D7,".,.",260,".,.",869,".,.",779,"0.227,0.47",0.459,".,.",probably_damaging,".,.",0.999,0.551,".,.",".,.",0.035,".,.",1.079,0.01,deleterious,869,".,.",S/*,260,".,.",tCg/tAg,".,.",1.876,0.015,779,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr3,57402386,57402387,T,C,DNAH12,ENST00000351747,,,,-/3092,LOW,MED,,,None,None,.,rs6445873,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000174844,Dynein axonemal heavy chain 12,"['Cancer-related genes', 'Predicted intracellular proteins']",['Ubl conjugation pathway'],"{'brain': '23.0', 'fallopian tube': '16.7', 'lung': '17.5', 'testis': '17.6'}",0.2,0.1,0.2,0.2,0.2,0.2,0.2,0.5,0.5,0,0,1.2,0.9,"DNAH9,DNAH5,DNAH5,DNAH12,DNAH12,DNAH12,DNAH6,DNAH6,DNAH6,DNAH6,DYNC2H1,DYNC2H1,DYNC2H1,DYNC2H1,DYNC2H1,DNAH14,DNAH14,DNAH14,DNAH14,DNAH14,DNAH14,DNAI2,DNAI2,DNAI2,DNAI2,DNAI2,DNAI2,DNAI2,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH1,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAH2,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1,DNAI1","DNAL4,DNAL4,DNAH9,DNAL4,DNAH9,DNAH5,DNAL4,DNAH9,DNAH5,DNAH12,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAI2,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAI2,DNAH1,DNAL4,DNAH9,DNAH5,DNAH12,DNAH6,DYNC2H1,DNAH14,DNAI2,DNAH1,DNAH2","[0.615, 0.542, 0.159258, 0.43, 0.552, 0.759, 0.487, 0.118816, 0.190322, 0.903, 0.162, 0.123375, 0.152086, 0.56, 0.111027, 0.421, 0.42, 0.759, 0.905, 0.390999, 0.213, 0.65, 0.757, 0.917, 0.479, 0.583, 0.442, 0.294, 0.484, 0.09504, 0.1518, 0.905, 0.109263, 0.1452, 0.905, 0.524, 0.558, 0.102808, 0.089355, 0.54, 0.06981, 0.06541, 0.397, 0.396, 0.082224, 0.63, 0.699, 0.899, 0.458, 0.609, 0.341, 0.267, 0.35399, 0.573, 0.44]","['intracellular', 'cell', 'cytoplasm', 'cytoskeleton', 'microtubule', 'microtubule associated complex', 'cilium', 'microtubule cytoskeleton', 'dynein complex', 'protein-containing complex', 'cell projection', 'organelle', 'non-membrane-bounded organelle', 'intracellular organelle', 'intracellular non-membrane-bounded organelle', 'organelle part', 'intracellular part', 'cytoskeletal part', 'intracellular organelle part', 'cell part', 'supramolecular complex', 'supramolecular polymer', 'supramolecular fiber', 'polymeric cytoskeletal fiber', 'plasma membrane bounded cell projection', 'catalytic complex', 'nucleotide binding', 'motor activity', 'microtubule motor activity', 'catalytic activity', 'binding', 'ATP binding', 'drug binding', 'pyrophosphatase activity', 'hydrolase activity', 'hydrolase activity, acting on acid anhydrides', 'hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides', 'ATPase activity', 'purine nucleotide binding', 'nucleoside-triphosphatase activity', 'adenyl nucleotide binding', 'ribonucleotide binding', 'purine ribonucleotide binding', 'adenyl ribonucleotide binding', 'purine ribonucleoside triphosphate binding', 'small molecule binding', 'ion binding', 'anion binding', 'organic cyclic compound binding', 'carbohydrate derivative binding', 'nucleoside phosphate binding', 'heterocyclic compound binding', 'Dynein heavy chain', 'Coiled coil', 'movement of cell or subcellular component', 'microtubule-based process', 'microtubule-based movement', 'cellular process']",MSDANKAAIAAEKEALNLKLPPIVHLPENIGVDTPTQSKLLKYRRSKEQQQKINQLVIDGAKRNLDRTLGKRTPLLPPPDYPQTMTSEMKKKGFNYIYMKQCVESSPLVPIQQEWLDHMLRLIPESLKEGKEREELLESLINEVSSDFENSMKRYLVQSVLVKPPVKSLEDEGGPLPESPVGLDYSNPWHSSYVQARNQIFSNLHIIHPTMKMLLDLGYTTFADTVLLDFTGIRAKGPIDCESLKTDLSIQTRNAEEKIMNTWYPKVINLFTKKEALEGVKPEKLDAFYSCVSTLMSNQLKDLLRRTVEGFVKLFDPKDQQRLPIFKIELTFDDDKMEFYPTFQDLEDNVLSLVERIAEALQNVQTIPSWLSGTSTPVNLDTELPEHVLHWAVDTLKAAVHRNLEGARKHYETYVEKYNWLLDGTAVENIETFQTEDHTFDEYTEELDCWVVWEVYF,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=low_complexity_region
START=4
END=20
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=125
END=140
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr3:57402387_T_C,7.327,-1,HGNC,C,protein_coding,HGNC:2943,ENST00000351747,ENSG00000174844,"['splice_region_variant', 'intron_variant']",DNAH12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr8,144355664,144355665,C,T,FBXL6,ENST00000455319,2017-09-09 00:00:00,Ggc/Agc,G/S,490/533,missense_variant,MED,benign,tolerated,None,None,.,.,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000182325,F-box and leucine rich repeat protein 6,['Predicted intracellular proteins'],['Ubl conjugation pathway'],None,13.4,14.3,8.3,9.9,6.3,19.1,6.2,0.7,2.4,1.9,4.3,0.8,1.2,"FBXW5,KIAA1875,CUL1,CUL1,FBXL6,FBXL6,FBXL6,FBXL6,FBXL6,GPAA1,GPAA1,GPAA1,ENSG00000272772,ENSG00000272772,MROH1,MROH1,MROH1,MROH1,ECT2L,ECT2L,ECT2L,ECT2L,ECT2L,TMEM249,TMEM249,TMEM249,TMEM249,TMEM249","SKP1,ADCK5,SKP1,FBXW5,SKP1,ADCK5,FBXW5,KIAA1875,CUL1,ADCK5,KIAA1875,FBXL6,CUL1,FBXL6,ADCK5,KIAA1875,FBXL6,GPAA1,SKP1,FBXW5,CUL1,FBXL6,ENSG00000272772,ADCK5,KIAA1875,FBXL6,GPAA1,MROH1","[0.448, 0.686, 0.97, 0.465, 0.608, 0.715, 0.694, 0.687, 0.586, 0.567, 0.693, 0.657, 0.521, 0.174, 0.665, 0.696, 0.672, 0.646, 0.396, 0.515, 0.25, 0.697, 0.356, 0.723, 0.715, 0.72, 0.604, 0.701]","['catalytic activity', 'ubiquitin-protein transferase activity', 'transferase activity', 'ubiquitin-like protein transferase activity', 'catalytic activity, acting on a protein', 'Leucine-rich repeat', 'F-box domain', 'Leucine-rich repeat, cysteine-containing subtype', 'Leucine-rich repeat domain superfamily', 'F-box-like domain superfamily', 'Alternative splicing', 'Leucine-rich repeat', 'Repeat', 'Ubl conjugation pathway', 'F-box domain', 'F-box-like', 'Leucine Rich repeat', 'cellular protein modification process', 'proteolysis', 'nitrogen compound metabolic process', 'metabolic process', 'cellular process', 'protein ubiquitination', 'protein metabolic process', 'protein modification by small protein conjugation', 'protein modification process', 'macromolecule metabolic process', 'macromolecule modification', 'cellular metabolic process', 'primary metabolic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'protein modification by small protein conjugation or removal', 'organic substance metabolic process', 'organonitrogen compound metabolic process', 'Leucine-rich repeats, outliers']",MAAPASRQVRRRARAAPRPRSAEDWWWDRLAPRGSGYHLLQSDSMLLVLSEPGPARPRAQRRASRRTPRQPPRGPSAAAKPKAGLRSEAAAAPAPAPAPTPTPEEGPDAGWGDRIPLEILVQIFGLLVAADGPMPFLGRAARVCRRWQEAASQPALWHTVTLSSPLVGRPAKGGVKAEKKLLASLEWLMPNRFSQLQRLTLIHWKSQLVGECCPRLTFLKLSGCHGVTADALVMLAKACCQLHSLDLQHSMVESTAVVSFLEEAGSRMRKLWLTYSSQTTAILGALLGSCCPQLQVLEVSTGINRNSIPLQLPVEALQKGCPQLQVLRLLNLMWLPKPPGRGVAPGPGFPSLEELCLASSTCNFVSNEVLGRLLHGSPNLRLLDLRGCARITPAGLQDLPCRELEQLHLGLYGTSDRLTLAKEGSPFLTQKWCHTLRELDLSGQGFSEKDLEQALAAFLSTPGGSHPALCSLNLRGTRVTPSTVSSVISSCPGLLYLNLESCRCLPRGLKRAYRGLEEVQWCLEQLLTSPSPS,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=7

DOMAIN=low_complexity_region
START=2
END=22
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=52
END=73
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=89
END=103
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=LRR
START=213
END=238
EVALUE=4.90681257463499
TYPE=SMART
STATUS=visible|OK

DOMAIN=LRR
START=377
END=402
EVALUE=1.51026582018285
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=477
END=490
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=LRR
START=491
END=522
EVALUE=605.754401298074
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr8:144355665_C_T,14.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,39899633,39899634,C,T,FCGBP,ENST00000620799,2017-04-11 00:00:00,Gtg/Atg,V/M,482/1642,MODERATE,MED,benign,tolerated,None,0.00002649000089,TILa domain&VWFC domain&VWFC domain,rs781806947,None,0.001000000048,None,0.003299999982,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39899634_C_T,0.579,-1,HGNC,T,protein_coding,HGNC:13572,ENST00000620799,ENSG00000275395,['missense_variant'],FCGBP,,482,,1444,,1444,,0,,benign,,0.134,-0.929,,T,0,,-1.397,0.51,tolerated,1444,0.0138822411134,V/M,482,,Gtg/Atg,T,-1.644,0,1444,,,6.5068,0.07916766,N,0.8551997785,0,0.029,T,0.615465,T,T,N,0.05279959857,N,,T,N,,,,,,,,,,,
chr19,39899635,39899636,A,C,FCGBP,ENST00000620799,2017-04-11 00:00:00,gTc/gGc,V/G,481/1642,MODERATE,MED,benign,tolerated,None,0.00002705999941,TILa domain&VWFC domain&VWFC domain,rs782093060,None,0.001099999994,None,0.003500000108,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39899636_A_C,4.845,-1,HGNC,C,protein_coding,HGNC:13572,ENST00000620799,ENSG00000275395,['missense_variant'],FCGBP,,481,,1442,,1442,,0.001,,benign,,0,-0.955,,T,0,,-0.269,1,tolerated,1442,0.0401082797425,V/G,481,,gTc/gGc,T,0.223,0,1442,,,6.6383,0.002896475,N,0.217595478,0,0.081,T,0.615465,T,T,N,0.00001217987167,N,,T,N,,,,,,,,,,,
chr19,39902273,39902274,G,C,FCGBP,ENST00000620799,2017-02-11 00:00:00,caC/caG,H/Q,383/1642,MODERATE,MED,benign,tolerated,None,None,"Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich",rs139175656,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39902274_G_C,5.854,-1,HGNC,C,protein_coding,HGNC:13572,ENST00000620799,ENSG00000275395,['missense_variant'],FCGBP,,383,,1149,,1149,,0.148,,benign,,0.02,-0.153,,T,0.947,,-0.794,0.74,tolerated,1149,,H/Q,383,,caC/caG,T,-1.248,0,1149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,39902286,39902287,A,G,FCGBP,ENST00000616721,2017-08-28 00:00:00,gTg/gCg,V/A,1514/4204,MODERATE,MED,benign,,None,None,"Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich",rs200977347,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39902287_A_G,14.97,-1,HGNC,T,protein_coding,HGNC:13572,ENST00000616721,ENSG00000275395,['missense_variant'],FCGBP,,1514,,4549,,4541,,0.401,,benign,,0,-0.107,,T,0.836,,0.194,0.3,tolerated,4549,,V/E,1514,,gTg/gAg,T,0.313,0,4541,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,39902557,39902558,A,G,FCGBP,ENST00000616721,2017-08-28 00:00:00,Tcc/Ccc,S/P,1424/4204,MODERATE,MED,benign,,None,None,"von Willebrand factor, type D domain",rs80068592,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39902558_A_G,17.43,-1,HGNC,G,protein_coding,HGNC:13572,ENST00000616721,ENSG00000275395,['missense_variant'],FCGBP,,1424,,4278,,4270,,0.004,,benign,,0,-0.107,,T,0.001,,0.203,1,tolerated,4278,,S/P,1424,,Tcc/Ccc,T,2.317,0.999,4270,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,39899548,39899549,C,T,FCGBP,ENST00000620799,,,,-/1642,splice_region_variant,MED,,,None,None,.,.,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000275395,Fc fragment of IgG binding protein,['Predicted intracellular proteins'],None,"{'cervix, uterine': '13.9', 'gallbladder': '46.6', 'intestine': '43.3', 'stomach 1': '17.0', 'thyroid gland': '20.9'}",43.3,15.2,0.2,0.2,16.7,16.9,17,0.6,2.3,0,0.9,1.3,3.2,"NPAS4,C1QC,C1QC,PCDH17,PCDH17,PCDH17,ZG16,AGR2,AGR2,CHURC1,CHURC1,CHURC1,CHURC1,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP,FCGBP","NPTX2,NPTX2,NPAS4,NPTX2,NPAS4,C1QC,CLCA1,CLCA1,ZG16,NPTX2,NPAS4,C1QC,PCDH17,CLCA1,CAPZA1,NPTX2,MEP1B,NPAS4,C1QC,PCDH17,ZG16,AGR2,CHURC1","[0.678, 0.456, 0.453, 0.479, 0.443, 0.401, 0.609, 0.509, 0.52, 0.652, 0.573, 0.541, 0.654, 0.613, 0.574, 0.556, 0.569, 0.529, 0.466, 0.527, 0.649, 0.542, 0.664]","['EGF-like domain', 'VWFC domain', 'von Willebrand factor, type D domain', 'Trypsin Inhibitor-like, cysteine rich domain', 'Follistatin-like, N-terminal', 'Uncharacterised domain, cysteine-rich', 'TILa domain', 'Serine protease inhibitor-like superfamily', 'von Willebrand factor type D domain', 'Trypsin Inhibitor like cysteine rich domain', 'C8 domain', 'TILa domain', 'EGF domain, unclasssified subfamily', 'VWC_def', 'von Willebrand factor (vWF) type C domain', 'von Willebrand factor (vWF) type D domain', 'Follistatin-N-terminal domain-like', 'This domain contains 8 conserved cysteine residues, but this family only contains 7 of them to overlaps with other domains. It is found in disease-related proteins including von Willebrand factor, Alpha tectorin, Zonadhesin and Mucin.']",MGALWSWWILWAGATLLWGLTQEASVDLKNTGREEFLTAFLQNYQLAYSKAYPRLLISSLSESPASVSILSQADNTSKKVTVRPGESVMVNISAKAEMIGSKIFQHAVVIHSDYAISVQALNAKPDTAELTLLRPIQALGTEYFVLTPPGTSARNVKEFAVVAGAAGASVSVTLKGSVTFNGKFYPAGDVLRVTLQPYNVAQLQSSVDLSGSKVTASSPVAVLSGHSCAQKHTTCNHVVEQLLPTSAWGTHYVVPTLASQSRYDLAFVVASQATKLTYNHGGITGSRGLQAGDVVEFEVRPSWPLYLSANVGIQVLLFGTGAIRNEVTYDPYLVLIPDVAAYCPAYVVKSVPGCEGVALVVAQTKAISGLTIDGHAVGAKLTWEAVPGSEFSYAEVELGTADMIHTAEATTNLGLLTFGLAKAIGYATAADCGRTVLSPVEPSCEGMQCAAGQRCQVVGGKAGCVAESTAVCRAQGDPHYTTFDGRRYDMMGTCSYTMVELCSEDDTLPAFSVEAKNEHRGSRRVSYVGLVTVRAYSHSVSLTRGEVGFVLVDNQRSRLPVSLSEGRLRVYQSGPRAVVELVFGLVVTYDWDCQLALSLPARFQDQVCGLCGNYNGDPADDFLTPDGALAPDAVEFASSWKLDDGDYLCEDGCQNNCPACTPGQAQHYEGDRLCGMLTKLDGPFAVCHDTLDPRPFLEQCVYDLCVVGGERLSLCRGLSAYAQACLELGISVGDWRSPANCPLSCPANSRYELCGPACPTSCNGAAAPSNCSGRPCVEGCVCLPGFVASGGACVPASSCGCTFQGLQLAPGQEVWADELCQRRCTCNGATHQVTCRDKQSCPAGERCSVQNGLLGCYPDRFGTCQGSGDPHYVSFDGRRFDFMGTCTYLLVGSCGQNAALPAFRVLVENEHRGSQTVSYTRAVRVEARGVKVAVRREYPGQVLVDDVLQYLPFQAADGQVQVFRQGRDAVVRTDFGLTVTYDWNARVTAKVPSSYAEALCGLCGNFNGDPADDLALRGGGQAANALAFGNSWQEETRPGCGATEPGDCPKLDSLVAQQLQSKNECGILADPKGPFRECHSKLDPQGAVRDCVYDRCLLPGQSGPLCDALATYAAACQAAGATVHPWRSEELCPLSCPPHSHYEACSYGCPLSCGDLPVPGGCGSECHEGCVCDEGFALSGESCLPLASCGCVHQGTYHPPGQTFYPGPGCDSLCHCQEGGLVSCESSSCGPHEACQPSGGSLGCVAVGSSTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQQMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPTPCPPGSEDCIPSHKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRTETFCPMECPPNSHYELCADTCSLGCSALSAPPQCQDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHAGKGMVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGSPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFNFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGRRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSEGCIPSEECPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGQVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGAYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVNKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVTQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLAPGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVTLPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAGSLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLREWRRPDFCPFQCPAHSHYELCGDSCPGSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDDRYYPLGQTFYPGPGCDSLCRCREGGEVSCEPSSCGPHETCRPSGGSLGCVAVGSTTCQASGDPHYTTFDGHRFDFMGTCVYVLAQTCGTRPGLHRFAVLQENVAWGNGRVSVTRVITVQVANFTLRLEQRQWKVTVNGVDMKLPVVLANGQIRASQHGSDVVIETDFGLRVAYDLVYYVRVTVPGNYYQLMCGLCGNYNGDPKDDFQKPNGSQAGNANEFGNSWEEVVPDSPCLPPPTCPPGSAGCIPSDKCPPELEKKYQKEEFCGLLSSPTGPLSSCHKLVDPQGPLKDCIFDLCLGGGNLSILCSNIHAYVSACQAAGGHVEPWRNETFCPMECPQNSHYELCADTCSLGCSALSAPLQCPDGCAEGCQCDSGFLYNGQACVPIQQCGCYHNGVYYEPEQTVLIDNCRQQCTCHVGKVVVCQEHSCKPGQVCQPSGGILSCVTKDPCHGVTCRPQETCKEQGGQGVCLPNYEATCWLWGDPHYHSFDGRKFDFQGTCNYVLATTGCPGVSTQGLTPFTVTTKNQNRGNPAVSYVRVVTVAALGTNISIHKDEIGKVRVNGVLTALPVSVADGRISVAQGASKALLVADFGLQVSYDWNWRVDVTLPSSYHGAVCGLCGNMDRNPNNDQVFPNGTLAPSIPIWGGSWRAPGWDPLCWDECRGSCPTCPEDRLEQYEGPGFCGPLSSGTGGPFTTCHAHVPPESFFKGCVLDVCMGGGDRDILCKALASYVAACQAAGVVIEDWRAQVGCEITCPENSHYEVCGPPCPASCPSPAPLTTPAVCEGPCVEGCQCDAGFVLSADRCVPLNNGCGCWANGTYHEAGSEFWADGTCSQWCRCGPGGGSLVCTPASCGLGEVCGLLPSGQHGCQPVSTAECQAWGDPHYVTLDGHRFDFQGTCEYLLSAPCHGPPLGAENFTVTVANEHRGSQAVSYTRSVTLQIYNHSLTLSARWPRKLQVDGVFVALPFQLDSLLHAHLSGADVVVTTTSGLSLAFDGDSFVRLRVPAAYAASLCGLCGNYNQDPADDLKAVGGKPAGWQVGGAQGCGECVSKPCPSPCTPEQQESFGGPDACGVISATDGPLAPCHGLVPPAQYFQGCLLDACQVQGHPGGLCPAVATYVAACQAAGAQLGEWRRPDFCPLQCPAHSHYELCGDSCPVSCPSLSAPEGCESACREGCVCDAGFVLSGDTCVPVGQCGCLHDGRYYPLGEVFYPGPECERRCECGPGGHVTCQEGAACGPHEECRLEDGVQACHATGCGRCLANGGIHYITLDGRVYDLHGSCSYVLAQVCHPKPGDEDFSIVLEKNAAGDLQRLLVTVAGQVVSLAQGQQVTVDGEAVALPVAVGRVRVTAEGRNMVLQTTKGLRLLFDGDAHLLMSIPSPFRGRLCGLCGNFNGNWSDDFVLPNGSAASSVETFGAAWRAPGSSKGCGEGCGPQGCPVCLAEETAPYESNEACGQLRNPQGPFATCQAVLSPSEYFRQCVYDLCAQKGDKAFLCRSLAAYTAACQAAGVAVKPWRTDSFCPLHCPAHSHYSICTRTCQGSCAALSGLTGCTTRCFEGCECDDRFLLSQGVCIPVQDCGCTHNGRYLPVNSSLLTSDCSERCSCSSSSGLTCQAAGCPPGRVCEVKAEARNCWATRGLCVLSVGANLTTFDGARGATTSPGVYELSSRCPGLQNTIPWYRVVAEVQICHGKTEAVGQVHIFFQDGMVTLTPNKGVWVNGLRVDLPAEKLASVSVSRTPDGSLLVRQKAGVQVWLGANGKVAVIVSNDHAGKLCGACGNFDGDQTNDWHDSQEKPAMEKWRAQDFSPCYG,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=68

DOMAIN=low_complexity_region
START=160
END=172
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FOLN
START=443
END=465
EVALUE=0.00226385621936905
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=462
END=627
EVALUE=4.34051142556342e-46
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=667
END=742
EVALUE=3.55462130178998e-34
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=801
END=847
EVALUE=1.08064162156814
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=834
END=857
EVALUE=20.1737166472873
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=850
END=1019
EVALUE=2.95747988709447e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1058
END=1133
EVALUE=3.26655010774975e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1108
END=1121
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1191
END=1282
EVALUE=0.0509978928350083
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1240
END=1406
EVALUE=1.48865438287024e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1424
END=1436
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=1454
END=1529
EVALUE=8.04318982627981e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1462
END=1473
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=1587
END=1650
EVALUE=0.308252145300348
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1618
END=1640
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=1644
END=1666
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=1662
END=1831
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=1871
END=1947
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1961
END=1977
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=1978
END=2001
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2009
END=2102
EVALUE=0.00414806521315379
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2062
END=2227
EVALUE=5.82573573089512e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=2259
END=2334
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2309
END=2323
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=2362
END=2385
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=2392
END=2483
EVALUE=0.10977870905523
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2441
END=2607
EVALUE=5.55585460294439e-44
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2625
END=2637
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=2655
END=2730
EVALUE=6.5331002118413e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2663
END=2674
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=2788
END=2851
EVALUE=0.171215219950995
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2819
END=2841
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=2845
END=2867
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=2863
END=3032
EVALUE=2.71780182012394e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3072
END=3148
EVALUE=3.02750067711676e-28
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3162
END=3173
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=3179
END=3202
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3210
END=3303
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3263
END=3428
EVALUE=9.46393561220585e-38
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=3460
END=3535
EVALUE=2.02799680664396e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3510
END=3524
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=3563
END=3586
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=3593
END=3684
EVALUE=0.148486334498902
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=3642
END=3808
EVALUE=2.04224032781513e-42
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3826
END=3838
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=3856
END=3931
EVALUE=9.90232821843351e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=3864
END=3875
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=VWC
START=3989
END=4052
EVALUE=0.155232173793756
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4020
END=4042
EVALUE=2.2825956239697
TYPE=SMART
STATUS=visible|OK

DOMAIN=FOLN
START=4046
END=4068
EVALUE=5.16793417991919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4064
END=4233
EVALUE=1.76603283030365e-37
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4273
END=4349
EVALUE=3.78437585275306e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4363
END=4374
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF_like
START=4380
END=4403
EVALUE=41.120283688919
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4411
END=4504
EVALUE=0.00455202965641893
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4464
END=4629
EVALUE=4.84553500903028e-35
TYPE=SMART
STATUS=visible|OK

DOMAIN=C8
START=4661
END=4736
EVALUE=1.53693417867445e-29
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=4711
END=4725
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=EGF_like
START=4764
END=4787
EVALUE=62.8014009232629
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=4794
END=4886
EVALUE=0.00707803560179289
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=4846
END=5002
EVALUE=7.80483620782737e-39
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5023
END=5036
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=C8
START=5043
END=5118
EVALUE=8.6204774094659e-33
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWC
START=5176
END=5235
EVALUE=0.37608098246106
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=5192
END=5204
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=FOLN
START=5207
END=5236
EVALUE=53.7797589349626
TYPE=SMART
STATUS=visible|OK

DOMAIN=VWD
START=5226
END=5388
EVALUE=1.53561125630053e-05
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr19:39899549_C_T,1.742,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,171208950,171208951,C,T,FMO2,ENST00000209929,2017-09-09 00:00:00,Cag/Tag,Q/*,472/535,HIGH,HIGH,,,None,None,.,rs6661174,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000131781,Flavin containing monooxygenase 5,"['Cancer-related genes', 'Enzymes', 'Predicted intracellular proteins', 'Predicted membrane proteins']",None,"{'intestine': '61.1', 'liver': '119.4', 'stomach 1': '38.6'}",61.1,12.5,0.7,0.8,8.2,53.6,38.6,9.2,4.9,6.2,12.1,1,2,"TG,CYP2C9,CYP2B6,CYP2B6,CYP3A4,CYP3A4,CYP3A4,CYP2D6,CYP2D6,CYP2D6,NPR1,CYP2C8,CYP2C8,CYP2C8,CYP2C8,DIS3,CYP3A7,CYP3A7,CYP3A7,CYP3A7,CYP3A7,CYP3A7,GJA5,GJA5","FMO2,FMO2,FMO2,CYP2C9,FMO2,CYP2C9,CYP2B6,FMO2,CYP2C9,CYP3A4,FMO2,FMO2,CYP2C9,CYP2B6,CYP3A4,FMO2,FMO2,CYP2C9,CYP2B6,CYP3A4,CYP2D6,CYP2C8,FMO2,NPR1","[0.535, 0.231, 0.394, 0.0506, 0.226, 0.328416, 0.336501, 0.253, 0.100934, 0.358105, 0.65, 0.402, 0.019341, 0.04558, 0.330225, 0.439, 0.343, 0.25567, 0.262824, 0.01462, 0.272742, 0.25944, 0.527, 0.376]","['intracellular', 'cell', 'cytoplasm', 'endoplasmic reticulum', 'endoplasmic reticulum membrane', 'endomembrane system', 'membrane', 'organelle membrane', 'organelle subcompartment', 'nuclear outer membrane-endoplasmic reticulum membrane network', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle part', 'intracellular part', 'membrane part', 'endoplasmic reticulum part', 'cytoplasmic part', 'intracellular organelle part', 'cell part', 'endoplasmic reticulum subcompartment', 'nucleotide binding', 'catalytic activity', 'monooxygenase activity', 'N,N-dimethylaniline monooxygenase activity', 'binding', 'oxidoreductase activity', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen', 'oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen', 'small molecule binding', 'ion binding', 'anion binding', 'cofactor binding', 'flavin adenine dinucleotide binding', 'NADP binding', 'coenzyme binding', 'organic cyclic compound binding', 'nucleoside phosphate binding', 'heterocyclic compound binding', 'Flavin monooxygenase FMO', 'Flavin monooxygenase-like', 'FAD/NAD(P)-binding domain superfamily', 'Acetylation', 'Endoplasmic reticulum', 'FAD', 'Flavoprotein', 'Magnesium', 'Membrane', 'Microsome', 'Monooxygenase', 'NADP', 'Oxidoreductase', 'Polymorphism', 'Ubl conjugation', 'Flavin-binding monooxygenase-like', 'Pyridine nucleotide-disulphide oxidoreductase', 'L-lysine 6-monooxygenase (NADPH-requiring)', 'Pyridine nucleotide-disulphide oxidoreductase', 'organic acid metabolic process', 'nucleobase-containing compound metabolic process', 'cellular aromatic compound metabolic process', 'coenzyme metabolic process', 'oxidoreduction coenzyme metabolic process', 'NADP metabolic process', 'nucleoside phosphate metabolic process', 'phosphorus metabolic process', 'phosphate-containing compound metabolic process', 'xenobiotic metabolic process', 'nitrogen compound metabolic process', 'metabolic process', 'nucleotide metabolic process', 'toxin metabolic process', 'response to xenobiotic stimulus', 'cellular process', 'drug metabolic process', 'pyridine nucleotide metabolic process', 'organophosphate metabolic process', 'secondary metabolic process', 'cellular nitrogen compound metabolic process', 'response to chemical', 'cellular metabolic process', 'primary metabolic process', 'small molecule metabolic process', 'heterocycle metabolic process', 'nicotinamide nucleotide metabolic process', 'response to stimulus', 'cofactor metabolic process', 'cellular response to stimulus', 'nucleobase-containing small molecule metabolic process', 'oxidation-reduction process', 'cellular response to chemical stimulus', 'NADPH oxidation', 'cellular response to xenobiotic stimulus', 'organic substance metabolic process', 'pyridine-containing compound metabolic process', 'oxygen metabolic process', 'organic cyclic compound metabolic process', 'organonitrogen compound metabolic process', 'Metabolism', 'Biological oxidations', 'Phase I - Functionalization of compounds', 'FMO oxidises nucleophiles']",MAKKVAVIGAGVSGLISLKCCVDEGLEPTCFERTEDIGGVWRFKENVEDGRASIYQSVVTNTSKEMSCFSDFPMPEDFPNFLHNSKLLEYFRIFAKKFDLLKYIQFQTTVLSVRKCPDFSSSGQWKVVTQSNGKEQSAVFDAVMVCSGHHILPHIPLKSFPGMERFKGQYFHSRQYKHPDGFEGKRILVIGMGNSGSDIAVELSKNAAQVFISTRHGTWVMSRISEDGYPWDSVFHTRFRSMLRNVLPRTAVKWMIEQQMNRWFNHENYGLEPQNKYIMKEPVLNDDVPSRLLCGAIKVKSTVKELTETSAIFEDGTVEENIDVIIFATGYSFSFPFLEDSLVKVENNMVSLYKYIFPAHLDKSTLACIGLIQPLGSIFPTAELQARWVTRVFKGLCSLPSERTMMMDIIKRNEKRIDLFGESQSQTLQTNYVDYLDELALEIGAKPDFCSLLFKDPKLAVRLYFGPCNSYQYRLVGPGQWEGARNAIFTQKQRILKPLKTRALKDSSNFSVSFLLKILGLLAVVVAFFCQLQWS,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=transmembrane_domain
START=510
END=532
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr1:171208951_C_T,42,1,HGNC,T,protein_coding,HGNC:3770,ENST00000209929,ENSG00000094963,['stop_gained'],FMO2,,472,,1480,,1414,0.562,0.96,,,,,0.599,,,0.985,,1.026,,,1480,,Q/*,472,,Cag/Tag,,7.905,1,1414,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr9,65737983,65737984,G,C,FOXD4L4,ENST00000377413,2017-01-01 00:00:00,gGg/gCg,G/A,280/416,MODERATE,MED,benign,T,None,None,.,rs10796795,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000184659,Forkhead box D4 like 4,"['Predicted intracellular proteins', 'Transcription factors']","['Transcription', 'Transcription regulation']",{'brain': '1.5'},0.2,0,0.2,0.1,0.1,0.4,0.1,0.2,0,0,0,0,0.7,"STX19,ZNF772,ZNF772,DUSP19,FOXD4L4,FOXD4L4,FOXD4L4,FOXD4L4,HIC2,MAP10,MAP10,MAP10,FOXR2,GTF2A1,PCDHB9,PCDHB9","PRB4,PRB4,STX19,STX19,PRB4,STX19,ZNF772,DUSP19,FOXD4L4,STX19,DUSP19,FOXD4L4,FOXD4L4,FOXD4L4,STX19,FOXD4L4","[0.422, 0.536, 0.416, 0.585, 0.479, 0.534, 0.4, 0.452, 0.448, 0.582, 0.519, 0.46, 0.446, 0.443, 0.423, 0.475]","['intracellular', 'cell', 'nucleus', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular part', 'cell part', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'DNA-binding transcription factor activity', 'binding', 'sequence-specific DNA binding', 'organic cyclic compound binding', 'transcription regulator activity', 'heterocyclic compound binding', 'Fork head domain', 'Fork head domain conserved site1', 'Fork head domain conserved site 2', 'Winged helix-like DNA-binding domain superfamily', 'Winged helix DNA-binding domain superfamily', 'DNA-binding', 'Nucleus', 'Transcription', 'Transcription regulation', 'Forkhead domain', 'nucleobase-containing compound metabolic process', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'anatomical structure morphogenesis', 'regulation of biosynthetic process', 'cellular process', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'cell differentiation', 'regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'developmental process', 'RNA biosynthetic process', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'heterocycle metabolic process', 'anatomical structure development', 'cellular developmental process', 'regulation of biological process', 'regulation of cellular process', 'regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'regulation of macromolecule metabolic process', 'biological regulation', 'organic substance metabolic process', 'regulation of primary metabolic process', 'nucleic acid metabolic process', 'nucleic acid-templated transcription', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'FORKHEAD']",MNLPRAERPRSTPQRSLRDSDGEDGKIDVLGEEEDEDEVEDEEEEARQQFLEQSLQPGLQVARWGGVALPREHIEGGGGPSDPSEFGTKFRAPPRSAAASEDARQPAKPPYSYIALITMAILQNPHKRLTLSGICAFISGRFPYYRRKFPAWQNSIRHNLSLNDCFVKIPREPGHPGKGNYWSLDPASQDMFDNGSFLRRRKRFKRHQLTPGAHLPHPFPLPAAHAALHNPHPGPLLGAPAPPQPVPGAYPNTAPGRRPYALLHPHPLRYLLLSARVYAGAPKKAEGADLATPAPFPCCSPHLVLSLGRRARVWRRHREADASLSALRVLCKGSGERVQGLRRVCPRPRGATATCSSDHQACCIPKPLPLCCKCPPPLLLGQFCSNSSSIRRTAPTAALPPRARCWAGTCRPRRRC,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=7

DOMAIN=low_complexity_region
START=32
END=45
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=FH
START=106
END=196
EVALUE=1.21329219159419e-54
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=211
END=251
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=257
END=273
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=309
END=318
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=362
END=380
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=391
END=404
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr9:65737984_G_C,3.858,1,HGNC,C,protein_coding,HGNC:23762,ENST00000377413,ENSG00000184659,['missense_variant'],FOXD4L4,N,280,,1430,,839,0.121,0,D,benign,,0,-0.848,,T,0.008,,-0.297,0.08,tolerated_low_confidence,1430,0.632155945983,G/A,280,,gGg/gCg,T,-0.517,0,839,,,3.6279,0.09501508,N,0.4874609201,0,0.147,T,0.487112,D,T,N,0.000001279736736,N,0.366,T,U,,,,,,,,,,,
chrX,49304889,49304890,C,T,GAGE10,ENST00000407599,2017-02-05 00:00:00,Cct/Tct,P/S,11/116,MODERATE,MED,benign,tolerated,None,None,.,rs782631403,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000215274,G antigen 10,['Predicted intracellular proteins'],None,"{'ovary': '3.9', 'pituitary gland': '3.1', 'testis': '2.9'}",0.2,0,0,0.6,0.3,0,0,0,0.7,0,0.5,0.1,0.5,"FAM188A,CHAC2,CHAC2,ZNF428,ZNF428,ZNF428,GAGE10,GAGE10,GAGE10,GAGE10,GAGE10,GAGE10,GAGE10,RWDD1,RWDD1,RWDD1,RWDD1,RWDD1,UBL7,UBL7,UBL7,UBL7,UBL7,UBL7,ZNF48,ZNF48,ZNF48,ZNF48,ZNF48,ZNF48,ZNF48","CCDC97,CCDC97,FAM188A,CCDC97,FAM188A,CHAC2,PPP1R3F,SAMHD1,CCDC97,FAM188A,CHAC2,ZNF428,CRYZL1,CCDC97,FAM188A,CHAC2,ZNF428,GAGE10,CCDC97,FAM188A,CHAC2,ZNF428,GAGE10,RWDD1,CCDC97,FAM188A,CHAC2,ZNF428,GAGE10,RWDD1,UBL7","[0.565, 0.557, 0.486, 0.615, 0.572, 0.568, 0.633, 0.641, 0.571, 0.474, 0.475, 0.575, 0.64, 0.618, 0.582, 0.573, 0.65, 0.548, 0.656, 0.604, 0.603, 0.661, 0.557, 0.66, 0.471, 0.41, 0.425, 0.49, 0.473, 0.481, 0.497]","['GAGE family', 'GAGE', 'GAGE protein', 'This family consists of several GAGE and XAGE proteins which are found exclusively in humans. The function of this family is unknown although they have been implicated in human cancers (PMID:11992404)']",MSWRGRSTYRSRPRLYVEPPEMIGPMLPEQFSDEVEPATPEEGEPATQRQDPAAAQEGEDEGASAGQGPKPEADSQEQVHPKTGCECGDGPDGQEMGLPNPEEVKRPEEGEKQSQC,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=2

DOMAIN=GAGE
START=1
END=116
EVALUE=6.95074260073265e-48
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=34
END=47
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

-- FINISHED --
",chrX:49304890_C_T,0.235,1,HGNC,T,protein_coding,HGNC:30968,ENST00000407599,ENSG00000215274,['missense_variant'],GAGE10,,11,,124,,31,0.114,0,,benign,,0.086,-1.472,,,0,,-1.221,0.23,tolerated,124,,P/S,11,,Cct/Tct,T,-2.194,0,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr20,35434588,35434589,C,A,GDF5,ENST00000374369,2017-02-02 00:00:00,Gcc/Tcc,A/S,276/501,MODERATE,MED,possibly_damaging,".,.",None,None,"TGF-beta, propeptide,TGF-beta, propeptide",rs224331,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000204183,Growth differentiation factor 5 opposite strand,['Predicted intracellular proteins'],None,{'blood': '2.3'},0.2,0,0.4,0.6,0,0.1,0,1,0.6,2.3,0.5,0.5,1.3,"ACVR2A,NOG,NOG,BMPR1A,BMPR1A,BMPR1A,BMPR1A,GDF5,GDF5,GDF5,GDF5,GDF5,GDF5,BMPR2,BMPR2,BMPR2,BMPR2,BMPR2,BMPR2,COL2A1,COL2A1,COL2A1,ACAN,ACAN,ACAN,ACAN,BMPR1B,BMPR1B,BMPR1B,BMPR1B,BMPR1B,BMPR1B,BMPR1B","CHRD,CHRD,ACVR2A,CHRD,ACVR2A,AMHR2,NOG,CHRD,ACVR2A,AMHR2,NOG,BMPR1A,TNMD,CHRD,ACVR2A,AMHR2,NOG,BMPR1A,GDF5,CHRD,TNMD,GDF5,NOG,TNMD,GDF5,COL2A1,CHRD,ACVR2A,AMHR2,NOG,BMPR1A,GDF5,BMPR2","[0.434, 0.868, 0.45, 0.628, 0.155652, 0.175808, 0.736, 0.561, 0.436, 0.162, 0.716, 0.722, 0.732, 0.605, 0.1411, 0.100998, 0.667, 0.239232, 0.564, 0.318, 0.472, 0.745, 0.399, 0.592, 0.799, 0.414936, 0.61, 0.162048, 0.167314, 0.698, 0.02548, 0.811, 0.218373]","['extracellular region', 'extracellular space', 'cell', 'plasma membrane', 'membrane', 'extracellular region part', 'cell part', 'cell periphery', 'signaling receptor binding', 'cytokine activity', 'cytokine receptor binding', 'transforming growth factor beta receptor binding', 'binding', 'protein binding', 'growth factor activity', 'cytokine binding', 'receptor regulator activity', 'BMP binding', 'identical protein binding', 'receptor ligand activity', 'molecular function regulator', 'TGF-beta, propeptide', 'Transforming growth factor-beta, C-terminal', 'Transforming growth factor-beta-related', 'Transforming growth factor beta, conserved site', 'Cystine-knot cytokine', 'Cleavage on pair of basic residues', 'Cytokine', 'Disease mutation', 'Dwarfism', 'Glycoprotein', 'Growth factor', 'Membrane', 'Polymorphism', 'Signal', 'Chondrogenesis', 'Secreted', 'Cell membrane', 'Disulfide bond', 'Disease', 'Transforming growth factor beta like domain', 'TGF-beta propeptide', 'skeletal system development', 'ossification', 'regulation of protein phosphorylation', 'positive regulation of protein phosphorylation', 'chondrocyte differentiation', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cell communication', 'signal transduction', 'cell surface receptor signaling pathway', 'enzyme linked receptor protein signaling pathway', 'transmembrane receptor protein serine/threonine kinase signaling pathway', 'transforming growth factor beta receptor signaling pathway', 'cell-cell signaling', 'multicellular organism development', 'nervous system development', 'negative regulation of cell population proliferation', 'response to external stimulus', 'response to mechanical stimulus', 'response to abiotic stimulus', 'anatomical structure morphogenesis', 'response to endogenous stimulus', 'embryo development', 'tissue development', 'regulation of biosynthetic process', 'positive regulation of metabolic process', 'regulation of signal transduction', 'positive regulation of signal transduction', 'cellular process', 'response to organic substance', 'regulation of gene expression', 'regulation of signaling receptor activity', 'regulation of macromolecule biosynthetic process', 'positive regulation of phosphorus metabolic process', 'positive regulation of macromolecule metabolic process', 'regulation of cell communication', 'positive regulation of cell communication', 'positive regulation of cell development', 'positive regulation of pathway-restricted SMAD protein phosphorylation', 'regulation of cell death', 'regulation of nucleobase-containing compound metabolic process', 'regulation of phosphate metabolic process', 'regulation of metabolic process', 'neurogenesis', 'regulation of signaling', 'signaling', 'positive regulation of signaling', 'cell differentiation', 'embryonic limb morphogenesis', 'regulation of BMP signaling pathway', 'positive regulation of BMP signaling pathway', 'regulation of cellular metabolic process', 'positive regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'regulation of protein modification process', 'positive regulation of protein modification process', 'regulation of cellular protein metabolic process', 'positive regulation of cellular protein metabolic process', 'regulation of chondrocyte differentiation', 'negative regulation of chondrocyte differentiation', 'positive regulation of chondrocyte differentiation', 'multicellular organismal process', 'developmental process', 'appendage morphogenesis', 'limb morphogenesis', 'embryonic appendage morphogenesis', 'forelimb morphogenesis', 'hindlimb morphogenesis', 'regulation of growth', 'regulation of multicellular organism growth', 'regulation of cell population proliferation', 'response to chemical', 'regulation of phosphorylation', 'positive regulation of phosphorylation', 'regulation of apoptotic process', 'negative regulation of apoptotic process', 'regulation of programmed cell death', 'negative regulation of programmed cell death', 'regulation of MAPK cascade', 'regulation of neuron apoptotic process', 'negative regulation of neuron apoptotic process', 'ossification involved in bone remodeling', 'regulation of cell differentiation', 'negative regulation of cell differentiation', 'positive regulation of cell differentiation', 'regulation of neuron differentiation', 'positive regulation of neuron differentiation', 'positive regulation of phosphate metabolic process', 'bone remodeling', 'cell development', 'animal organ development', 'positive regulation of biological process', 'negative regulation of biological process', 'positive regulation of cellular process', 'negative regulation of cellular process', 'regulation of response to stimulus', 'positive regulation of response to stimulus', 'embryonic morphogenesis', 'regulation of developmental growth', 'generation of neurons', 'system development', 'appendage development', 'tissue remodeling', 'anatomical structure development', 'cellular developmental process', 'regulation of epithelial cell proliferation', 'negative regulation of epithelial cell proliferation', 'regulation of neurogenesis', 'positive regulation of neurogenesis', 'regulation of biological process', 'regulation of developmental process', 'regulation of cellular process', 'response to stimulus', 'negative regulation of developmental process', 'positive regulation of developmental process', 'regulation of nitrogen compound metabolic process', 'positive regulation of nitrogen compound metabolic process', 'regulation of phosphorus metabolic process', 'cartilage development', 'regulation of multicellular organismal process', 'positive regulation of multicellular organismal process', 'negative regulation of multicellular organismal process', 'regulation of protein metabolic process', 'positive regulation of protein metabolic process', 'regulation of RNA metabolic process', 'cellular response to stimulus', 'regulation of nervous system development', 'positive regulation of nervous system development', 'limb development', 'regulation of macromolecule metabolic process', 'regulation of cell development', 'regulation of SMAD protein signal transduction', 'regulation of pathway-restricted SMAD protein phosphorylation', 'SMAD protein signal transduction', 'negative regulation of cell death', 'chondroblast differentiation', 'regulation of cartilage development', 'positive regulation of cartilage development', 'negative regulation of cartilage development', 'connective tissue development', 'biological regulation', 'regulation of molecular function', 'response to growth factor', 'cellular response to chemical stimulus', 'cellular response to organic substance', 'cellular response to growth factor stimulus', 'cellular response to endogenous stimulus', 'response to transforming growth factor beta', 'cellular response to transforming growth factor beta stimulus', 'regulation of primary metabolic process', 'regulation of transmembrane receptor protein serine/threonine kinase signaling pathway', 'positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway', 'regulation of cellular response to growth factor stimulus', 'regulation of neuron death', 'negative regulation of neuron death', 'regulation of intracellular signal transduction', 'regulation of nucleic acid-templated transcription', 'regulation of multicellular organismal development', 'regulation of cellular macromolecule biosynthetic process', 'regulation of mesenchymal cell apoptotic process', 'negative regulation of mesenchymal cell apoptotic process', 'regulation of RNA biosynthetic process', 'Extracellular matrix organization', 'Elastic fibre formation', 'Molecules associated with elastic fibres', 'Transforming growth  factor-beta (TGF-beta) family']",MIQSSQPMSLKLTCSAFRLQRALRFLLGRLPWRVASGARRFRRWLNRYSYTVLSSWPERALISLKNRSRFLVRPNTRNRAFSWTCRAARSKPRPRRSTALPRSQASSSRHSWAEFLKFRKSFQMSNTSQPDPSRPGTERTSSKEAGCRPLGQLDSFSWAARPPPGAAGLAVSEGFFRKIRSSAPSSPSFSRALMSNTYLCFLTTGPRSSRENTQKSFPATSPREPVTSRLRGKAPALSPSRELSFTSAPF,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=4

DOMAIN=low_complexity_region
START=16
END=30
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=86
END=97
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=159
END=170
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=180
END=192
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr20:35434589_C_A,18.9,-1,HGNC,T,protein_coding,HGNC:4220,ENST00000374369,ENSG00000125965,['missense_variant'],GDF5,".,.",276,".,.",1126,".,.",826,"0.015,0.023",0.999,".,.",benign,".,.",0.015,-0.237,".,.","T,T",0.987,".,.",0.128,0.73,tolerated,1126,".,.",A/T,276,".,.",Gcc/Acc,"T,T",2.45,0.852,826,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr20,35434873,35434874,A,C,GDF5OS,ENST00000374375,2017-02-02 00:00:00,cAg/cCg,Q/P,239/250,MODIFIER,MED,benign,tolerated_low_confidence,None,None,.,rs224332,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000204183,Growth differentiation factor 5 opposite strand,['Predicted intracellular proteins'],None,{'blood': '2.3'},0.2,0,0.4,0.6,0,0.1,0,1,0.6,2.3,0.5,0.5,1.3,,,[],"['intracellular', 'cell', 'cytoplasm', 'mitochondrion', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular part', 'cytoplasmic part', 'cell part', 'Mitochondrion', 'Transit peptide']",MIQSSQPMSLKLTCSAFRLQRALRFLLGRLPWRVASGARRFRRWLNRYSYTVLSSWPERALISLKNRSRFLVRPNTRNRAFSWTCRAARSKPRPRRSTALPRSQASSSRHSWAEFLKFRKSFQMSNTSQPDPSRPGTERTSSKEAGCRPLGQLDSFSWAARPPPGAAGLAVSEGFFRKIRSSAPSSPSFSRALMSNTYLCFLTTGPRSSRENTQKSFPATSPREPVTSRLRGKAPALSPSRELSFTSAPF,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=4

DOMAIN=low_complexity_region
START=16
END=30
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=86
END=97
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=159
END=170
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=180
END=192
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr20:35434874_A_C,5.11,1,HGNC,G,lncRNA,HGNC:33435,ENST00000374375,ENSG00000204183,['non_coding_transcript_exon_variant'],GDF5-AS1,,,,1158,,,,,,,,,,,,,,,,,1158,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr8,143213307,143213308,T,G,GPIHBP1,ENST00000622500,2017-01-04 00:00:00,tTc/tGc,F/C,14/184,MODERATE,MED,unknown,tolerated,None,None,.,rs11538389,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000277494,Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1,"['Disease related genes', 'Predicted intracellular proteins']",['Transport'],"{'adipose tissue': '47.6', 'brain': '18.5'}",1.7,0.4,2,1.3,0.4,0.3,0.4,0,0,0,0,0,0,"LY6K,ANGPTL4,LPL,LPL,ANGPTL3,ANGPTL3,ANGPTL3,LY6H,LY6H,APOA5,APOA5,APOA5,APOA5,APOC2,APOC2,APOC2,APOC2,APOC2,C19orf80,C19orf80,C19orf80,GPIHBP1,GPIHBP1,GPIHBP1,GPIHBP1,GPIHBP1,GPIHBP1,GPIHBP1,GPIHBP1,GPIHBP1,GPIHBP1","LYPD3,APOC3,APOC3,ANGPTL4,APOC3,ANGPTL4,LPL,LYPD3,LY6K,APOC3,ANGPTL4,LPL,ANGPTL3,APOC3,ANGPTL4,LPL,ANGPTL3,APOA5,ANGPTL4,LPL,ANGPTL3,APOC3,LYPD3,LY6K,ANGPTL4,LPL,ANGPTL3,LY6H,APOA5,APOC2,C19orf80","[0.326, 0.575, 0.86, 0.815, 0.67, 0.139621, 0.731, 0.424, 0.728, 0.86, 0.53, 0.745, 0.67, 0.921, 0.475, 0.893, 0.539, 0.79, 0.727, 0.661, 0.918, 0.628, 0.542, 0.604, 0.649, 0.895, 0.669, 0.748, 0.885, 0.791, 0.593]","['extracellular region', 'extracellular space', 'intracellular', 'cell', 'plasma membrane', 'external side of plasma membrane', 'cell surface', 'membrane', 'basolateral plasma membrane', 'apical plasma membrane', 'intrinsic component of membrane', 'anchored component of membrane', 'intrinsic component of plasma membrane', 'intrinsic component of external side of plasma membrane', 'anchored component of external side of plasma membrane', 'protein-containing complex', 'protein-lipid complex', 'plasma lipoprotein particle', 'high-density lipoprotein particle', 'extracellular region part', 'membrane part', 'plasma membrane part', 'cell part', 'apical part of cell', 'anchored component of plasma membrane', 'cell periphery', 'side of membrane', 'plasma membrane region', 'lipoprotein particle', 'transporter activity', 'binding', 'protein binding', 'lipid binding', 'protein transmembrane transporter activity', 'protein transporter activity', 'enzyme binding', 'transmembrane transporter activity', 'macromolecule transmembrane transporter activity', 'lipase binding', 'amide transmembrane transporter activity', 'protein-containing complex binding', 'lipoprotein particle binding', 'protein-lipid complex binding', 'peptide transmembrane transporter activity', 'Ly-6 antigen/uPA receptor-like', 'Disease mutation', 'Glycoprotein', 'GPI-anchor', 'HDL', 'Lipid-binding', 'Lipoprotein', 'Membrane', 'Polymorphism', 'Signal', 'Transport', 'Cell membrane', 'Disulfide bond', 'Disease', 'u-PAR/Ly-6 domain', 'transport', 'intracellular protein transport', 'protein localization', 'response to organic substance', 'response to organonitrogen compound', 'regulation of lipoprotein particle clearance', 'positive regulation of lipoprotein particle clearance', 'protein transport', 'peptide transport', 'vesicle-mediated transport', 'protein import', 'regulation of protein stability', 'macromolecule localization', 'protein localization to cell surface', 'cellular protein localization', 'response to chemical', 'response to drug', 'homeostatic process', 'cholesterol homeostasis', 'amide transport', 'positive regulation of catalytic activity', 'positive regulation of molecular function', 'transcytosis', 'establishment of protein localization', 'intracellular transport', 'positive regulation of biological process', 'chemical homeostasis', 'regulation of biological process', 'regulation of catalytic activity', 'protein stabilization', 'response to stimulus', 'regulation of lipoprotein lipase activity', 'positive regulation of lipoprotein lipase activity', 'localization', 'establishment of localization', 'regulation of multicellular organismal process', 'positive regulation of multicellular organismal process', 'regulation of hydrolase activity', 'positive regulation of hydrolase activity', 'cellular localization', 'establishment of localization in cell', 'transmembrane transport', 'lipid homeostasis', 'acylglycerol homeostasis', 'sterol homeostasis', 'regulation of lipase activity', 'positive regulation of lipase activity', 'positive regulation of triglyceride lipase activity', 'response to anticoagulant', 'biological regulation', 'regulation of biological quality', 'regulation of molecular function', 'triglyceride homeostasis', 'cellular macromolecule localization', 'response to heparin', 'organic substance transport', 'nitrogen compound transport', 'protein transmembrane transport', 'response to nitrogen compound', 'response to oxygen-containing compound', 'Metabolism', 'Signal Transduction', 'Post-translational modification: synthesis of GPI-anchored proteins', 'Plasma lipoprotein assembly, remodeling, and clearance', 'Metabolism of vitamins and cofactors', 'Visual phototransduction', 'Signaling by GPCR', 'Transport of small molecules', 'GPCR downstream signalling', 'Metabolism of proteins', 'G alpha (i) signalling events', 'Post-translational protein modification', 'Metabolism of fat-soluble vitamins', 'Assembly of active LPL and LIPC lipase complexes', 'Plasma lipoprotein remodeling', 'Chylomicron remodeling', 'Retinoid metabolism and transport', 'Ly-6 antigen / uPA receptor -like domain']",MKALGAVLLALLLCGRPGRGQTQQEEEEEDEDHGPDDYDEEDEDEVEEEETNRLPGGRSRVLLRCYTCKSLPRDERCNLTQNCSHGQTCTTLIAHGNTESGLLTTHSTWCTDSCQPITKTVEGTQVTMTCCQSSLCNVPPWQSSRVQDPTGKGAGGPRGSSETVGAALLLNLLAGLGAMGARRP,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=4

DOMAIN=low_complexity_region
START=3
END=13
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=25
END=50
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=LU
START=63
END=148
EVALUE=0.0841190287067417
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=165
END=181
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr8:143213308_T_G,6.564,1,HGNC,G,protein_coding,HGNC:24945,ENST00000622500,ENSG00000277494,['missense_variant'],GPIHBP1,,14,,91,,41,0.243,0,,benign,,0,-0.107,,,0.001,,0.158,1,tolerated,91,,F/C,14,,tTc/tGc,T,0.176,0,41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr17,38335199,38335200,T,C,GPR179,ENST00000621958,2017-07-11 00:00:00,cAc/cGc,H/R,494/2368,MODERATE,MED,benign,".,.",None,None,"GPCR family 3, C-terminal&GPCR family 3, C-terminal,GPCR family 3, C-terminal&GPCR family 3, C-terminal",rs4550493,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000277399,G protein-coupled receptor 179,['Predicted membrane proteins'],None,"{'brain': '3.0', 'retina': '7.5'}",0.1,0.3,0,0,0,0.3,0.5,0,0,0,0,0,0.4,"GPRC6A,CABP4,CABP4,NYX,NYX,NYX,RGS7,RGS7,CACNA1F,CACNA1F,CACNA1F,CACNA1F,RGS11,RGS11,RGS11,TRPM1,TRPM1,TRPM1,TRPM1,TRPM1,TRPM1,LRIT3,LRIT3,LRIT3,LRIT3,LRIT3,LRIT3,GPR179,GPR179,GPR179,GPR179,GPR179,GPR179,GPR179,GPR179,GPR179,GPR179","GRM6,GRM6,SLC24A1,GRM6,SLC24A1,CABP4,GRM6,NYX,GRM6,SLC24A1,CABP4,NYX,GRM6,NYX,RGS7,GRM6,CABP4,NYX,RGS7,CACNA1F,RGS11,GRM6,SLC24A1,CABP4,CACNA1F,RGS11,TRPM1,GRM6,SLC24A1,GPRC6A,CABP4,NYX,RGS7,CACNA1F,RGS11,TRPM1,LRIT3","[0.091887, 0.646, 0.57, 0.802, 0.472, 0.71, 0.537, 0.483, 0.581, 0.411, 0.801, 0.804, 0.588, 0.502, 0.117983, 0.805, 0.605, 0.812, 0.575, 0.605, 0.664, 0.641, 0.615, 0.683, 0.591, 0.451, 0.704, 0.712, 0.583, 0.637, 0.698, 0.757, 0.685, 0.628, 0.732, 0.77, 0.815]","['cell', 'plasma membrane', 'membrane', 'integral component of membrane', 'intrinsic component of membrane', 'membrane part', 'cell part', 'cell periphery', 'transmembrane signaling receptor activity', 'G protein-coupled receptor activity', 'signaling receptor activity', 'molecular transducer activity', 'GPCR family 3, C-terminal', 'Disease mutation', 'G-protein coupled receptor', 'Glycoprotein', 'Membrane', 'Polymorphism', 'Receptor', 'Sensory transduction', 'Signal', 'Transducer', 'Transmembrane', 'Vision', 'Cell membrane', 'Congenital stationary night blindness', 'Transmembrane helix', 'Disease', '7 transmembrane sweet-taste receptor of 3 GCPR', 'system process', 'cell communication', 'signal transduction', 'G protein-coupled receptor signaling pathway', 'sensory perception', 'visual perception', 'cellular process', 'signaling', 'multicellular organismal process', 'regulation of biological process', 'regulation of cellular process', 'nervous system process', 'response to stimulus', 'sensory perception of light stimulus', 'cellular response to stimulus', 'biological regulation', 'Epidermal growth factor-like domain.']",MGTRGAVMPPPMWGLLGCCFVCAWALGGPRPIRSLPPLSSQVKPGSVPMQVPLEGAEAALAYLYSGDAQQLSQVNCSERYEARGAGAMPGLPPSLQGAAGTLAQAANFLNMLLQANDIRESSVEEDVEWYQALVRSVAEGDPRVYRALLTFNPPPGASHLQLALQATRTGEETILQDLSGNWVQEENPPGDLDTPALKKRVLTNDLGSLGSPKWPQADGYVGDTQQVRLSPPFLECQEGRLRPGWLITLSATFYGLKPDLSPEVRGQVQMDVDLQSVDINQCASGPGWYSNTHLCDLNSTQCVPLESQGFVLGRYLCRCRPGFYGASPSGGLEESDFQTTGQFGFPEGRSGRLLQCLPCPEGCTSCMDATPCLVEEAAVLRAAVLACQACCMLAIFLSMLVSYRCRRNKRIWASGVVLLETVLFGFLLLYFPVFILYFKPSVFRCIALRWVRLLGFAIVYGTIILKLYRVLQLFLSRTAQRSALLSSGRLLRRLGLLLLPVLGFLAVWTVGALERGIQHAPLVIRGHTPSGRHFYLCHHDRWDYIMVVAELLLLCWGSFLCYATRAVLSAFHEPRYMGIALHNELLLSAAFHTARFVLVPSLHPDWTLLLFFFHTHSTVTTTLALIFIPKFWKLGAPPREEMVDEVCEDELDLQHSGSYLGSSIASAWSEHSLDPGDIRDELKKLYAQLEVHKTKEMAANNPHLPKKRGSSCQGLGRSFMRYLAEFPEALARQHSRDSGSPGHGSLPGSSRRRLLSSSLQEPEGTPALHKSRSTYDQRREQDPPLLDSLLRRKLAKKASRTESRESVEGPPALGFRSASAHNLTVGERLPRARPASLQKSLSVASSREKALLMASQAYLEETYRQAKEREERKKAKAAMASLVRRPSARRLERPRGAPLSAPPSPAKSSSVDSSHTSGRLHEEARRRLPHPPIRHQVSTPILALSGGLGEPRMLSPTSTLAPALLPALAPTPAPALAPVPVSPQSPNLLTYICPWENAELPAKQENVPQEGPSGPERGHHSPAPARARLWRALSVAVEKSRAGENEMDAEDAHHQREANDVDEDRPKIFPKSHSLKAPVQQGSMRSLGLAIKALTRSRSTYREKESVEESPEGQNSGTAGESMGAPSRSPRLGRPKAVSKQAALIPSDDKESLQNQQNAHTSRMLQVCQREGSREQEDRGRRMTQGLGERKAERAGKTGLAMLRQVSRDKNIKQSKETPVGWQELPKAGLQSLGSADHRVAEVCPWEVTESETRQPDSGNKAEICPWETSEGAPESRALRQDPGDSQKKRGEARGKSEPIDVVPMMRKKPERLVREQEAVCPWESADRGGLSPGSAPQDPGRIRDKSEAGDSVEARKVEKPGWEAAGPEAHTPDITKAEPCPWEASEGGEDGKPAQEAVKDLPQEKQKTRKATFWKEQKPGGDLESLCPWESTDFRGPSAVSIQAPGSSECSGSLGSGIAEVCLWEAGDAPAIQKAEICPWELDDNVMGQEMLSLGTGRESLQEKEKASRKGSFGEMGEQTVKAVQKLSQQQESVCPRESTVPGHSSPCLDNSSSKAGSQFLCNGGSRATQVCPQEDLRPEAQEATPAKTEICPWEVNERTREEWTSAQVPRGGESQKDKEKMPGKSEIEDVTAWEKPEGQIQKQEAVGPWESVDPGSFSPQPRPQDTERPQTLLQMSGSVGSKAADICPLDVEENLTAGKAEICPWEVGAGAGEERALGAEAIRKSPNDTGKVSADLGPRERAVTAPEKPQKPTPEWEVACPWGSVGPGACSQHPGTLDADGPKAGFQELDHMGCRPGEVCPWEAQEAATSEKAKICPWEVSEGTTGKGLDQKAGSESAEQREKALEKGRLTSLGEDVSKGMAKLCQQQETICIWENKDLRESPAQAPKISDLPSSMSSEVAEGHSLEATEKGDLRQDPKTGSFPEHITQEKAPAADTEEFTTEDGEKTSHELQSVCPWETTAPADSVSHLDRQRPDQPKASSQRLVSTGGRAADVCPWDVPDAGVYKSDSSAKAETCPWEVTERIPVKGVSRQDGKGDSQEEKGRAPEKSEPKGVPVQKKPEMADFRQQEAVCPWESQDGKGLSPQPAPDASDRSRGSSEAAGSVETRVAEVCLWEVVEAPSAKKAEICPWEAGGGAAEEGEQERESQGQGEMFLQKAGPGGTEEHFSKAAAKPREQEAVCPGEGTGSGGLLPQSGALDPELKVSPKEAGSMGSRMAELCQWEITDPEGNKIKGTMADICPGEETGVPSEESGLLALTATRREFFPTAPEKPLCLLVHGPLDHFFPESKIPCPKVSRPASTFTLEGVRELQGPSGLEPRTSLAPEPSLQEAESQSSSLTEDSGQVAFEAQYEEFTPPTVYPWDWE,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=24

DOMAIN=low_complexity_region
START=26
END=40
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=53
END=64
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=95
END=106
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=EGF
START=281
END=338
EVALUE=21.136732350978
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=372
END=391
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=381
END=403
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=415
END=429
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=416
END=438
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=448
END=470
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=481
END=505
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=transmembrane_domain
START=490
END=512
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=545
END=567
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=transmembrane_domain
START=606
END=628
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=607
END=625
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=738
END=759
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=866
END=878
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=884
END=895
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=897
END=914
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=954
END=983
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1022
END=1033
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1447
END=1458
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=1708
END=1723
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2134
END=2154
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=2326
END=2340
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr17:38335200_T_C,7.386,-1,HGNC,C,protein_coding,HGNC:31371,ENST00000621958,ENSG00000277399,['missense_variant'],GPR179,".,.",494,".,.",1502,".,.",1481,"0.277,0.299",0.152,".,.",benign,".,.",0,-0.927,".,.",".,.",0.445,".,.",-0.704,1,tolerated,1502,".,.",H/R,494,".,.",cAc/cGc,"T,T",1.951,0.998,1481,,ENSG00000174100,,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,48991031,48991032,A,G,GRIPAP1,ENST00000622599,2017-05-24 00:00:00,cTg/cCg,L/P,134/796,missense_variant,MED,benign,tolerated,None,None,.,.,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000068400,GRIP1 associated protein 1,['Predicted intracellular proteins'],"['Protein transport', 'Transport']",None,7.3,8.3,7,10.5,6.9,11.1,8.5,11.5,10,21.2,12.2,12.9,9.1,"ARHGEF9,AMER1,AMER1,SPIN3,SPIN3,SPIN3,GRIPAP1,GRIPAP1,GRIPAP1,GRIPAP1,GRIPAP1,GRIPAP1,GRIPAP1,GRIP1,FOXR2,FOXR2,FOXR2,FOXR2,FOXR2,GRIP2,GRIP2,GRIP2","KIAA2022,KIAA2022,ARHGEF9,KIAA2022,ARHGEF9,AMER1,KIAA2022,ARHGEF9,AMER1,RAB4A,TCP10L2,RALGDS,SPIN3,GRIPAP1,KIAA2022,ARHGEF9,AMER1,SPIN3,GRIPAP1,RALGDS,GRIPAP1,GRIP1","[0.694, 0.665, 0.703, 0.722, 0.691, 0.672, 0.706, 0.706, 0.695, 0.681, 0, 0.716, 0.733, 0.659, 0.642, 0.67, 0.626, 0.678, 0.654, 0.621, 0.8, 0.033417]","['intracellular', 'cell', 'nucleus', 'nucleoplasm', 'cytoplasm', 'endosome', 'early endosome', 'cytosol', 'endosome membrane', 'endomembrane system', 'membrane', 'cell junction', 'axon', 'dendrite', 'organelle membrane', 'cytoplasmic vesicle', 'early endosome membrane', 'membrane-enclosed lumen', 'nuclear lumen', 'vesicle', 'somatodendritic compartment', 'cell projection', 'neuron projection', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'nuclear part', 'cytoplasmic vesicle part', 'endosomal part', 'cytoplasmic part', 'intracellular organelle part', 'synapse part', 'cell projection part', 'cell part', 'synapse', 'recycling endosome', 'recycling endosome membrane', 'intracellular organelle lumen', 'dendritic tree', 'neuron part', 'intracellular vesicle', 'bounding membrane of organelle', 'postsynapse', 'whole membrane', 'postsynaptic recycling endosome', 'postsynaptic endosome', 'plasma membrane bounded cell projection', 'plasma membrane bounded cell projection part', 'Acetylation', 'Alternative splicing', 'Coiled coil', 'Membrane', 'Phosphoprotein', 'Polymorphism', 'Protein transport', 'Synapse', 'Transport', 'Cell junction', 'Cell projection', 'Endosome', 'transport', 'intracellular protein transport', 'protein localization', 'cellular process', 'protein transport', 'peptide transport', 'cellular component organization', 'vesicle-mediated transport', 'endosomal transport', 'protein-containing complex localization', 'protein transport within lipid bilayer', 'macromolecule localization', 'cellular protein localization', 'protein localization to synapse', 'amide transport', 'establishment of protein localization', 'intracellular transport', 'regulation of biological process', 'regulation of cellular process', 'regulation of synapse structure or activity', 'regulation of synapse organization', 'regulation of cellular component organization', 'localization', 'establishment of localization', 'cellular localization', 'establishment of localization in cell', 'localization within membrane', 'membrane organization', 'establishment of protein localization to plasma membrane', 'biological regulation', 'regulation of biological quality', 'cellular macromolecule localization', 'organic substance transport', 'nitrogen compound transport', 'cellular component organization or biogenesis', 'protein localization to membrane', 'protein localization to plasma membrane', 'establishment of protein localization to membrane', 'receptor localization to synapse', 'vesicle-mediated transport to the plasma membrane', 'neurotransmitter receptor transport to plasma membrane', 'neurotransmitter receptor transport, endosome to postsynaptic membrane', 'neurotransmitter receptor transport to postsynaptic membrane', 'regulation of postsynaptic membrane neurotransmitter receptor levels', 'protein transport within plasma membrane', 'neurotransmitter receptor transport', 'endosome to plasma membrane protein transport', 'neurotransmitter receptor transport, endosome to plasma membrane', 'protein localization to postsynaptic membrane', 'establishment of protein localization to postsynaptic membrane', 'regulation of modification of synaptic structure', 'retrograde transport, endosome to plasma membrane', 'protein localization to cell periphery']",MAQALSEEEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQEVEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVAQAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGLAPTVLAPMPLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQTEKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHAAALRALQDQIQTAKTQELNMLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQEIGQEKEQLTQELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLRHEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQTVEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAELKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKGSAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPSRTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNMHLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=17

DOMAIN=coiled_coil_region
START=4
END=33
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=53
END=66
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=61
END=162
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=106
END=119
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=120
END=130
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=191
END=208
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=208
END=610
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=224
END=241
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=302
END=313
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=335
END=349
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=379
END=390
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=469
END=484
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=499
END=518
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=633
END=640
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=650
END=670
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=670
END=704
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=coiled_coil_region
START=755
END=795
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chrX:48991032_A_G,3.494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,74797023,74797024,G,T,GTF2IRD2,ENST00000451013,16/16,Cag/Aag,Q/K,830/949,MODERATE,MED,benign,tolerated,None,None,.,rs142434912,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000174428,GTF2I repeat domain containing 2B,"['Disease related genes', 'Predicted intracellular proteins']","['Transcription', 'Transcription regulation']",None,11,2.7,5.4,7.3,5.7,5.6,8.7,12.8,1.5,5.1,1.9,1.6,3.3,"NCF1,ZNF449,PRRC2B,PRRC2B,ELN,NCF2,NCF2,POM121L2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B","DECR1,SEC14L5,SEC14L5,ZNF449,DECR1,DECR1,NCF1,SPDYE1,DECR1,SEC14L5,SPDYE1,NCF1,ZNF449,PRRC2B,ELN,NCF2,POM121L2,DECR1,SEC14L5,SPDYE1,NCF1,ZNF449,PRRC2B,ELN,NCF2,POM121L2,GTF2IRD2","[0.92, 0.5, 0.512, 0.473, 0.482, 0.892, 0.976, 0.564, 0.47, 0.46, 0.44, 0.641, 0.452, 0.455, 0.527, 0.469, 0.442, 0.469, 0.42, 0.412, 0.64, 0.42, 0.41, 0.507, 0.468, 0.418, 0]","['intracellular', 'cell', 'nucleus', 'nucleoplasm', 'cytoplasm', 'membrane-enclosed lumen', 'nuclear lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'nuclear part', 'intracellular organelle part', 'cell part', 'intracellular organelle lumen', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'DNA-binding transcription factor activity', 'binding', 'organic cyclic compound binding', 'transcription regulator activity', 'heterocyclic compound binding', 'GTF2I-like repeat', 'Ribonuclease H-like superfamily', 'GTF2I-like repeat superfamily', 'Alternative splicing', 'DNA-binding', 'Nucleus', 'Polymorphism', 'Repeat', 'Transcription', 'Transcription regulation', 'Williams-Beuren syndrome', 'Disease', 'GTF2I-like repeat', 'nucleobase-containing compound metabolic process', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'multicellular organism development', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'regulation of biosynthetic process', 'cellular process', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'multicellular organismal process', 'developmental process', 'RNA biosynthetic process', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'heterocycle metabolic process', 'anatomical structure development', 'regulation of biological process', 'regulation of cellular process', 'regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'regulation of macromolecule metabolic process', 'biological regulation', 'organic substance metabolic process', 'regulation of primary metabolic process', 'nucleic acid metabolic process', 'nucleic acid-templated transcription', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'zinc finger']",PEQKQVFANPSPTQKSPVQPVEDLAGNLWEKLREKIRSFVAYSIAIDEITDINNTTQLAIFIRGVDENFDVSEELLDTVPMTGTKSGNEIFLRVEKSLKKFCINWSRLVSVASTGTPAMVDANNGLVTKLKSRVATFCKGAELKSICCIIHPESLCAQKLKMDHVMDVVVKSVNWICSRGLNHSEFTTLLYELDSQYGSLLYYTEIKWLSRGLVLKRFFESLEEIDSFMSSRGKPLPQLSSIDWIRDLAFLVDMTMHLNALNISLQGHSQIVTQMYDLIRAFLAKLCLWETHLTRNNLAHFPTLKLVSRNESDGLNYIPKIAELKTEFQKRLSDFKLYESELTLFSSPFSTKIDSVHEELQMEVIDLQCNTVLKTKYDKVGIPEFYKYLWGSYPKYKHHCAKILSMFGSTYICEQLFSIMKLSKTKYCSQLKDSQWDSVLHIAT,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Sequence submitted into the processing queue</title>
<meta http-equiv=""refresh"" content=""3;url=job_status.pl?jobid=184147158237401591597370394ukRxMVhewP"" />
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
<h2>Job 184147158237401591597370394ukRxMVhewP entered our processing queue at <span style=""background:#ecdb7a;font-weight:bold"">position 10</span>.</h2>
You will be redirected to your job's status page in a few seconds. If your browser doesn't support redirection, <a href='job_status.pl?jobid=184147158237401591597370394ukRxMVhewP'>click here</a>. 
",chr7:74797024_G_T,1.299,-1,HGNC,T,protein_coding,HGNC:30775,ENST00000451013,ENSG00000196275,['missense_variant'],GTF2IRD2,,830,,2678,,2488,0.112,0.105,,benign,,0,-0.314,,,0.008,,-0.11,1,tolerated,2678,,Q/K,830,,Cag/Aag,T,0.533,0.033,2488,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NCF1, NCF2"
chr7,74797696,74797697,G,C,GTF2IRD2,ENST00000451013,16/16,aaC/aaG,N/K,605/949,MODERATE,MED,benign,tolerated,None,None,.,rs707394,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000174428,GTF2I repeat domain containing 2B,"['Disease related genes', 'Predicted intracellular proteins']","['Transcription', 'Transcription regulation']",None,11,2.7,5.4,7.3,5.7,5.6,8.7,12.8,1.5,5.1,1.9,1.6,3.3,"NCF1,ZNF449,PRRC2B,PRRC2B,ELN,NCF2,NCF2,POM121L2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B","DECR1,SEC14L5,SEC14L5,ZNF449,DECR1,DECR1,NCF1,SPDYE1,DECR1,SEC14L5,SPDYE1,NCF1,ZNF449,PRRC2B,ELN,NCF2,POM121L2,DECR1,SEC14L5,SPDYE1,NCF1,ZNF449,PRRC2B,ELN,NCF2,POM121L2,GTF2IRD2","[0.92, 0.5, 0.512, 0.473, 0.482, 0.892, 0.976, 0.564, 0.47, 0.46, 0.44, 0.641, 0.452, 0.455, 0.527, 0.469, 0.442, 0.469, 0.42, 0.412, 0.64, 0.42, 0.41, 0.507, 0.468, 0.418, 0]","['intracellular', 'cell', 'nucleus', 'nucleoplasm', 'cytoplasm', 'membrane-enclosed lumen', 'nuclear lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'nuclear part', 'intracellular organelle part', 'cell part', 'intracellular organelle lumen', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'DNA-binding transcription factor activity', 'binding', 'organic cyclic compound binding', 'transcription regulator activity', 'heterocyclic compound binding', 'GTF2I-like repeat', 'Ribonuclease H-like superfamily', 'GTF2I-like repeat superfamily', 'Alternative splicing', 'DNA-binding', 'Nucleus', 'Polymorphism', 'Repeat', 'Transcription', 'Transcription regulation', 'Williams-Beuren syndrome', 'Disease', 'GTF2I-like repeat', 'nucleobase-containing compound metabolic process', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'multicellular organism development', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'regulation of biosynthetic process', 'cellular process', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'multicellular organismal process', 'developmental process', 'RNA biosynthetic process', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'heterocycle metabolic process', 'anatomical structure development', 'regulation of biological process', 'regulation of cellular process', 'regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'regulation of macromolecule metabolic process', 'biological regulation', 'organic substance metabolic process', 'regulation of primary metabolic process', 'nucleic acid metabolic process', 'nucleic acid-templated transcription', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'zinc finger']",PEQKQVFANPSPTQKSPVQPVEDLAGNLWEKLREKIRSFVAYSIAIDEITDINNTTQLAIFIRGVDENFDVSEELLDTVPMTGTKSGNEIFLRVEKSLKKFCINWSRLVSVASTGTPAMVDANNGLVTKLKSRVATFCKGAELKSICCIIHPESLCAQKLKMDHVMDVVVKSVNWICSRGLNHSEFTTLLYELDSQYGSLLYYTEIKWLSRGLVLKRFFESLEEIDSFMSSRGKPLPQLSSIDWIRDLAFLVDMTMHLNALNISLQGHSQIVTQMYDLIRAFLAKLCLWETHLTRNNLAHFPTLKLVSRNESDGLNYIPKIAELKTEFQKRLSDFKLYESELTLFSSPFSTKIDSVHEELQMEVIDLQCNTVLKTKYDKVGIPEFYKYLWGSYPKYKHHCAKILSMFGSTYICEQLFSIMKLSKTKYCSQLKDSQWDSVLHIAT,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Sequence submitted into the processing queue</title>
<meta http-equiv=""refresh"" content=""3;url=job_status.pl?jobid=184147158237401631597370395SDLAKIhtJl"" />
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
<h2>Job 184147158237401631597370395SDLAKIhtJl entered our processing queue at <span style=""background:red;font-weight:bold"">position 11</span>.</h2>
You will be redirected to your job's status page in a few seconds. If your browser doesn't support redirection, <a href='job_status.pl?jobid=184147158237401631597370395SDLAKIhtJl'>click here</a>. 
",chr7:74797697_G_C,2.038,-1,HGNC,T,protein_coding,HGNC:30775,ENST00000451013,ENSG00000196275,['missense_variant'],GTF2IRD2,,605,,2005,,1815,0.107,0.001,,benign,,0,-0.393,,,0.369,,-0.805,1,tolerated,2005,,N/K,605,,aaC/aaA,T,0.095,0.266,1815,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NCF1, NCF2"
chr7,74798012,74798013,G,A,GTF2IRD2,ENST00000451013,16/16,tCa/tTa,S/L,500/949,HIGH,MED,benign,tolerated,None,None,.,rs200619072,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000174428,GTF2I repeat domain containing 2B,"['Disease related genes', 'Predicted intracellular proteins']","['Transcription', 'Transcription regulation']",None,11,2.7,5.4,7.3,5.7,5.6,8.7,12.8,1.5,5.1,1.9,1.6,3.3,"NCF1,ZNF449,PRRC2B,PRRC2B,ELN,NCF2,NCF2,POM121L2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B,GTF2IRD2B","DECR1,SEC14L5,SEC14L5,ZNF449,DECR1,DECR1,NCF1,SPDYE1,DECR1,SEC14L5,SPDYE1,NCF1,ZNF449,PRRC2B,ELN,NCF2,POM121L2,DECR1,SEC14L5,SPDYE1,NCF1,ZNF449,PRRC2B,ELN,NCF2,POM121L2,GTF2IRD2","[0.92, 0.5, 0.512, 0.473, 0.482, 0.892, 0.976, 0.564, 0.47, 0.46, 0.44, 0.641, 0.452, 0.455, 0.527, 0.469, 0.442, 0.469, 0.42, 0.412, 0.64, 0.42, 0.41, 0.507, 0.468, 0.418, 0]","['intracellular', 'cell', 'nucleus', 'nucleoplasm', 'cytoplasm', 'membrane-enclosed lumen', 'nuclear lumen', 'organelle', 'membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'nuclear part', 'intracellular organelle part', 'cell part', 'intracellular organelle lumen', 'DNA-binding transcription factor activity, RNA polymerase II-specific', 'nucleic acid binding', 'DNA binding', 'DNA-binding transcription factor activity', 'binding', 'organic cyclic compound binding', 'transcription regulator activity', 'heterocyclic compound binding', 'GTF2I-like repeat', 'Ribonuclease H-like superfamily', 'GTF2I-like repeat superfamily', 'Alternative splicing', 'DNA-binding', 'Nucleus', 'Polymorphism', 'Repeat', 'Transcription', 'Transcription regulation', 'Williams-Beuren syndrome', 'Disease', 'GTF2I-like repeat', 'nucleobase-containing compound metabolic process', 'transcription, DNA-templated', 'regulation of transcription, DNA-templated', 'regulation of transcription by RNA polymerase II', 'cellular aromatic compound metabolic process', 'nitrogen compound metabolic process', 'multicellular organism development', 'metabolic process', 'biosynthetic process', 'macromolecule biosynthetic process', 'regulation of biosynthetic process', 'cellular process', 'gene expression', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'RNA metabolic process', 'heterocycle biosynthetic process', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'aromatic compound biosynthetic process', 'regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'multicellular organismal process', 'developmental process', 'RNA biosynthetic process', 'cellular nitrogen compound metabolic process', 'cellular macromolecule biosynthetic process', 'nucleobase-containing compound biosynthetic process', 'macromolecule metabolic process', 'cellular metabolic process', 'primary metabolic process', 'cellular biosynthetic process', 'cellular macromolecule metabolic process', 'cellular nitrogen compound biosynthetic process', 'heterocycle metabolic process', 'anatomical structure development', 'regulation of biological process', 'regulation of cellular process', 'regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'regulation of macromolecule metabolic process', 'biological regulation', 'organic substance metabolic process', 'regulation of primary metabolic process', 'nucleic acid metabolic process', 'nucleic acid-templated transcription', 'organic cyclic compound metabolic process', 'organic cyclic compound biosynthetic process', 'organic substance biosynthetic process', 'regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'zinc finger']",PEQKQVFANPSPTQKSPVQPVEDLAGNLWEKLREKIRSFVAYSIAIDEITDINNTTQLAIFIRGVDENFDVSEELLDTVPMTGTKSGNEIFLRVEKSLKKFCINWSRLVSVASTGTPAMVDANNGLVTKLKSRVATFCKGAELKSICCIIHPESLCAQKLKMDHVMDVVVKSVNWICSRGLNHSEFTTLLYELDSQYGSLLYYTEIKWLSRGLVLKRFFESLEEIDSFMSSRGKPLPQLSSIDWIRDLAFLVDMTMHLNALNISLQGHSQIVTQMYDLIRAFLAKLCLWETHLTRNNLAHFPTLKLVSRNESDGLNYIPKIAELKTEFQKRLSDFKLYESELTLFSSPFSTKIDSVHEELQMEVIDLQCNTVLKTKYDKVGIPEFYKYLWGSYPKYKHHCAKILSMFGSTYICEQLFSIMKLSKTKYCSQLKDSQWDSVLHIAT,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Sequence submitted into the processing queue</title>
<meta http-equiv=""refresh"" content=""3;url=job_status.pl?jobid=184147158237401701597370396LApUNOyfNV"" />
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
<h2>Job 184147158237401701597370396LApUNOyfNV entered our processing queue at <span style=""background:red;font-weight:bold"">position 12</span>.</h2>
You will be redirected to your job's status page in a few seconds. If your browser doesn't support redirection, <a href='job_status.pl?jobid=184147158237401701597370396LApUNOyfNV'>click here</a>. 
",chr7:74798013_G_A,17.98,-1,HGNC,T,protein_coding,HGNC:30775,ENST00000451013,ENSG00000196275,['stop_gained'],GTF2IRD2,,500,,1689,,1499,0.055,0.024,,probably_damaging,,0.997,0.498,,,0.042,,0.672,0.07,tolerated,1689,,S/*,500,,tCa/tAa,T,1.951,0.026,1499,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NCF1, NCF2"
chrX,104013292,104013293,T,C,H2BFWT,ENST00000611083,2017-01-02 00:00:00,cAc/cGc,H/R,123/175,MODERATE,MED,benign,".,.",None,None,".,.",rs553509,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000123569,"H2B histone family member W, testis specific",['Predicted intracellular proteins'],None,{'testis': '3.2'},0,0,0,0,0,0,0,0,0.2,0,0,0,0,"H2AFV,HIST2H2AC,HIST2H2AC,HIST1H2AD,HIST1H2AD,HIST1H2AD,H2BFWT,H2BFWT,H2BFWT,H2BFWT,H2AFY2,H2AFY,H2AFY,H2AFY,H2AFY,HIST2H2AA3,HIST2H2AA3,HIST2H2AA3,HIST2H2AA3,HIST2H2AA3,HIST1H2AL,HIST1H2AL,HIST1H2AL,HIST1H2AL,HIST1H2AL,HIST1H2AL,HIST1H2AL,H2AFB3,H2AFB3,H2AFB1,H2AFB1,H2AFB1,H2AFB1,H2AFB1,H2AFB1","H2AFZ,H2AFZ,H2AFV,H2AFZ,H2AFV,HIST2H2AC,H2AFZ,H2AFV,HIST2H2AC,HIST1H2AD,H2BFWT,H2AFZ,HIST2H2AC,H2BFWT,H2AFY2,H2AFZ,H2AFV,HIST2H2AC,H2BFWT,H2AFY,H2AFZ,H2AFV,HIST2H2AC,H2BFWT,H2AFY2,H2AFY,HIST2H2AA3,H2AFZ,H2BFWT,H2AFZ,H2AFV,HIST2H2AC,HIST1H2AD,H2BFWT,H2AFB3","[0.010288, 0.044512, 0.02907, 0.010282, 0.00951600000000001, 0.003162, 0.416, 0.233, 0.264, 0.325, 0.447, 0.04788, 0.029025, 0.327, 0.02367, 0.045368, 0.029692, 0.00892800000000001, 0.284, 0.02921, 0.03267, 0.018815, 0.011016, 0.213, 0.01372, 0.023312, 0.010256, 0.114912, 0.417, 0.143824, 0.08484, 0.06968, 0.030602, 0.604, 0.00848000000000001]","['chromatin', 'nucleosome', 'intracellular', 'cell', 'nucleus', 'nuclear envelope', 'chromosome', 'endomembrane system', 'membrane', 'organelle membrane', 'nuclear membrane', 'organelle envelope', 'envelope', 'protein-containing complex', 'protein-DNA complex', 'organelle', 'membrane-bounded organelle', 'non-membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular non-membrane-bounded organelle', 'organelle part', 'intracellular part', 'chromosomal part', 'nuclear part', 'intracellular organelle part', 'cell part', 'DNA packaging complex', 'nucleic acid binding', 'DNA binding', 'binding', 'protein binding', 'protein heterodimerization activity', 'protein dimerization activity', 'organic cyclic compound binding', 'heterocyclic compound binding', 'Histone H2B', 'Histone H2A/H2B/H3', 'Histone-fold', 'Chromosome', 'DNA-binding', 'Membrane', 'Nucleus', 'Nucleosome core', 'Polymorphism', 'Core histone H2A/H2B/H3/H4', 'DNA packaging', 'chromatin organization', 'chromatin assembly or disassembly', 'nucleosome assembly', 'organelle organization', 'cellular process', 'cellular component organization', 'cellular component assembly', 'chromatin assembly', 'cellular protein-containing complex assembly', 'nucleosome organization', 'protein-containing complex subunit organization', 'cellular component biogenesis', 'chromosome organization', 'protein-containing complex assembly', 'protein-DNA complex assembly', 'DNA conformation change', 'protein-DNA complex subunit organization', 'cellular component organization or biogenesis', 'Histone H2B']",MLRTEVPRLPRSTTAIVWSCHLMATASAMAGPSSETTSEEQLITQEPKEANSTTSQKQSKQRKRGRHGPRRCHSNCRGDSFATYFRRVLKQVHQGLSLSREAVSVMDSLVHDILDRIATEAGRLARSTKRQTITAWETRMAVRLLLPGQMGKLAESEGTKAVLRTSLYAIQQQRK,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=H2B
START=71
END=167
EVALUE=6.37311690917282e-29
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chrX:104013293_T_C,0.001,-1,HGNC,C,protein_coding,HGNC:27252,ENST00000611083,ENSG00000123569,['missense_variant'],H2BW1,".,.",123,".,.",368,".,.",368,"0.085,0.082",0,".,.",benign,".,.",0,-4.379,".,.",".,.",0,".,.",-5.551,1,tolerated,368,".,.",H/R,123,".,.",cAc/cGc,"T,T",0.052,0.93,368,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr2,171976273,171976274,T,C,HAT1,ENST00000264108,2017-09-11 00:00:00,gTg/gCg,V/A,314/419,MODERATE,MED,benign,tolerated,None,None,.,rs73976541,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000144891,Angiotensin II receptor type 1,"['Disease related genes', 'FDA approved drug targets', 'G-protein coupled receptors', 'Predicted membrane proteins', 'Transporters']",None,"{'liver': '29.6', 'placenta': '44.9'}",5.5,0,0.5,0,1,0.7,1.7,0,0,0,0,0,0,"NASP,ASF1B,ASF1B,HAT1,HAT1,HAT1,HIST1H4C,HIST1H4C,HIST1H4C,HIST1H4C,RBBP7,RBBP7,RBBP7,RBBP7,RBBP7,HIST4H4,HIST4H4,HIST4H4,HIST4H4,HIST4H4,HIST4H4,HIST2H4A,HIST2H4A,HIST2H4A,HIST2H4A,HIST2H4A,HIST2H4A,HIST2H4A,HIST1H4A,HIST1H4A,HIST1H4A,HIST1H4A,HIST1H4A,HIST1H4A,HIST1H4A,HIST1H4A,HIST1H4I,HIST1H4I,HIST1H4I,HIST1H4I,HIST1H4I,HIST1H4I,HIST1H4I,HIST1H4I,HIST1H4I,HIST1H4E,HIST1H4E,HIST1H4E,HIST1H4E,HIST1H4E,HIST1H4E,HIST1H4E,HIST1H4E,HIST1H4E,HIST1H4E","ASF1A,ASF1A,NASP,ASF1A,NASP,ASF1B,ASF1A,NASP,ASF1B,HAT1,ASF1A,NASP,ASF1B,HAT1,HIST1H4C,ASF1A,NASP,ASF1B,HAT1,HIST1H4C,RBBP7,ASF1A,NASP,ASF1B,HAT1,HIST1H4C,RBBP7,HIST4H4,ASF1A,NASP,ASF1B,HAT1,HIST1H4C,RBBP7,HIST4H4,HIST2H4A,ASF1A,NASP,ASF1B,HAT1,HIST1H4C,RBBP7,HIST4H4,HIST2H4A,HIST1H4A,ASF1A,NASP,ASF1B,HAT1,HIST1H4C,RBBP7,HIST4H4,HIST2H4A,HIST1H4A,HIST1H4I","[0.728, 0.024244, 0.735, 0.68, 0.824, 0.695, 0.424, 0.391, 0.371, 0.927, 0.538, 0.697, 0.516, 0.753, 0.759, 0.424, 0.39, 0.371, 0.927, 0.00681600000000001, 0.759, 0.424, 0.391, 0.371, 0.927, 0.00681600000000001, 0.759, 0.00681600000000001, 0.424, 0.391, 0.371, 0.927, 0.00681600000000001, 0.759, 0.00681600000000001, 0.00681600000000001, 0.424, 0.391, 0.371, 0.927, 0.00681600000000001, 0.759, 0.00681600000000001, 0.00681600000000001, 0.00681600000000001, 0.425, 0.39, 0.371, 0.927, 0.00681600000000001, 0.759, 0.00681600000000001, 0.00681600000000001, 0.00681600000000001, 0.00681600000000001]","['nuclear chromosome', 'chromatin', 'nuclear chromatin', 'intracellular', 'cell', 'nucleus', 'nucleoplasm', 'chromosome', 'cytoplasm', 'nuclear matrix', 'membrane-enclosed lumen', 'nuclear lumen', 'protein-containing complex', 'nuclear periphery', 'organelle', 'membrane-bounded organelle', 'non-membrane-bounded organelle', 'intracellular organelle', 'intracellular membrane-bounded organelle', 'intracellular non-membrane-bounded organelle', 'organelle lumen', 'organelle part', 'intracellular part', 'chromosomal part', 'nuclear part', 'intracellular organelle part', 'nuclear chromosome part', 'cell part', 'intracellular organelle lumen', 'catalytic activity', 'histone acetyltransferase activity', 'binding', 'protein binding', 'N-acetyltransferase activity', 'H4 histone acetyltransferase activity', 'acetyltransferase activity', 'N-acyltransferase activity', 'transferase activity', 'transferase activity, transferring acyl groups', 'transferase activity, transferring acyl groups other than amino-acyl groups', 'peptide N-acetyltransferase activity', 'histone binding', 'peptide-lysine-N-acetyltransferase activity', 'Acyl-CoA N-acyltransferase', 'Acetylation', 'Acyltransferase', 'Alternative splicing', 'Nucleus', 'Phosphoprotein', 'Polymorphism', 'Transferase', 'Cytoplasm', 'DNA packaging', 'chromatin organization', 'chromatin assembly or disassembly', 'nucleosome assembly', 'DNA replication-dependent nucleosome assembly', 'DNA replication-independent nucleosome assembly', 'chromatin silencing', 'chromatin silencing at telomere', 'regulation of transcription, DNA-templated', 'cellular protein modification process', 'protein acetylation', 'internal protein amino acid acetylation', 'nitrogen compound metabolic process', 'organelle organization', 'response to nutrient', 'metabolic process', 'response to external stimulus', 'regulation of biosynthetic process', 'negative regulation of biosynthetic process', 'negative regulation of metabolic process', 'cellular process', 'response to extracellular stimulus', 'regulation of gene expression', 'regulation of macromolecule biosynthetic process', 'negative regulation of macromolecule biosynthetic process', 'negative regulation of macromolecule metabolic process', 'negative regulation of gene expression', 'cellular component organization', 'gene silencing', 'covalent chromatin modification', 'histone modification', 'histone acetylation', 'peptidyl-amino acid modification', 'peptidyl-lysine modification', 'internal peptidyl-lysine acetylation', 'peptidyl-lysine acetylation', 'regulation of nucleobase-containing compound metabolic process', 'regulation of metabolic process', 'protein metabolic process', 'cellular component assembly', 'regulation of cellular metabolic process', 'negative regulation of cellular metabolic process', 'regulation of cellular biosynthetic process', 'negative regulation of cellular biosynthetic process', 'chromatin assembly', 'response to nutrient levels', 'chromatin organization involved in regulation of transcription', 'cellular protein-containing complex assembly', 'DNA replication-dependent nucleosome organization', 'DNA replication-independent nucleosome organization', 'nucleosome organization', 'protein modification process', 'regulation of gene expression, epigenetic', 'response to chemical', 'macromolecule metabolic process', 'macromolecule modification', 'protein acylation', 'protein-containing complex subunit organization', 'histone H4 acetylation', 'cellular component biogenesis', 'cellular metabolic process', 'primary metabolic process', 'cellular macromolecule metabolic process', 'cellular protein metabolic process', 'negative regulation of gene expression, epigenetic', 'negative regulation of transcription, DNA-templated', 'negative regulation of nucleobase-containing compound metabolic process', 'negative regulation of biological process', 'negative regulation of cellular process', 'regulation of biological process', 'regulation of cellular process', 'response to stimulus', 'regulation of nitrogen compound metabolic process', 'negative regulation of nitrogen compound metabolic process', 'regulation of RNA metabolic process', 'negative regulation of RNA metabolic process', 'chromosome organization', 'regulation of macromolecule metabolic process', 'protein-containing complex assembly', 'protein-DNA complex assembly', 'biological regulation', 'DNA conformation change', 'organic substance metabolic process', 'protein-DNA complex subunit organization', 'cellular component organization or biogenesis', 'regulation of primary metabolic process', 'chromatin organization involved in negative regulation of transcription', 'organonitrogen compound metabolic process', 'negative regulation of RNA biosynthetic process', 'regulation of nucleic acid-templated transcription', 'negative regulation of nucleic acid-templated transcription', 'regulation of cellular macromolecule biosynthetic process', 'negative regulation of cellular macromolecule biosynthetic process', 'regulation of RNA biosynthetic process', 'HATs acetylate histones', 'Chromatin modifying enzymes', 'Chromatin organization']",MFRVEYASKVDENFDCVEADDVEGKIRQIIPPGFCTNTNDFLSLLEKEVDFKPFGTLLHTYSVLSPTGGENFTFQIYKADMTCRGFREYHERLQTFLMWFIETASFIDVDDERWHYFLVFEKYNKDGATLFATVGYMTVYNYYVYPDKTRPRVSQMLILTPFQGQGHGAQLLETVHRYYTEFPTVLDITAEDPSKSYVKLRDFVLVKLCQDLPCFSREKLMQGFNEDMAIEAQQKFKINKQHARRVYEILRLLVTDMSDAEQYRSYRLDIKRRLISPYKKKQRDLAKMRKCLRPEELTNQMNQIEISMQHEQLEESFQELVEDYRRVIERLAQE,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Too many jobs from this IP</title>
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
<h2>This machine (184147158237) already has 4 or more jobs in the queue...</h2>
<p>Please wait until they finish before submitting more jobs</p>
</div><div id=""footer"">
<div style=""float:left"">&copy; 2019 EMBL | <a href='https://www.embl.de/aboutus/privacy_policy/index.html'>Privacy Policy</a></div>Send comments to <a href=""http://www.letunic.com"">Ivica Letunic</a></div>
<script type=""text/javascript"">
  var _paq = _paq || [];
  _paq.push(['trackPageView']);
  _paq.push(['enableLinkTracking']);
  (function() {
    var u=""//tr-denbi.embl.de/heimdall/"";
    _paq.push(['setTrackerUrl', u+'p.php']);
    _paq.push(['setSiteId', '5']);
    var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
    g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'p.js'; s.parentNode.insertBefore(g,s);
  })();
</script>
</body></html>
",chr2:171976274_T_C,16.71,1,HGNC,C,protein_coding,HGNC:4821,ENST00000264108,ENSG00000128708,['missense_variant'],HAT1,,314,,981,,941,0.162,0.917,,benign,,0,-0.845,,,0.694,,-0.233,1,tolerated,981,,V/A,314,,gTg/gCg,T,1.474,0.86,941,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,32553076,32553077,A,G,HLA-DRB6,ENST00000411500,,,,,LOW,MED,,,None,None,.,rs73729138,None,None,rs6927022,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",DTLDFSQQ,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Error</title>
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
You've put a too short or no sequence in.</div><div id=""footer"">
<div style=""float:left"">&copy; 2019 EMBL | <a href='https://www.embl.de/aboutus/privacy_policy/index.html'>Privacy Policy</a></div>Send comments to <a href=""http://www.letunic.com"">Ivica Letunic</a></div>
<script type=""text/javascript"">
  var _paq = _paq || [];
  _paq.push(['trackPageView']);
  _paq.push(['enableLinkTracking']);
  (function() {
    var u=""//tr-denbi.embl.de/heimdall/"";
    _paq.push(['setTrackerUrl', u+'p.php']);
    _paq.push(['setSiteId', '5']);
    var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
    g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'p.js'; s.parentNode.insertBefore(g,s);
  })();
</script>
</body></html>
",chr6:32553077_A_G,6.264,-1,HGNC,G,processed_transcript,HGNC:4954,ENST00000411500,ENSG00000229391,"['splice_region_variant', 'intron_variant', 'non_coding_transcript_variant']",HLA-DRB6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,105840504,105840505,T,C,IGHD,ENST00000613640,2017-05-06 00:00:00,Agg/Ggg,R/G,330/384,LOW,MED,benign,tolerated,None,None,Immunoglobulin C1-set&Immunoglobulin-like domain&Immunoglobulin C1-set,rs709589,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000099904,Zinc finger DHHC-type containing 8,"['Enzymes', 'Predicted membrane proteins']",None,None,9.9,11.6,13.9,15.4,7,11.2,15.9,2,4.1,4,1.5,1.3,2.5,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",GTTGT,"<!DOCTYPE html PUBLIC ""-//W3C//DTD XHTML 1.0 Strict//EN""
    ""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"">
<html xmlns=""http://www.w3.org/1999/xhtml"" lang=""en"" xml:lang=""en"">
 <head>
<title>SMART: Error</title>
  <meta http-equiv=""Content-Type"" content=""text/html; charset=iso-8859-1"" />
   <script type=""text/javascript"" src=""/js/overlib.js""></script>
   <script type=""text/javascript"" src=""/js/jquery-1.7.1.min.js""></script>
   <script type=""text/javascript"" src=""/js/kendo.web.min.js""></script>
   <script type=""text/javascript"" src=""/js/zeroclipboard.js""></script>
   <script type=""text/javascript"" src=""/js/humane.min.js""></script>
   <link rel=""stylesheet"" type=""text/css"" href=""/css/kendo.common.min.css"" media=""screen"" />
   <link rel=""stylesheet"" type=""text/css"" href=""/css/humane-bigbox.css"" media=""screen"" />
   <script type=""text/javascript"" src=""/js/scripts.js""></script>
<link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/css/kendo.smart.css"" /><link rel=""stylesheet"" type=""text/css"" media=""screen"" href=""/smart.css"" />
 </head>  
 <body>
 <div id=""overDiv"" style=""position:absolute; visibility:hidden; z-index:1000;""></div>
<div id='cHelper' style='position:absolute; left:-2000px; top:-2000px'></div>
  <div id=""header"">
        <div id='searchBox'>
          <form method=""get"" action=""/smart/search.cgi""><input type='text' style='width: 100px' name='keywords' value='keywords...' onblur=""if (this.value=='') {this.value='keywords...';} return cClick();"" onfocus=""if (this.value=='keywords...') this.value=''; return overlib('Type the search terms and press enter.', STICKY)"" /><br /><input style='width: 100px!important;' class='inpB' type='submit' value='Search SMART'/></form>
        </div>

   <div id=""textlogo"">
<img src='/images/smart_l2.png' alt='l2' />
<!--    <span class=""logoH1"">S</span><span class=""logoT2"">imple</span><br />
     <span class=""logoH2"">M</span><span class=""logoT1"">odular</span><br />
      <span class=""logoH1"">A</span><span class=""logoT2"">rchitecture</span><br />
       <span class=""logoH2"">R</span><span class=""logoT1"">esearch</span><br />
	<span class=""logoH1"">T</span><span class=""logoT2"">ool</span><br />
-->
      </div>
      <div id=""queueBox"">
	  <a href=""/smart/change_mode.pl"">SMART MODE:</a>
	<p>
<span class=""selectedmode"">NORMAL</span> <a href=""/smart/set_mode.cgi?GENOMIC=1"">GENOMIC</a>
	</p>
      </div>
      <a href=""/"">
<img src=""/images/new_logo2.png"" alt=""SMART"" />      </a>
    <p>
      Letunic et al. (2014) <em>Nucleic Acids Res</em> <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25300481"" rel=""external"">doi: 10.1093/nar/gku949</a><br/>
      Letunic et al. (2017) <em>Nucleic Acids Res</em> <a href=""https://academic.oup.com/nar/article-abstract/doi/10.1093/nar/gkx922/4429069/20-years-of-the-SMART-protein-domain-annotation"" rel=""external"">doi: 10.1093/nar/gkx922</a>
    </p>
    <ul>
     <li><a href=""/"">HOME</a></li>
     <li><a href=""/smart/save_user_preferences.pl"">SETUP</a></li>
     <li><a href=""/help/FAQ.shtml"">FAQ</a></li>
     <li><a href=""/help/smart_about.shtml"">ABOUT</a></li>
     <li><a href=""/help/smart_glossary.shtml"">GLOSSARY</a></li>
     <li><a href=""/help/latest.shtml"">WHAT'S NEW</a></li>
     <li><a href=""/help/feedback.shtml"">FEEDBACK</a></li>
    </ul>
  </div>
<div id=""mainbody"">
Looks like you submited a DNA or RNA sequence. SMART annotates PROTEIN domains. Please resubmit the corresponding protein sequence.<p></div><div id=""footer"">
<div style=""float:left"">&copy; 2019 EMBL | <a href='https://www.embl.de/aboutus/privacy_policy/index.html'>Privacy Policy</a></div>Send comments to <a href=""http://www.letunic.com"">Ivica Letunic</a></div>
<script type=""text/javascript"">
  var _paq = _paq || [];
  _paq.push(['trackPageView']);
  _paq.push(['enableLinkTracking']);
  (function() {
    var u=""//tr-denbi.embl.de/heimdall/"";
    _paq.push(['setTrackerUrl', u+'p.php']);
    _paq.push(['setSiteId', '5']);
    var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
    g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'p.js'; s.parentNode.insertBefore(g,s);
  })();
</script>
</body></html>
",chr14:105840505_T_C,4.49,-1,HGNC,G,protein_coding,HGNC:5480,ENST00000613640,ENSG00000211898,['synonymous_variant'],IGHD,,330,,988,,988,,0,,benign,,0,-2.203,,,0.002,,-1.047,1,tolerated,988,,R,330,,Agg/Cgg,,-1.138,0,988,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,106538006,106538007,T,G,IGHG1,ENST00000618756,2017-02-13 00:00:00,gaA/gaC,E/D,52/475,missense_variant,MED,benign,tolerated,None,None,.,rs35005563,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=4

DOMAIN=IGc1
START=22
END=93
EVALUE=3.78724713173402e-13
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=62
END=76
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=IG_like
START=139
END=214
EVALUE=0.019818089622508
TYPE=SMART
STATUS=visible|OK

DOMAIN=IGc1
START=245
END=318
EVALUE=1.2052663544563e-38
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr14:106538007_T_G,0.007,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,105855557,105855558,C,T,IGHM,ENST00000390559,2017-02-04 00:00:00,Ggc/Agc,G/S,191/453,MODERATE,MED,benign,tolerated,None,None,.,rs1059216,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,ENSG00000125755,Symplekin,"['Plasma proteins', 'Predicted intracellular proteins']","['Cell adhesion', 'mRNA processing']",None,18.2,18.6,17.4,27.2,12.2,18,19.4,7.9,9.2,6.5,7.1,4.2,5.2,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MASAAVESFVTKQLDLLELERDAEVEERRSWQENISLKELQSRGVCLLKLQVSSQRTGLYGRLLVTFEPRRYGSAAALPSNSFTSGDIVGLYDAANEGSQLATGILTRVTQKSVTVAFDESHDFQLSLDRENSYRLLKLANDVTYRRLKKALIALKKYHSGPASSLIEVLFGRSAPSPASEIHPLTFFNTCLDTSQKEAVLFALSQKELAIIHGPPGTGKTTTVVEIILQAVKQGLKVLCCAPSNIAVDNLVERLALCKQRILRLGHPARLLESIQQHSLDAVLARSDSAQIVADIRKDIDQVFVKNKKTQDKREKSNFRNEIKLLRKELKEREEAAMLESLTSANVVLATNTGASADGPLKLLPESYFDVVVIDECAQALEASCWIPLLKARKCILAGDHKQLPPTTVSHKAALAGLSLSLMERLAEEYGARVVRTLTVQYRMHQAIMRWASDTMYLGQLTAHSSVARHLLRDLPGVAATEETGVPLLLVDTAGCGLFELEEEDEQSKGNPGEVRLVSLHIQALVDAGVPARDIAVVSPYNLQVDLLRQSLVHRHPELEIKSVDGFQGREKEAVILSFVRSNRKGEVGFLAEDRRINVAVTRARRHVAVICDSRTVNNHAFLKTLVEYFTQHGEVRTAFEYLDDIVPENYSHENSQGSSHAATKPQGPATSTRTGSQRQEGGQEAAAPARQGRKKPAGKSLASEAPSQPSLNGGSPEGVESQDGVDHFRAMIVEFMASKKMQLEFPPSLNSHDRLRVHQIAEEHGLRHDSSGEGKRRFITVSKRAPRPRAALGPPAGTGGPAPLQPVPPTPAQTEQPPREQRGPDQPDLRTLHLERLQRVRSAQGQPASKEQQASGQQKLPEKKKKKAKGHPATDLPTEEDFEALVSAAVKADNTCGFAKCTAGVTTLGQFCQLCSRRYCLSHHLPEIHGCGERARAHARQRISREGVLYAGSGTKNGSLDPAKRAQLQRRLDKKLSELSNQRTSRRKERGT,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=13

DOMAIN=coiled_coil_region
START=12
END=35
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=low_complexity_region
START=148
END=157
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=DEXDc
START=188
END=447
EVALUE=0.00107632142394481
TYPE=SMART
STATUS=visible|OK

DOMAIN=AAA
START=206
END=375
EVALUE=1.04275594070466e-05
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=214
END=223
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=coiled_coil_region
START=306
END=341
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=320
END=335
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=599
END=610
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=R3H
START=706
END=785
EVALUE=3.45937550581453e-23
TYPE=SMART
STATUS=visible|OK

DOMAIN=low_complexity_region
START=785
END=815
EVALUE=0
TYPE=INTRINSIC
STATUS=hidden|overlap

DOMAIN=low_complexity_region
START=864
END=870
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

DOMAIN=ZnF_AN1
START=897
END=937
EVALUE=4.69852219282368e-10
TYPE=SMART
STATUS=visible|OK

DOMAIN=coiled_coil_region
START=964
END=989
EVALUE=0
TYPE=INTRINSIC
STATUS=visible|OK

-- FINISHED --
",chr14:105855558_C_T,16.28,-1,HGNC,T,IG_C_gene,HGNC:5541,ENST00000390559,ENSG00000211899,['missense_variant'],IGHM,,191,,571,,571,,,,benign,,0,,,,,,,1,tolerated,571,,G/S,191,,Ggc/Agc,,,,571,['cds_start_NF'],,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,106507392,106507393,A,G,IGHV1-45,ENST00000390621,2017-01-02 00:00:00,gTc/gCc,V/A,14/117,missense_variant,MED,benign,tolerated,None,None,.,.,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MDWTWRILFLVAAVTDAYSQMQLVQSGAEVKKTGSSVKVSCKASGYTFTYRYLHWVRQAPGQALEWMGWITPFNGNTNYAQKFQDRVTITRDRSMSTAYMELSSLRSEDTAMYYCAR,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=IGv
START=36
END=117
EVALUE=1.16139225888261e-31
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr14:106507393_A_G,6.903,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,106129663,106129664,G,T,IGHV3-13,ENST00000390602,2017-02-02 00:00:00,Cca/Aca,P/T,76/116,MODERATE,MED,benign,tolerated_low_confidence,None,None,.,rs11625174,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MELGLSWVFLVAILEGVQCEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDPYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCAR,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=IGv
START=36
END=116
EVALUE=1.16139225888261e-31
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr14:106129664_G_T,6.783,-1,HGNC,T,IG_V_gene,HGNC:5581,ENST00000390602,ENSG00000211942,['missense_variant'],IGHV3-13,,76,,306,,226,,,,benign,,0,,,,,,,1,tolerated_low_confidence,306,,P/T,76,,Cca/Aca,,,,226,['cds_end_NF'],,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,106268888,106268889,C,A,IGHV3-23,ENST00000390609,2017-02-02 00:00:00,Gtg/Ttg,V/L,24/117,missense_variant,MED,benign,tolerated_low_confidence,None,None,.,.,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MEFGLSWLFLVAILKGVQCEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAK,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=IGv
START=36
END=117
EVALUE=2.46838547872276e-35
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr14:106268889_C_A,13.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,106557128,106557129,C,A,IGHV3-49,ENST00000613477,2017-02-02 00:00:00,Gtc/Ttc,V/F,45/114,missense_variant,MED,benign,deleterious_low_confidence,None,None,.,rs2073674,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MEFGLSWVFLVAILKGVQCEVQLVESGGGLVQPGRSLRLSCTASGFTFGDYAMSWVRQAPGKGLEWVGFIRSKAYGGTTEYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYCTR,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=IGv
START=36
END=119
EVALUE=4.86230237567059e-34
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr14:106557129_C_A,9.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,106592949,106592950,T,A,IGHV3-53,ENST00000390627,2017-02-02 00:00:00,Act/Tct,T/S,26/116,MODERATE,MED,benign,tolerated_low_confidence,None,None,.,rs2731154,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MEFWLSWVFLVAISKGVQCEVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=IGv
START=36
END=116
EVALUE=3.54428792919109e-36
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr14:106592950_T_A,9.352,-1,HGNC,C,IG_V_gene,HGNC:5610,ENST00000390627,ENSG00000211967,['missense_variant'],IGHV3-53,,26,,297,,76,,,,benign,,0.003,,,,,,,0,deleterious_low_confidence,297,,T/A,26,,Act/Gct,,,,76,['cds_end_NF'],,,,,,,,,,,,,,,,,,,,,,,,,,,,
chr14,106593085,106593086,G,A,IGHV3-53,ENST00000390627,2017-01-02 00:00:00,tCa/tTa,S/L,14/116,missense_variant,MED,benign,tolerated_low_confidence,None,None,.,.,None,None,None,0,None,None,None,None,None,TSK_13633_015415,AR,,,,,,,,,,,,,,,,,,,"nan,nan","nan,nan","[nan, nan]","[nan, nan]",MEFWLSWVFLVAISKGVQCEVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR,"-- SMART RESULT TEXTFORMAT --

CRC_PASSED=1
NUMBER_OF_FEATURES_FOUND=1

DOMAIN=IGv
START=36
END=116
EVALUE=3.54428792919109e-36
TYPE=SMART
STATUS=visible|OK

-- FINISHED --
",chr14:106593086_G_A,7.664,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,